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SUMMARY
Published studies on morbidity and mortality associated with HIV 
infection have focused on patients with AIDS or advanced HIV disease and 
on "oppoitunistic diseases". But morbidity and mortality can be increased 
even in the very early years of HIV infection. The aim of this thesis is to 
document the early natur al history of HIV infection.
A medical clinic for the car e of HIV infected patients was established in 
Edinburgh in October 1985. By November 1989, 409 patients had attended 
this clinic and most were under regular follow up. Most patients were 
injection drug users (IDUs) accounting for 78% attenders, 12% were 
homosexual men, 7% were infected heterosexually, 1% fr om blood products 
and in 2% there were no documented risk factors. Most of the IDUs 
acquired HIV infection between September 1983 and June 1984 and are a 
unique cohort for prospective natural history studies. The other clinic 
attenders provide a valuable comparison group.
The first four' year s of the clinic were chosen as the cut off point for early 
natural history, being six years after the introduction of HIV into the IDU 
population of Edinburgh. Morbidity was assessed by hospital admissions. 
All hospital admissions by HIV positive patients in Edinbmgh were 
analysed. These included admissions to the designated HIV unit and to all 
other general and psychiatric hospitals in Edinburgh. All deaths before 
November 1989 were analysed, whether they occurred in hospital or at home 
and all post mortem results were obtained.
By November 1989, 910 admissions were recorded. Although 612 of 
these were to the designated HIV unit, 298 were to other hospitals in 
Edinburgh. IDUs accounted for 702 (77%) admissions, homosexual men for 
136 (15%), patients with heterosexually acquired HIV infection for 62 (7%)
and recipients of blood products for 10 (1%). The most frequent admissions 
were for conditions directly related to drug use. These comprised overdose, 
trauma, injection injuries and detoxification and accounted for 220 
admissions. From comparisons with published data this number is in excess 
of what would be expected in a historical cohort of HIV negative IDUs. 
Most days in hospital were used by patients with respiratory conditions (187 
admissions). These were the single commonest reason for admission to the 
designated HIV unit. The majority (97) were for bacterial chest infections 
(BCIs) and only 48 were with Pneumocystis carinii pneumonia (PCP). Of 
these 48 admissions, seven had a concomitant BCI. Differentiating BCIs and 
PCP clinically was difficult, as was the diagnosis of PCP in IDUs. A clinical 
algoritlrm was therefore drawn up for the management and investigation of 
IDUs presenting with respiratory symptoms and a separate study of the use 
of induced sputum techniques was conducted. This latter study confirmed 
the value of these techniques, obviating the need for bronchoscopy, the usual 
"gold standard".
Most of the patients admitted did not have AIDS (only 32% admissions to 
the designated HIV unit had AIDS), and most had disease classed as 
"asymptomatic" by the 1987 CDC staging system (40% of admissions to the 
designated HIV unit had CDC disease stage 2 or 3).
A total of 189 admissions were with bacterial infections. Most of these 
were chest and urinary tract infections and pelvic inflammatory disease. 
IDUs and women were disproportionately represented amongst these 
admissions and most of these admissions were in patients with CDC stage 2 
or 3 disease. A fiuther study was caixied out to assess the prevalence of 
bacteriuria amongst hospitalised patients. From this, the prevalence of 
asymptomatic bacteriuria was 13% in women and 3% in men, considerably 
higher than expected from studies of HIV negative patients without urinary 
tract abnormalities. Among samples from symptomatic patients, bacteriuria 
was found in 43% women and 6% men.
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Unlike other cohorts of IDUs there was only one admission with 
tuberculosis. This is most likely to be due to the low prevalence of 
tuberculous infection in the UK. A study of the records of tuberculin testing 
and BCG vaccinations given in the schools programme confirmed this to be 
the case. From 310 records matched of patients attending the HIV clinic 
who had records available fiom the Edinburgh schools BCG programme, 243 
had been given BCG. Only nineteen chidren (6%) had evidence of previous 
tuberculous infection and none of these had reactivated by 1994.
Thirly four deaths were recorded before November 1989, of which 19 
were due to AIDS, two to liver disease and 13 were ascribed to drug use. 
Post mortem examination revealed that one of the deaths in the latter 
category was due to a florid meningoencephalitis. Despite the prevalence of 
bacterial infections, no deaths were attributable to tliis. Multiple pathology 
was detected in all patients dying of AIDS, with unexpected findings in eight 
of the nine patients who had post mortem examinations.
These findings demonstr ate a high level of morbidity and mortality even 
in the early years of HIV infection. Most previously published studies have 
focused on homosexual men and patients with advanced HIV disease and 
AIDS. This thesis has the advantage of documenting disease in patients 
hitherto not the focus of research, namely women, IDUs and patients with 
early stage HIV infection. It also provides a complete picture of an epidemic 
in one city, having studied all hospital admissions and deaths. The 
preponderance of bacterial infections as a cause of morbidity is important for 
prevention and prophylaxis. The documentation of health care utilisation is 
vital for planning of futur e resour ces.
11
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General Introduction
The first intimation of the twentieth century pandemic which has been 
described as the gr eatest new public health challenge this century/ was in the 
Morbidity and Mortality Weekly Report of 5 Jime 1981 where five cases of 
Pneumocystis carinii pneumortia (PCP) in homosexual men were described/ 
Following this the Centers for Disease Control (CDC) in Atlanta began 
active suiweillance. The condition was named the acquhed 
immunodeficiency syndrome (AIDS) and the causative vims, a retrovhns, 
now termed the human immunodeficiency vhns (HIV) was identified in 
1983. Antibody testing for HIV became available in 1985. By the end of 
December 1990, 307,379 AIDS cases had been reported by 157 countries to 
the World Health Organisation and an estimated 10 million people were HIV 
infected worldwide.^ The United Kingdom accounted for 4098 of the AIDS 
cases.
The vims is transmitted by sexual intercourse with an infected person, by 
inoculation of infected blood whether by transfusion or by sharing of 
infected needles, and by vertical transmission from mother to child. The 
vims specifically infects and destroys CD4 helper inducer lymphocytes and 
the resulting immunological depression places the patient at risk of 
neoplasms and infections which are not normally seen with an intact immune 
system. These infections are termed opporturnstic infections (OIs) and there 
are certain characteristic infections typical of HIV induced 
immunosupression. A CDC classification for the clinical definition of AIDS 
and HIV infection was introduced in 1986 and revised in 1987 and 1992. -^^  
Other classification systems have been formulated but the CDC system is the 
most widely used and the 1987 version is the one used in this thesis. The 
CDC classification divides HIV infection into foin* stages (figure 1.1). Stage 
1 is primary HIV infection which in some cases is associated with a
14
glandular fever type seroconversion illness. Stage 2 is asymptomatic HIV 
infection and stage 3 describes persistent generalised lympbadenopatby. 
Stage 4 is indicative of symptomatic HIV infection and includes all AIDS 
conditions. Stage 4a was originally termed AIDS-related complex (ARC) 
and describes constitutional symptoms, stage 4b describes neurological 
conditions, stage 4c2 is for "minor" OIs and stage 4e incorporates a variety 
of other conditions including any which the physician feels is indicative of 
symptomatic HIV infection and which is not otherwise itemised. Some 
neurological conditions in stage 4b and some conditions in 4e are AIDS 
defming. Stages 4c 1 and 4d are AIDS defining. Stage 4c 1 describes major 
OIs such as PCP and 4d describes opportunistic tumours such as Kaposi's 
sarcoma and lymphoma. Generally most patients will progress througli the 
four stages although they may present for medical care at any point. The 
time from initial HIV infection to AIDS (progression) and then to death 
(survival) is as yet unknown and varies between individuals.^-^ An 
approximate figur e is that 50% of patients will progress to AIDS within ten 
year s of seroconversion.
Numerous studies are in progress to try to identify the rate of progression 
of HIV disease and any factors, known as cofactors, which may influence 
this. Most good studies come fi om centres car ing for large numbers of AIDS 
patients such as New York or San Francisco and these centres are able to 
produce statistically significant and meaningful results because of the large 
numbers of patients involved. But despite well documented cohorts these 
studies are often limited by the lack of accuiate seroconversion data, 
particularly in cohorts of homosexual men who may not have required 
medical care (and therefore had no blood taken) prior to developing 
symptomatic HIV disease. Seroconversion data are best foimd from cohorts 
of patients infected through blood products, particularly haemophiliac gr oups 
who were often followed prospectively before HIV infection and in whom 
not only the exact date of infection but some idea of the amount of the
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infecting inoculum (by number of units of factor VIII infused) is known. But 
rates of progression may vary between risk groups and accurate data taken 
from one cohort carmot necessarily be extrapolated for use in others. Two 
well studied cohorts are the Royal Free Hospital haemophiliac cohort from 
London and the Edinburgh haemophiliac cohort. " These two cohorts have 
particular relevance for comparison with the City Hospital, Edinburgh cohort 
because they involve primarily Caucasian heterosexual British men who all 
receive theti medical care within the National Health Service system. In the 
Royal Free cohort, 112 HIV positive haemophiliacs have been followed 
prospectively since December 1979. The earliest serum found to be HIV 
positive was on 12 December 1979 and then last seroconversion was 
estimated to be in July 1985.'’ This cohort has found age, druation of HIV 
infection and previous cytomegalovirus infection to be important cofactors 
for progression. " The year' of AIDS diagnosis also has an important 
effect on smwival, mainly as a result of anthetroviral treatment with 
zidovudine (since 1987) and PCP prophylaxis with inhaled pentamidine 
(since 1 9 8 8 ) . importance of the Edinburgh haemophiliac cohort lies 
in the fact that 32 patients with haemophila A who were exposed to the same 
batch of HIV contaminated factor VIII concentrate are being prospectively 
studied; 18 patients seroconverted to become HIV positive, and the 14 who 
did not remain imder observation as a control g r o u p . Studies of this cohort 
have identified that the extent of host immune reactivity, which may be 
genetically deter'mined, can affect p rog ression .S tud ies of HIV infected 
blood transfusion recipients have identified tire clinical state of the blood 
donor, and age as important predictors of disease progression. '^-^^ 
Worldwide, older age has been found to be the most important c o f a c t o r .  
Controversy continues about the importance of previous cytomegalovhus 
infection,27-29 duration of HIV i n f e c t i o n , continued injection di'ug use,^ '-^  ^
and the occmr ence of an HIV seroconversion i l l n e s s .
16
The large American cohorts, in addition to identifying cofactors for 
progression, have identified clinical and laboratory markers as predictors of 
disease progression - important for identifying those patients who might gain 
most fiom early antiretroviral or other therapy. The initial cohort studies are 
fiom San Francisco where many homosexual men were taking part in studies 
of the incidence, prevalence and prophylaxis of hepatitis B infection before 
the advent of HIV.^o The important MACS (Multi Center AIDS Cohort 
Study) study has recruited homosexual men in order to study the 
epidemiology of HIV infection.^^ The San Francisco cohort has identified B2 
microglobulin, packed cell volume, HIV p24 antigenaemia and the 
proportion and number of CD4 lymphocytes as independent and important 
laboratory predictors of clinical progression.^^ Other laboratory markers for 
progression include n e o p t e r i n , b u t  controversy continues over the 
importance of elevated immunoglobulins A and and
thrombocytopenia.^'^^ Some markers such as B2 microglobulin are only of 
use in selected risk g r o u p s . C D 4  lymphocyte counts and percentages, 
although still not yet available in many centres as routine laboratory tests, are 
now widely used as a marker for starting treatment and as sunogate end­
points for clinical t r i a l s . T h e  major limitation of CD4 counts is in their 
variability - due to laboratory factors, prolonged transit time to the 
laboratory, time of day at which the sample was taken and the influence of 
intercuiTent infections. CD4 counts in immunocompetent people can vary by 
as much as 1000 cells/mm^ and the normal range is usually between 500 and 
1500 cells/mm4^ Serial CD4 cormts provide a very valuable guide to 
clinical caie. CD4 counts have been shown to fall by about 80 cells per year 
in HIV infected i n d i v id u a l s .C e r t a in  opportunistic infections have been 
shown to occur below particular' CD4 cut-off points.^? For instance, PCP is 
unlikely to develop at CD4 counts above 200 cells/mm^ ,^ ®'^^  and it is therefore 
now recommended that a CD4 count of 200 cells/mm^ be used as a guide for 
institution of primary PCP prophy lax i s .The  AIDS Clinical Trials Group 
(ACTG) in America base much of their str atification within clinical tr ials on
17
CD4 counts. For instance, in their trial ACTG 019 of asymptomatic HIV 
infected patients randomly assigned to placebo, zidovudine 500mg per day or 
zidovudine 1500mg per day the results were analysed in three groups; 
namely patients with CD4 counts above 500 cells/mm^ those with CD4 
counts between 200 and 500cells/mm3 and those with CD4 counts below 200 
cells/mm4^‘
The antiretroviral ding zidovudine became available in Britain in 1987 and 
has been shown to prolong suivival in patients with AIDS and symptomatic 
HIV i n f e c t i o n . 52-54 Controversy still exists over the benefit of using it in 
patients who are asymptomatic and whose CD4 counts are above 200 
cells/mm\5L55-57 %ts use is limited by its toxic effects of severe anaemia and 
leucopenia, myopathy, headaches and nausea and v o m i t i n g . 58-59 At the time 
of writing, zidovudine is the only licensed antireùoviral ding in Britain but 
trials ar e on-going of other drngs including didanosine (ddl), dideoxycytidine 
(ddC), soluble CD4, immunoglobulin, diethylcarbamazine, interferon and 
vaccine therapy either singly or in combination.
The epidemic among injection ding users
The fii'St evidence of HIV infection in injection ding users (IDUs) came 
from three cases of AIDS in childr en in New York in 1977.^° These babies 
had not received blood transfusions but were bom to mothers known to be 
IDUs. The earliest known case of AIDS in an adult IDU occuned in 1979 in 
a man who was also known to be homosexual. The first five known cases of 
AIDS among heterosexual IDUs occurred in 1980.“ Since then IDU has 
been implicated in thousands of HIV reports worldwide. By the end of 1990 
over 60,000 AIDS cases had been reported in IDUs from more than 25 
coun t r i es .By  1981 HIV was widespread among injectors in New York and
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I t a l y , I t  had spread to South America by 1983, to Australia by 1985 and 
to Asia by 1987/^ In some cities the incidence was more striking than in 
others. In New York, seroprevalence increased fiom less than 20% in 1978 
to over 50% in 1983.“ This was followed by reports fiom Edinburgh of 
seroprevalence of 51% among IDUs by 1985“ and fiom Bangkok where 
seroprevalence increased fiom less than 10% in 1986 to over 40% in 1987.^’ 
By contrast some IDU commimities continue to show low rates of infection. 
In Britain there are some striking regional differences. Glasgow, 70 km fiom 
Edinbmgh, had a seroprevalence rate of less than 4.5% in 1985“ and a report 
from the following year from South London showed a seroprevalence of less 
than 1%.“ Data from Merseyside from 1991 continue to show a zero-rate of 
locally acquired HIV infection.“
Studies comparing risk behaviour between IDU communities with low and 
high rates of HIV infection have been done^ ® but the most elegant studies to 
determine risk factors for acquisition of HIV infection by IDU have been 
among participants in methadone maintenance programmes (MMPs). 
Marmor reported on a 1987 study of 308 IDUs recrnited fiom methadone 
maintenance or drug detoxification programmes in Manhattan, New York 
City, of whom 50.7% were HIV positive.^ The most significant risk factors 
for HIV acquisition were the frequency of drug injection and the proportion 
of injections in “shooting galleries” (places in which drugs bought elsewhere 
can be injected either with rented or with personally owned needles and 
syringes). Schoenbaum studied 452 patients emolled in a methadone 
treatment programme in the Bronx, New York. Almost 4.2% were HIV 
positive and similar* risk factors were identified.^” The most significant were 
the frequency of drug injection (cocaine in particular) and the percentage of 
injections with used or shared needles. In addition, the presence of HIV 
infection was independently associated with being black or Hispanic or of 
low income. The number of heterosexual sex partners who used intravenous 
drugs was associated with HIV infection in women. These risk factors have
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been confiimed in numerous other s t u d i e s D u r  ation of drug use has been 
associated in some studies with acquisition of HIV infection but refuted in 
others.“^^
Following the identification of risk factors for HIV infection, many 
countries have assessed then attempts at risk reduction among IDUs/^ The 
most widely accepted method of risk reduction has been with oral methadone 
substitution, either as maintenance therapy or in a detoxification 
programme/'^ Programmes which have received the most scientific review 
include the Dutch system and the New York programmes. The Dutch system 
of low thr eshold methadone (“methadone by bus”) has led to a stabilisation 
of the number of drug addicts at 20,000 (0.15% of the population) and a 
stable seroprevalence of HIV infection at 30%.^^’^  ^ In the New York system 
the programmes are more restrictive, but many results have shown a marked 
decrease in acquisition of HIV infection once IDUs have entered a 
methadone maintenance programme.®'^ '^^® Needle and syringe exchange 
schemes are generally not legally available in tire United States but have 
been evaluated in the Netherlands and the United Kingdom where they have 
been found to be effective.^”®” “Cleaner injecting” and bleach programmes 
are, however, available in the United States.^ ® In Merseyside where, as 
quoted above, the incidence and prevalence of HIV infection is 0%, 
ampoules and reefers of heroin are prescribed to IDUs.“ Par amount in any 
risk reduction programme is education of those at risk.^’’^,76
The natural history of HIV infection in IDUs has many important 
differences compar ed with other risk groups. Much of this is related to the 
morbidity and mortality of IDU itself, umelated to HIV infection. Before the 
HIV epidemic there were few resources available in most countries for IDUs 
and very little published research on the effects of drug use. In a 1967 
review of the major medical complications of drug addiction Lomia 
estimated that 1% of IDUs in New York City per year died as a result of 
overdose.®' Endocarditis, puhnonaiy emboli, pulmonary fibrosis and
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granulomatosis, lung abscess, pneumonia, hepatitis, tetanus and malaria were 
other medical conditions which gave rise to substantial morbidity and 
mortality.®' In a British study published the following year* Bewley noted 
that there had been a steady increase in the number of addicts notified to the 
Home Office and that British heroin addicts had a mortality rate of 28 times 
that of the general population and twice the reported rate of heroin addicts in 
New York.®^  A subsequent Home Office study of 1499 deaths among IDUs 
in Britain for the years 1967-81 estimated the mortality of drug addicts at 16 
times that of the age and sex matched population - described as “the elusive 
natural history of addiction”.®" More recent studies since the onset of the 
epidemic have identified overdose, violence, endocarditis, cirrhosis and 
septicaemia as causes of excess mortality in IDUs without AIDS.®^ ®^  
Although in these studies the patients did not have AIDS, HIV infection 
without AIDS could affect the natural history of these diseases. In many 
studies the mortality rates due to violence and overdose amongst IDUs have 
stayed stable since the onset of the AIDS e p i d e m i c . E x c e s s  morbidity in 
HIV negative IDUs has been demonstrated particularly for tuberculosis and 
bacterial pneumonia.®® ®^ In Selwyn’s study of 144 HIV positive and 289 HIV 
negative IDUs in a New York methadone maintenance programme, the 
cumulative yearly incidence of pneumococcal pneumonia in seronegative 
IDUs was over eight times that of the general US population.®” Other 
complications of drirg use which result in increased morbidity in IDUs are 
thrombophlebitis and soft tissue infection, bone and joint infection, 
rhabdomyolysis associated with temazepam injection, deep venous 
thrombosis, Candida endophthalmitis and sexually transmitted diseases 
resulting from prostitution.”” ”^  Some complications, such as benzodiazepine 
withdrawal seizures or temazepam injection skin necrosis, are particularly 
common in areas such as Scotland where new drug users are likely to be 
“polydiirg” abusers of phannaceutical drugs such as temazepam, 
buprenorphine, dihydro codeine, cyclizine and dipipanone.”®”^
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Apart from the above non-HIV related complications of drug use (which 
have mainly stayed at a steady state during the AIDS epidemic) the natural 
history of HIV infection itself is different among IDUs.®^  AIDS defining 
illnesses differ among risk groups (such as the preponderance of Kaposi’s 
sarcoma among homosexual men) and oesophageal candidosis, 
cryptococcosis and PCP are more frequent AIDS defining diagnoses in IDUs 
when compared with other risk gr oups.”^  To concentrate on AIDS defining 
diagnoses as evidence of differing natur al history of HIV infection in IDUs 
would miss the wider spectrum of HIV related diseases. In a New York 
analysis of 7884 deaths in IDUs between 1978 and 1986, Stonebmner found 
that deaths due to pneumonia, endocarditis and tuberculosis were markedly 
increased.®^ In a further analysis of selected case records he surmised that 
HIV was implicated in 44% of these pneumonia deaths, 32% of the 
endocarditis deaths and 69% of the tuberculosis deaths. Selwyn 
demonstrated an increase in mortality from bacterial pneumonia and sepsis 
from 3.6/1000 in 1984 to 13.6/1000 in 1987 amongst IDUs in MMPs in New 
York.®® The HIV status of these IDUs was not known but the dates are co­
incident with the AIDS epidemic. Morbidity, which can be more difficult to 
define than mortality, has also increased amongst IDUs for diseases such as 
tuberculosis and bacterial pneumonia. Hospitalisations for pulmonary 
tuberculosis (not an AIDS defining illness by the 1987 CDC definition) have 
increased amongst HIV positive IDUs in New York.®®’®® In his study 
comparing 144 HIV positive with 289 HIV negative IDUs, Selwyn found 
that seropositive subjects (none of whom had developed AIDS) were five 
times more likely to develop bacterial pneumonia than the seronegative 
group.®” Similar studies have confirmed these findings.”®' Incidence, severity 
and mortality of endocarditis have been reported to be increased in HIV 
positive IDUs compared with negatives.”®””
Partly as a result of different disease manifestations within the natur al 
history of HIV infection, progression to AIDS and smvival with AIDS are
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known to differ between risk groups.'” The situation with regard to IDUs is 
further complicated in that IDUs as a group comprise a larger percentage of 
women, tend to be younger and, in United States studies, are more likely to 
be non-Caucasian than some other risk groups. Many studies when ascribing 
differing rates of HIV disease progression and differences in survival have 
failed to take account of these variables. Also, in studies so far reported, 
cohorts of haemophiliac patients and homosexual men have been studied for 
longer and more completely than IDU cohorts and therefore are not directly 
comparable.'” As an example, a reasonably large study of 526 New York 
AIDS patients, 47% of whom were IDUs, reported that although the initial 
AIDS defining diagnosis was the most powerful predictor of survival, the 
combination of male sex and IDU, black race and younger age were 
associated with more favourable survival.'”” Compare this with a study of 
5833 New York AIDS patients, 28% of whom were IDUs.'”' This study also 
found that the manifestations of disease at AIDS diagnosis to be the most 
powerful predictor of survival but that smwival was somewhat worse for 
those infected via IDU and that it was particularly poor for black female 
IDUs. With regard to studies reporting on risk of progression to AIDS 
among IDUs, much attention has focused on the risks of continued drag 
injecting. Many, although not all, studies have found an association between 
continued IDU and progression.®^’^® Markers for disease progression also 
differ in IDUs compared with other groups and in particular, serum B2 
microglobulin is of very little predictive value."” '”^
Another aspect which has particular relevance to American studies on 
IDUs (particularly progression and survival) is access to health care.'”® 
Studies from the methadone maintenance programmes, mainly from New 
York, usually compare HIV negative and positive IDUs and have made an 
important contribution to our knowledge of the epidemic in IDUs.®®’®” 
However they cannot be directly compared with equally important 
progression studies of homosexual white men fiom San Francisco.®^
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Em op eau studies have to a certain extent redressed this balance with as 
much research, particularly in Italy and Spain, concentrating on IDUs as on 
other patient groups. In Britain all patients have equal rights to healtli care 
although some patients may have more difficulty in accessing it than others. 
In Edinburgh most of the patients are indigenous Caucasians who access 
health care equally. With a cohort comprised mainly of IDUs with known 
seroconversion dates and a comparison group of heterosexually and 
homosexually infected Caucasians, studies of this group will help to answer 
some of the above problems and questions about rates of progression, 
sm*vival and ear ly natmal history of HIV infection.
The Edinburgh epidemic
Edinbmgh is a small city of 300,000 inhabitants most of whom are 
indigenous Caucasians. In 1985 there were an estimated 2,000 injection 
drug users in the city.’”"* Drugs in Edinburgh were primarily taken by 
injection and the dominant drug used was heroin which, usually brought in 
via the port of Leith, was in plentiful supply in the early 1980s.^ Because of 
an acute shortage of needles and syringes in Edinbmgh fr om 1982 onwards 
(the local legal retailer closed and there was subsequent unofficial 
prohibition by pharmacists) injecting equipment began to be widely shared. 
The situation became very similar to the “shooting galleries” of New York® ™ 
when up to 20 people would share injecting equipment in quick succession. 
Equipment was not cleaned between users rmless the syringe was rinsed with 
tap-water. The practice of “washout” - when blood was drawn back into the 
syringe in order to flush out any remaining heroin - was routine and must 
have increased the contamination of the syringe. In a study of 78 IDUs in 
Edinbmgh, 49 (63%) shared needles at least weekly and 33 (42%) reported 
daily sharing.
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The first intimation of the HIV epidemic among IDUs in Edinburgh was 
published in a letter to the Lancet in November 1985.™'^  A eommercial anti- 
HIV assay had recently become available following which several workers 
from different countries documented seroprevalence rates among IDUs 
varying fiom 1.5% in England™’ to 48% in Spain.™ One hundred and six 
seriun samples from IDUs attending the Royal Infirmary of Edmburgh were 
tested of which 40 (38%) were found to be positive. At that time no clinical 
data were available but samples found to be HIV positive were much more 
likely also to have evidence of past hepatitis B infection (90% vs 62%). 
Following this discovery, further serological studies were made, including 
retr ospective testing of stored sera from IDUs. This was possible because of 
the interest taken in IDUs by a group of general practitioners, and because of 
an outbreak of hepatitis B amongst IDUs in Edinburgh in 1982.^ ^^  This 
outbreak was attr ibuted at the time to the increase in the sharing of needles 
and syringes as described above. Dining and following the hepatitis B 
outbreak, all IDUs who attended the West Granton Medical Group (a general 
medical practice serving a population of 18,000 patients in a depr ived ar ea of 
Edinburgh where drug use is common) had blood taken for hepatitis B 
markers as a routine, and any rmused sera was stored by the virology 
laboratory. In 1985, sera from 164 IDUs were tested for HIV and 83 (51%) 
were found to be positive. Because of the availability of stored sera, samples 
which were found to be positive had previous samples tested successively 
rmtil a negative result was formd, thereby identifying the period during which 
seroconversion occmred. In some cases a very accurate time of 
seroconversion was obtained - the time between the last negative and the fir st 
positive specimens being less than a month. No positive results were 
obtained before September 1983 which is when HIV was probably 
introduced to the drug using population in Edinburgh. This study was not 
anonymous and samples were linked with clinical information. There was a 
statistically significant corr élation between the frequency of needle sharing 
and seropositivity. There was no sex difference between the seropositive
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and seronegative groups (60 men and 23 women were seropositive) but the 
seropositive patients were significantly younger and had used heroin for a 
shorter time (average 4.6 years). Follow up of this cohort in 1988 found 94 
of 146 (64%) patients tested to be HIV pos i t ive .Because  many of the 
group who injected fiom 1982 onwards have not been tested, the 
seroprevalence of HIV amongst this group could be as high as 80%. It is this 
study, the availability of sera stored from 1982 onwards and the resultant 
accurate seroconversion dates which make this cohort of IDUs a unique and 
valuable cohort to study the natural history of HIV infection.
Interestingly, on the same day that Robertson’s study was published in the 
British Medical Jomnal,^ an HIV seroprevalence study of IDUs in Glasgow 
was published in the Lancet.® The Glasgow drug using population in 1983 
was estimated at a minimum of 5,000™® and provides a valuable comparison 
with Edinburgh. Twenty seven of 606 (4.5%) samples from Glasgow IDUs 
tested in 1985 were HIV positive. Analysis of clinical information available 
revealed that in 20 of these samples the patient had a home base in or had 
recently moved away fr om Edinbmgh and only thr ee of the IDUs were based 
in the west of Scotland (i.e. aroimd Glasgow). But 70% of that study 
population had evidence of hepatitis B infection. Comparisons of self 
reported habits between IDUs in Edinburgh, Glasgow and London revealed 
more shar ing of injecting equipment in Edinburgh.® ®
A voluntary self-refenal clinic was established in the Edinburgh Regional 
Infectious Diseases Unit at the City Hospital to provide open access for 
counselling and HIV antibody testing.'™ The clinic was opened on 16 
October 1985 to coincide with the start of HIV testing of all blood donations 
by the National Blood Transfusion service. Apart Rom self-referrals, 
patients could be referred by social workers, general practitioners, other 
hospitals or drng self help agencies. A medical officer was present whenever 
the clinic was open although the clinic was not medical. All patients with 
positive HIV antibody tests were offered full medical screening and follow-
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up in the infectious diseases clinic (held in the same department). The aim 
of the clinic was to present a non-medical but confidential counselling 
image. Within the first year 441 new patients had been counselled at 980 
clinic attendances."' IDUs accounted for 191 patients (119 men and 72 
women) among whom the seropositivity rate was 52%. One hundred and 
foiuteen (26%) attenders were HIV positive of whom 100 (88%) were IDUs. 
This reinforced the importance of the HIV epidemic among IDUs in 
Edinburgh. Whereas in Robertson’s study® all patients came fiom one 
general practice in the north of Edinbmgh, patients attending the City 
Hospital counselling clinic were referred from all over Edinburgh. Of 441 
patients attending, 78% were from within the city of Edinbmgh, 12.5% were 
from the rest of Lothian region, 6% were from other parts of Scotland and 
0.5% were from England. Additionally, 44 (23%) Edinburgh based IDUs 
had shared needles in 48 other locations (including two in Amsterdam, one 
in Rotterdam, one in Paris, 15 in London and nine in Glasgow) and of these, 
52% were HIV positive.
Following the detection of the HIV epidemic in Edinburgh, the need for 
the cormselling clinic and for expansion of medical ser*vices, exti a medical 
clinics were established within the Infectious Diseases Unit""'"’ and patients 
requiring in-patient medical care were admitted to the infectious diseases 
wards. Alternative sites for HIV testing, cormselling and in-patient care exist 
in Edinbmgh including the genito-urinary medicirre clinic, the blood 
transfusion seiMce and through general practitioners and general medical 
hospital units. The cormselling clinic was set up as an alternative to these 
witli one specific aim of attracting IDUs who can be a particularly difficult 
group to access and to treat. Whilst most homosexual men attend the 
genitominary medicine clinics, the infectious diseases unit had been caring 
for and had experience in dealing with IDUs for some years because of 
complications associated with injection drug use including hepatitis B, 
endocarditis and abscesses.
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All attenders at the City hospital HIV clinic have been prospectively 
followed since October 1985. This group comprises HIV positive IDUs, 
homosexual men, heterosexually infected HIV patients and some HIV 
negative IDUs (usually partners of HIV positive IDUs). Records of every 
patient's eveiy outpatient attendance since October 1985 have been entered 
on a database computer file. Data collected include weight, height, age at 
first injection, number of years injected, whether drugs have been injected 
since the last out-patient attendance (and if so, which and how often), drug 
substitution therapy prescribed, antir etroviral (including trial drug) treatment 
and prophylaxis against opportunistic infections. Blood tests recorded 
include HIV seroconversion dates, lymphocyte surface markers, HIV antigen 
levels, full blood cormts, liver function tests and serology for syphilis, 
hepatitis B, C, D, toxoplasma and cytomegalo vhrrs. Accruate 
seroconversion data ar e available on the IDUs, most of whom seroconverted 
between September 1983 and mid 1984. Data are entered following a 
protocol by research assistants and all medical case notes are kept 
permanently in the clinic and are available for reference should any 
discrepancies be found in the database.
By November 1989, four years after the inception of the City Hospital 
clirric and six year s after the inti oduction of HIV into the Edinbmgh injecting 
population, 409 HIV positive patients had attended the City Hospital medical 
clinic - 319 (78 %) were IDUs, 50 (12%) were homosexual or bisexual men, 
28 (7%) were infected via heterosexual intercomse, fom* (1%) via blood 
products and in eight (2%) there were no documented risk factors.
This thesis will be analysing only those HIV positive patients in 
Edinburgh who have attended the City Hospital clinic. The aim of the thesis 
is to document the early natur al history of HIV infection. Observation and 
clinical management of these HIV positive patients in the early years of their 
infection revealed that they were suffering considerable morbidity. 
Morbidity and mortality in patients without advanced disease had not
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previously received much attention in the literatuie as most studies had 
focused on patients with AIDS or CDC stage 4 disease. Evaluation of this 
morbidity documents a wider specttixm of HIV related disease. An 
evaluation of the associated health caie utilisation is necessary for further 
allocation of health care resoruces both within Edinbm gh and elsewhere.
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Figure 1.1
1987 CDC classification of HIV disease®
Stage 1 : Seroconversion illness
Stage 2: Asymptomatic infection
Stage 3 : Persistent generalised lymphadenopathy
Stage 4: Symptomatic disease, comprising
4a: constitutional disease
4b: neurological disease
4cl: severe opportunistic infections **
4c2: lesser infections *
4d: tumours
4e: other diseases attributable to HIV or indicative of a defect in cell 
mediated immunity
** includes the following:
Candida of oesophagus or respiratory system 
extrapulmonary cryptococcosis 
chronic cryptosporidiosis 
chronic isosporiasis
cytomegalovirus other than liver, spleen or lymphatic 
chronic mucocutaneous/visceral herpes simplex 
disseminated histoplasmosis 
atypical or extrapulmonary tuberculosis 
Pneumocystis carinii infection 
cerebral toxoplasmosis > 1 year age 
disseminated coccidioidomycosis 
extraintestinal strongyloidiasis 
progressive multifocal leucoencephalopathy 
recurrent non-typhoidal salmonella septicaemia
* includes the following:
persistent or recurrent oral Candida 
oral hairy leucoplakia 
nocardiosis
pulmonary tuberculosis 
multidermatomal herpes zoster
From: Centers for Disease Control. Revision of the CDC surveillance case 
definition for acquired immunodeficiency syndrome. MMWR 1987; 36 (suppl 
1S):3S-15S.
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Intioduction
The data routinely collected on the HIV positive patients attending the 
City Hospital clinic are used to describe the Edinburgh cohort with particular 
reference to the natural history of HIV infection. Because data are on all 
patients attending and because markers of disease progression (CD4 count, 
HIV antigenaemia, CDC staging) and of drug use are prospectively recorded 
the data have been used to evaluate co-factors for disease progression.^:/^» 
The use of health car e resources has also been audited from study of the out­
patient reco rds.'*2 But no data were routinely collected on hospital 
admissions by this group of patients. Any data on in-patients would be 
complementary to the out-patient data since they would describe a more 
complete picture of the natmal history of HIV infection in each patient. Data 
on admissions would provide a more accurate picture of disease progr ession. 
A study was therefore peiTormed of all admissions by HIV positive patients 
to the Regional Infectious Diseases Unit (RIDU) at the City Hospital, the 
designated centre for in patient care of HIV positive patients.
Although most HIV positive patients who attend the City Hospital clinic 
are likely to have any medical admissions to the City Hospital (or if refened 
elsewhere to have the admission referred or supervised by the City Hospital) 
a study of City Hospital admissions alone might not be representative of all 
admissions and of the ear ly years of the Edinbmgh HIV epidemic. Particular 
categories of admissions which would be likely to be admitted to hospitals 
other than the City include self-poisoning, injection injuries and any 
gynaecological admissions. Edinbmgh has three main teaching/general 
hospitals (the Western General, the Eastern General and the Royal hifrrmary 
of Edinbmgh) and one central Accident and Emergency Unit at the Royal 
Infirmary. All three hospitals have acute general smgical wards (of which 
there are none at the City Hospital). All admissions in Edinburgh with self-
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poisoning aie refened direct to the Regional Poisons Unit at the Royal 
Infirmaiy. The Western General Hospital houses the Institute of 
Neurological Sciences and has a large gastio-enterology department. 
Gynaecological admissions in Edinbmgh are referred to the Royal Infmnary 
or the Wetern General Hospital. All psychiatric admissions in Edinbmgh are 
to the Royal Edinburgh Hospital (general acute psychiatry), the Royal 
Victoria Hospital (psychogeriatrics) or Gogarbmu hospital (mental 
handicap). Admissions by HIV positive patients who had attended the City 
Hospital as an out patient but who were admitted to other hospitals in 
Edinbmgh were included in the study. Excluded from the study were 
children under the age of 16 and any HIV positive patient who had not been 
admitted to, or had not attended the clinic at the City Hospital.
There ar e three main centr es of HIV car e in Edinburgh - the City Hospital 
RIDU, the Genitourinary Medicine Department at the Royal Infirmary and 
the Haematology Department at the Royal Infrnnary. Most patients whose 
out patient care is at the Genitominary Medicine Department but who requhe 
in patient care ar e refened to the City Hospital for admission. Most of these 
patients are homosexual men. The Haematology Department provides in 
patient and out patient care for haemophiliac patients and some other patients 
infected through blood products. Their admissions were not included in this 
study. Patients admitted to hospital but who did not attend a clinic on a 
regular basis or who leanit of their HIV positivity dming that admission 
would generally be referred to the City Hospital RIDU, as the designated 
HIV rmit, for on going care. This study therefore analyses most Edinbmgh 
admissions by HIV positive patients apart from the small group of 
haemophiliac men. The study period chosen was from October 1985 rmtil 
31st October 1989. The City Hospital HIV outpatient clinic was established 
in October 1985, hence the starting date of the study. The aim of the study 
was to describe admissions within the early years of the Edinbmgh HIV 
epidemic and therefore the cut off point was four years after the inception of
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the City Hospital clinic and six years after the introduction of HIV into the 
ding using community in Edinbmgh.
Methods
A database file of all inpatient admissions was retrospectively compiled. 
Two medical research fellows (LW, EC) reviewed the medical case notes of 
all HIV positive patients attending the City Hospital clinic. All case notes in 
which a City Hospital admission was recorded were examined fuifher and 
data extracted according to a protocol. These data comprised hospital 
identification number, date of birth, sex of the patient, risk factor for 
acquisition of HIV infection, date of admission to and discharge from 
hospital, CDC status on admission, CD4 lymphocyte count on admission, 
whether or not the patient was prescribed zidovudine or didanosine, date of 
death and primary and secondary causes of admission. A code for medical 
diagnoses was drawn up and each admission diagnosis was ascribed a code. 
The data were entered on to a database file (database III plus) and each 
record of the file contained one hospital admission. Each patient, therefore, 
had a varying number of records depending on the number of times he had 
been admitted to the City Hospital (range I - 22). The only variable with 
missing values was the CD4 lymphocyte count. Since October 1989 these 
data have been collected prospectively on a weekly update basis.
A separate database of admissions of HIV positive patients who had 
attended the City Hospital but who had been admitted to other hospitals was 
drawn up. The psychiatric admissions were obtained by a slightly different 
method from the general admissions. The methods for the general 
admissions are described first. Relevant admission diagnostic classifications 
were identified in the International Classification for Diseases handbook
34
(ICD-9). These comprised: AIDS, deficiency of cell-mediated immunity, 
HTLV-III, carrier or suspected caiiier of other specified infectious organism, 
contact with or exposure to other viral disease, dmg dependence, addiction 
and withdrawal, homosexuality, poisoning and gynaecological admissions. 
The Scottish Health Services Hospital Diagnostic and Operations Index for 
the years 1985 rmtil October 1989 inclusive was searched for admissions in 
the above categories to each of the three main teaching hospitals. 
Admissions imder each category were matched by name and date of birth 
with City Hospital indexes (although the City Hospital database files do not 
actually contain names). The gynaecological admissions were found to be so 
numerous that they were only matched if the admission diagnosis had some 
mention of HIV or AIDS. This was not the case for the categories of dmg 
dependence, addiction and withdrawal or poisoning. In these categories all 
the admissions were searched and patients who had attended the City 
Hospital HIV clinic were identified by name and date of birth. Therefore, in 
the category of admissions related directly to dmg use, patients who had not 
identified themselves as being HIV positive to the other hospitals, or who 
had not known themselves to be HIV positive at the time of admission, or in 
whom the Scottish Health Services Hospital Diagnostic and Operations Index 
did not contain details of HIV positivity, were still included in the study. 
Admissions not in the dmg related categories (eg bacterial chest infections) 
would however be missed unless there was mention of HIV infection on the 
Scottish Health Services Hospital Diagnostic and Operations Index.
Medical records for HIV positive patients known to the City Hospital but 
admitted to one of the three other hospitals before November 1989 were 
requested (ie excluding HIV positive patients who were admitted to other 
hospitals but who were not known to the City Hospital). This database was 
drawn up fiom the requested records in exactly the same way as described 
above. Data on CDC staging, CD4 count on admission and antiretroviral 
therapy were recorded so infrequently in these medical records that these
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categories were not included in the second database. Data recorded on the 
second database therefore included identifying number, date of birth, sex, 
risk group, date of admission and discharge Rom hospital, Rrst three 
diagnoses with coding and the hospital of admission. Both databases were 
searched for duplicates which were then removed eg. an inpatient Rom the 
City Hospital might have been referxed to and admitted to another hospital 
for a specialised investigation or procedure (eg CT scan or laparotomy) and 
would therefore have appeared on both databases.
All psychiaRic case records are kept in a cential records office (Lothian 
Psychiatiic Register). The hospital unit numbers were obtained Rom the 
central computer for all patients discharged with a diagnosis of HIV 
infection, AIDS, drug misuse or homosexuality (as per the general 
admissions study methods) and who were admitted between 1st November
1985 and 1st November 1989. The case records were taken for all 160 of 
these admissions, and, where the patient was HIV positive (whether or not 
this was known at the time) details were taken of admission and discharge 
dates, psychiaRic diagnoses, whether or not the HIV status was known at the 
time of discharge, CD4 count and CDC stage. Admissions before 1985 in 
these case records were also included. These psychiaRic admissions were all 
included in the second database.
The study period was Rom October 1985 until November 1989. A few 
admissions to the City Hospital were recorded before October 1985 and, 
where available, these admissions were included in the figures of the first 
year. The first year* of the study therefore refers to the 12 montlis from 
October 1985 to the end of October 1986, the second year* fi om November
1986 to October 1987, the third year* Rom November* 1987 to October 1988 
and the last year* of the study fi om November* 1988 to 31st October 1989.
Both admission databases were analysed primarily by admission diagnosis 
codes (chapter two) and thereafter by risk group, sex, CDC staging, CD4
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count, presence or absence of AIDS, year of admission and hospital of 
admission, of AIDS patients and of réadmissions (chapter thr ee). The 1987 
system of CDC staging was used.®
Analysis was mainly in the form of descriptive epidemiology. Statistics 
were calculated using the software package "Epi Info version 5.01b" for chi 
squar ed tests. Yates conection was used for two by two tables with a total 
of less than 100. Fisher's exact test was used when the expected value of any 
cell in the two by two table was less than five. Statistical significance was 
set at the 0.01 probability level. Confidence limits for odds ratios were 
calculated at the 95% level.
Ethical permission was obtained from the Lothian Health Boar d Ethics of 
Medical Research Sub-Committee for Medicine and Clinical Oncology 
(application MCO/57/92) and from the Sub-Committee for Psychiatry and 
Clinical Psychology (application 93/42). Permission was also obtained from 
the Information and Statistics Division, Common Services Agency and the 
clinical dhectors and principal medical records officers of all the hospitals 
concerned.
Results
Svnonsis
A total of 910 admissions were recorded; 612 to the City Hospital and 298 
to the other hospitals. The 612 admissions to the City Hospital were made 
by 208 patients and the 298 admissions to the other hospitals by 121 
patients. A total of 8738 bed days were occupied and mean length of 
admission was 9.6 days. IDUs accoimted for 702 (77%) admissions, 
homosexual men for 136 (15%), heterosexual patients for 62 (7%) and
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recipients of blood products for 10 (figure 2.1). By comparison over the 
same period, i.e. before November 1989, 409 patients had attended the City 
Hospital clinic; 78% were IDUs, 12% were homosexual, 7% heterosexual, in 
2% no risk factors were found and in 1% the patient was a recipient of blood 
products (figure 2.2).
The most fiequent admissions were for conditions directly related to drug 
use (figure 2.3). These comprised overdose, tiauma, injection injuries and 
detoxification and accounted for 220 admissions. The laigest amount of bed 
days were used for respiratoiy conditions which was the second most 
common reason for admission (187 admissions). One hundred and one 
admissions were for genitourinaiy and gynaecological conditions, 98 for 
gastiointestinal and hepatic conditions, 91 for nemological, 38 for 
psychiatric and 35 for haematological conditions. Foity seven admissions 
were for day tieatments, 45 for investigation and 48 for a vaiiety of other 
conditions. A total of 2195 bed days were used for respiratoiy conditions, 
1403 for dmg related conditions, 1192 for neurological, 984 for 
gastiointestinal and 531 for genitourinaiy and gynaecological conditions and 
442 bed days were for admissions for investigation.
Dmg related admissions
Overdose
Dmg related events were by far the most common reason for patients from 
the City Hospital cohort to be admitted to other hospitals. Injection injuiies, 
tiauma and overdose accounted for 48% (144) of all the admissions to other 
hospitals in Edinbmgh. Most (100) of these were due to overdose. Only two
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patients with overdose were admitted to the City Hospital. One was a patient 
with AIDS who had been attending the City Hospital frequently and the 
other was a homosexual man who took an overdose of 100 zidovudine 
capsules - this was uncomplicated and the admission lasted only two days. 
A fmther two admissions with overdose were to the Western General 
Hospital and the rest were to the Regional Poisons Unit in the Royal 
Infiimaiy. Fifty five admissions were in male IDUs, 41 in female IDUs and 
four were in women (two patients only) with heterosexually acquired 
infection. The average age was 24. Despite the laige number of admissions, 
only 155 bed days were occupied by overdoses. The patient stayed 
overnight in 85 admissions, seven admissions lasted two days, three lasted 
three days, one took four days, two took seven days, one took nine days and 
one lasted 20 days. Twenty nine of the overdoses were with a mixed 
concoction of dings and the predominant dings in eveiy case were opiates 
(heroin, methadone, dihydrocodeine, dipipaiione, dextiomoramide) and 
benzodiazepines (diazepam, tiiazolam, temazepam). In only two cases (in 
the same patient) were non-heroin dings specified as being taken 
intravenously. Other dings taken were paiacetamol (7), chloimethiazole (3), 
thioridazine (2), caibamazepine (2), cyclizine (1), temgesic (1), procyclidine 
(1), mefenamic acid (1), clonidine (1), amitiyptiline (1) and prednisolone (1). 
The two admissions in non-IDUs were for overdose of tiiazolam in one, and 
the other patient who was admitted three times took paiacetamol and 
diazepam on one occasion each and a mixture of chloipromazine and "speed" 
on the other. Only six admissions were "complicated" - by aspiration 
pneumonia in fbui cases, opiate induced pulmonaiy oedema in one and 
respiratoiy and renal failure in one. One patient with aspiration pneumonia 
died on the second day of admission with overdose of unknown substances - 
this was his fourth overdose admission. The patient with opiate induced 
pulmonary oedema had five overdose admissions in the space of six months. 
The first of these was a 20 day admission following an overdose of 
paiacetamol and unknown substances which resulted in respiratoiy and renal
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failme requiring dialysis and eight days of ventilation. The frequent number 
of réadmissions is reflected in the fact that only 43 patients were admitted 
with overdose - 23 patients were admitted once, ten patients twice, six were 
admitted on three occasions, two on four, one on five occasions and one 
female IDU was admitted 26 times within the study period. Her admissions 
were usually overnight (the longest stay was four days) and she took a large 
variety of substances - paracetamol on five occasions, caffeine (Proplus 
tablets) on two and thereafter mainly hypnotics and opiates.
Injection injuries
Of the remaining 44 admissions for ding related causes to other hospitals, 
20 were directly related to recent injection ding use. Seven of these were for 
incision and drainage of abscesses (five buttock, one thigh, one aim) and 
accounted for 41 bed days (range 1 - 27, mode 1). Fom men were admitted 
with cellulitis requhing antibiotics. Seven admissions were because of acute 
ischaemia. Buprenoiphine (Temgesic) was implicated in two cases, one of 
which resulted in ischaemic necrosis of the thigh. Diconal (a mixture of 
dipipanone and cyclizine) was implicated in another man in whom injection 
into the femoral artery (whilst in prison) resulted in a hindquarter 
amputation, acute renal failme and osteomyelitis. He was in the Royal 
Infirmaiy for 31 days before being transfened to the City Hospital for 113 
days convalescence. One man required paitial amputation of three digits of 
his left hand in Mar ch 1989 and in July was readmitted with acute ischaemia 
of his left hand after injection into his brachial aitery. These seven 
admissions accounted for 53 bed days.
Twenty nine admissions (356 bed days) were recorded to the City Hospital 
with injection related injmies. Nine were with abscesses accounting for 184 
bed days (range 2 - 2 7  days per admission), all in patients with CDC disease
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stage 2 or 3. One patient had thrombophlebitis and two patients had 
cellulitis. In 13 cases the injmy was not specified.
Detoxification
Fourteen admissions to the Royal Edinbmgh Hospital were for 
detoxification and these are documented in the section on psychiatric 
admissions. No admissions were recorded to any of the other hospitals for 
drug withdiawal. Twenty nine City Hospital admissions in 21 patients had a 
primary dischar ge diagnosis of detoxification. In this category of admission 
women outnumbered men (15 women, 14 men). Average length of 
admission was 13.5 days (total 392 days). Only three patients had CDC 
stage 4 disease. Assessing the outcome of these admissons was difficult. 
Three admissions were deemed successful, including a 38 day stay by a 
pregnant woman. Six admissions (in five patients) were successful at the 
time but the patients subsequently relapsed. Twelve admissions were 
thought to be unsuccessful at the time. Average length of stay was not 
significantly different between the successful and unsuccessful admissions 
(16.4 and 15,4 days respectively). Three admissions were for alcohol 
detoxification. Perhaps more significantly, nine patients admitted for other 
reasons had a second discharge diagnosis of detoxification. Five of these 
were in patients admitted with bacterial chest infections. The average length 
of stay in these five was 14.8 days, considerably longer than the mean for 
chest infections as a whole.
Other dmg and alcohol related admissions
There were six admissions in four patients with staphylococcal 
endocarditis. All were before 1986 in patients who had CDC stage 2 
disease. Average length of admission was 47 days (range 24 to 66). One
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woman spent six days in the Royal Infiimaiy before transfer to the City 
Hospital.
A fmther seven admissions (37 days) to the City Hospital were directly 
related to alcohol abuse. Two of these patients were homosexual men, one 
was a heterosexual woman and the rest were dmg users. The diagnosis in 
two was of acute intoxification and in the other five it was chronic alcohol 
abuse in whom in three cases admission was also precipitated by abdominal 
pain, altered bowel habit and a recent rape.
Trauma
Trauma accounted for 28 admissions and 157 bed days. Seven of these 
were specified as being stab wounds (thiee required laparotomy with 
eventual sutming of the liver in one and stomach in one, and one patient 
required scrotal exploration). Seven were for fractures (malar, orbital floor, 
mandible, nose, tibia and fibula). Four were for slashed wrists (and one of 
the overdose admissions had a concmient diagnosis of slashed wiists). One 
episode of üauma resulted in a black eye requiring a five day hospital 
admission in a patient known to have HIV-related thiombocytopenia. One 
patient fell out of a window sustaining injmies which required laparotomy, 
ventilation and tracheostomy and a ten day hospital admission. This last 
injmy may not have been enthely dmg related but did occur in a dmg user. 
Eight of the trauma admissions were to the Western General Hospital, five 
were to the City and the remainder were to the Royal Infirmary.
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Respiratory admissions
A total of 187 admissions (21% of all admissions) were for investigation 
and treatment of respiratoiy disorders. One hundred and eighty of these 
were to the City Hospital and constituted the single most common reason for 
admission to the City (29% of admissions). These cases were therefore 
studied in more detail. Because the same amount of detail was not available 
on the seven respiratory admissions to tlie other hospitals they are 
summaiised first. One homosexual man was admitted for 19 days to another 
hospital with Pneumocystis carinii pneumonia (PCP). The other admissions 
were all in IDUs. Two of these IDUs had unspecified bacterial chest 
infections, one had severe staphylococcal pneumonia and pyohaemothorax 
requhing 17 days in hospital, one had atypical chest pain and one patient 
with PCP was ttansferred from the City Hospital to the Western General for 
ventilation but died shortly after transfer (see below). In a fmfher eight 
admissions to other hospitals, a secondary diagnosis of respiratory disease 
was made. These patients were all IDUs and in six of the admissions the 
piimary diagnosis was of overdose. Three were cases of asphation 
pneumonia, one patient had respiratoiy failure requhing eight days of 
ventilation, one had opiate induced pulmonaiy oedema and one had an 
unspecified chest infection. The other two admissions were in one woman 
who developed chest infections dming admissions for cholecystectomy and 
pelvic inflammatoiy disease.
Of the 180 respiratory admissions to the City Hospital, 97 (ie 16% of all 
City admissions) were due to bacterial chest infections (BCIs), 48 (8% of 
City admissions) were due to PCP and 35 (6% of City admissions) to other 
chest related disorders (figme 2.4). The number of these admissions rose 
steadily over the four year s studied with 12 recorded in the first yeai (eight 
BCIs, one PCP, three other chest conditions), 25 in the second year (12,
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eight and five BCIs, PCP and other chest disorders respectively), 51 in the 
third yeai* (31, 12 and eight) and 92 in the fourth (46, 27 and 19).
Pneumocystis carinii pneumonia
Pneumocystis carinii pneumonia (PCP) was diagnosed in 42 patients and 
accounted for 48 admissions (25 in homosexual men, 16 in IDUs and seven 
in heterosexually HIV infected patients; 36 men and 12 women). Two 
female patients had three episodes of PCP and two male patients had two 
episodes. Average age was 33 (range 22-57). Two women were pregnant at 
the time of diagnosis of PCP. One pregnancy was tenninated. The other 
woman gave biith four weeks later to an initially healthy female child. 
Although the mother remained well for over one yeai' her child died of PCP 
at six months of age.’:® Two IDUs (5%) died, both during their first 
presentation with HIV disease and both with other concomitant HIV related 
illnesses (CMV pneumonitis in one and cerebral lymphoma in the other). 
Average length of hospital stay was 23 days (range 2 - 1 0 2  days) and PCP 
accoimted for a total of 1065 bed days.
Diagnostic teclmiques for PCP changed over the fom* year period. Initially 
diagnosis was made by cytological examination of silver staining of 
bronchoalveolar lavage fluid. Bronchoscopy was then mainly replaced by 
sputum induction and in 1989 silver staining was replaced by monoclonal 
antibody techniques. In 17 cases the diagnosis was made on the basis of 
clinical features and response to ti eatment. A definite diagnosis was made in 
31 cases, 12 by silver staining and 19 by immunofluorescent antibody 
techniques. Specimens were of induced sputum in 21 cases, bronchoalveolai 
lavage in nine and open-lung biopsy in one. In one patient bronchoalveolar 
lavage samples were negative but a positive result was obtained two weeks 
later fr om an induced sputum sample.
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Treatment was with co-trimoxazole in 34 cases, pentamidine in five and 
with both in six. One patient was initially tr eated with cotrhnoxazole and the 
treatment comse was completed with clindamycin and primaquine. In five 
patients antibiotic treatment was supplemented with oral steroids.
In seven (five IDUs, one homosexual man and one African heterosexual 
woman) of the 48 cases of PCP (15%), a concomitant BCI was diagnosed, 
Thrity two patients (73%) had a p02 < 1 0  kPa, of whom nine (20%) had a 
p02  < 7kPa but only six (14%) had a pC02 > 5.5 kPa. Chest X ray was 
abnormal in 75% and surprisingly that percentage remained static over the 
four year s studied despite increased physician awareness and earlier attempts 
at diagnosis with improved diagnostic techniques.
Chest infections due to other oppoitunistic organisms
These included three admissions for atypical mycobacterial infections 
(Mycobacterium kansasii and M. avium intracellulare) and one for 
pulmonary tuberculosis. One patient was in hospital for 106 days with 
presumed candidal pneumonia. He was treated empirically for both 
tuberculosis and PCP but a clinical improvement was not seen until 
anticandidal therapy was star ted.
Bacterial chest infections
Ninety-seven admissions (42 female and 55 male) were recorded for 
BCIs. Bacteria were identified in 72 cases (74%), including Haemophilus 
influenzae in 29 and Streptococcus pneumoniae (16 different serotypes) in 
22 .
No patients died but the associated morbidity was significant. BCIs 
accounted for 948 bed days with an average dm ation of hospitalisation of ten
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days (range 1 - 43, median 8). All patients were symptomatic and 50% had 
radiological pneumonia. Blood gas analysis was performed in 59 
admissions: 42 (71%) had a p02  < 10  kPa and 27 (46%) had a pC02 >5.5 
kPa. Peak flow measmements were carried out on 59 admissions and 14 
(24%) had readings of <3001/min. Lung function tests were performed on 
recovery in 64 admissions, and of these, 52% were found to have a 
ventilatory defect and 45% had reduced carbon monoxide transfer factor.
Most of these patients did not have AIDS or "symptomatic" HIV disease. 
There were 50 admissions in patients with CDC disease stage 2 and 3, 13 
with 4a, one with 4b, 16 with 4c 1, 14 with 4c2, two with 4d, and one with 
4e. The 50 admissions in patients who did not have "symptomatic" HIV 
disease accounted for 458 bed days (48% of total bed days used for BCIs).
Of all patients admitted with BCIs, 98% smoked cigarettes and most also 
smoked marijuana. At the time of admission 80% were receiving opiates and 
80% benzodiazepines.
Ninety (93%) of the 97 admissions due to BCIs were in IDUs (figure 2.5) 
compared with 71% of those attending the City Hospital HIV clinic having 
drug-related disease (x^^^ = 25.5, p < 0.0001). In this study, IDUs were 
five times more likely than the other HIV positive patients to be admitted 
with a BCI (95% confidence limit 2.75 - 9.520).
Differentiating BCIs from PCP was often difficult, particularly since 
several infections could occur concmiently. Symptoms of weight loss, fever 
and breathlessness were more marked in PCP whereas cough productive of 
sputum was more characteristic of BCIs. The average CD4 positive 
lymphocyte count at diagnosis of PCP was 56 cells/mm® (range 0 - 240) 
compared with an average for BCIs of 296 cells/mm® (range 0 - 1040). 
White cell count was low or normal in PCP compared with BCIs where 29% 
of patients were formd to have either a raised neutr ophil coimt or one which 
had doubled (p < 0.02, x^ = 5.72 with Yates conection). In many
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neutropenic patients, although the neutr ophil count had doubled, it was still 
below noimal. Comparison with previous neutr ophil counts was therefore an 
important part of assessment. Because of the difficulty in differentiating 
PCP and BCIs clinically an algorithm was drawn up and a study conducted 
to assess the value of induced sputum techniques in the diagnosis of PCP in 
IDUs (see chapter four).
Other respiratory disorders
Two patients were admitted with Influenza A and five admissions were 
found to be due to upper respiratory tract infections. In addition, ten 
admissions were for investigations of breathlessness, ten for exacerbations of 
chronic obstructive pulmonary disease and asthma and one for a 
pneumothorax.
Genito-urinaiy and gvnaecological admissions
Genito-minaiy (GU) diagnoses accounted for 101 admissions and 531 bed 
days. The most common diagnosis in this category was pelvic inflammatory 
disease for which there were 26 admissions. Fomteen of these were in IDUs 
and 12 were in heterosexual women. The average age of these women was 
24 year s. Many of these women were admitted on a number of occasions 
(one was admitted six times and two women had five admissions each) so 
that only ten women accounted for the 26 admissions. Four of these 
admissions were to the City Hospital, the rest to the other hospitals in 
Edinburgh. Pelvic inflammatory disease accoimted for 100 days in hospital, 
admissions ranging from one to 21 days (mode = 1 day). Organisms were 
specified in only three cases - Mycoplasma hominis in one and Neisseria 
gonorrhoeae in two.
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Ten admissions (25 bed days) were for teimination of pregnancy. One 
woman was admitted for two terminations and all but one of the women 
were IDUs. Three admissions to the City Hospital were because of a 
primaiy diagnosis of pregnancy. One of these admissions was elective and 
lasted 38 days because of a successful detoxification. The other two were in 
one woman who was admitted initially with vomiting. She had a 
concomitant diagnosis of a chest infection and was admitted later in the same 
pregnancy with a minaiy tract infection. Two admissions were for 
threatened abortion, one of which turned into a complete abortion and two 
were because of incomplete abortion. Pregnancy was a second diagnosis in 
three cases. One was a woman admitted with pyelonephritis. One woman 
was admitted on two occasions with PCP. She was found to be pregnant 
during the first admission and had a termination dming the second.
Other gynaecological diagnoses were vaginal bleeding (9), sterilisation (3) 
and vaginitis (1).
Urinary tiact infections accounted for 13 admissions - 11 women and two 
men. Total bed days for urinary tract infections were 103 days but excluding 
two admissions lasting 23 and 24 days, average length of admission was five 
days. Urinary tract infection was a second diagnosis in 15 patients (13 
women, two men) admitted to the City Hospital, six of whom had a primary 
diagnosis of a chest infection. One woman had four admissions with both 
chest and urinary tr act infections. Two women had pyelonephritis. One was 
known to have a congenital absence of a left kidney and one was in a woman 
who was pregnant and altogether had three admissions for urinary tract 
infections. Two admissions for septicaemia (in one male IDU with CDC 
stage 3 disease) were secondary to a urinary tr act infection - Escherichia coli 
was identified as the cause in one.
Prostatitis was a primary diagnosis in ten men and a second diagnosis in 
one (his primary diagnosis was a chest infection). Nine of the men were
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asymptomatic IDUs and one was a homosexual man with AIDS. Prostatitis 
accounted for 158 bed days (range 4 - 5 3  days per admission). The 
admission lasting 53 days was in an IDU who had a history of recmxent 
bacterial infections, who had had two previous admissions for prostatitis and 
who had a concomitant diagnosis of Campylobacter enteritis. Two 
admissions were for epididymo-orchitis and one for vasectomy.
One patient was admitted on three occasions for excision of vulval 
waits. Second diagnoses of peri-anal herpes were found in two homosexual 
men and one IDU, of genital herpes in one heterosexual woman, of genital 
warts in one male IDU and of anal warts in one male IDU and one 
heterosexual woman.
Gastro-intestinal admissions
Ninety eight admissions were for gastro-intestinal (GI) and hepatic 
disorders. Additionally, in 19 admissions a secondary GI diagnosis was 
noted. The most common Gl-related reason for admission was diaixhoea. 
Investigation and treatment of diarxhoea for which no specific cause was 
found accounted for 14 admissions - 12 IDUs and two homosexual men. 
Specific pathogens were found only in a minority of cases. There were three 
cases of enteritis due to Clostridium difficile, one of which was associated 
with pseudomembranous colitis. One patient had a diagnosis of "food 
poisoning" and there were three cases of Campylobacter enteritis. One 
homosexual patient was admitted with salmonella enteritis in 1987 and 
Campylobacter enteritis in 1988. Constipation accounted for nine admissions 
(five to the City and four to other hospitals). In eight of these admissions the 
patients were IDUs and one was a heterosexual woman. Three IDUs had a 
secondaiy diagnosis of constipation. Thhteen admissions were for non­
specific abdominal pain.
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Thr ee patients had acute appendicitis, all of whom required transfer to 
another hospital. In two cases the diagnosis was complicated - one had a 
gangrenous appendix and one had sepsis and intra-abdominal adhesions - 
and these patients spent 26 and 51 days in hospital respectively. In the third 
patient the histology of the appendix did not show any inflammation.
Six admissions in foru' women were with acute or chronic cholecystitis or 
biliary colic. Three patients had a cholecystectomy, in two cases comlicated 
by a chest infection. These admissions accounted for 70 bed days. Other 
"surgical" admissions were one case of acute alcoholic pancreatitis and one 
patient with small bowel obstruction caused by swallowing condoms full of 
dmgs.
Three men and three women (foru' IDUs, one heterosexual and one 
homosexual) were admitted because of oesophageal candidosis. One patient 
had oesophageal herpes simplex and one had a non-specific diagnosis of 
"oesophagitis". These admissions accounted for 91 bed days.
Eleven admissions were for hepatic diagnoses. One patient with cirrhosis, 
oesophageal varices and liver failme was admitted on six occasions and 
spent 37 days in hospital. He subsequently died at home of a massive 
variceal haemorrhage. One patient had hepatic encephalopathy and died at 
the end of his 29 day admission. Two admissions were for acute hepatitis 
and two were in one patient who had chronic active hepatitis and 
thrombocytopenia. This patient (who was a prisoner at the time) spent 60 
days in hospital and was treated with subcutaneous interferon.
Neurological admissions
A total of 91 admissions were recorded with a primary diagnosis of 
neurological disease. Eighty of these were to the City Hospital where a
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further 13 admissions also had a second diagnosis within the neurological 
category. Of the 80 admissions to the City Hospital 49 were in men and 31 
were in women; 44 were IDUs, 23 were homosexual men, eight were 
heterosexual (this category actually only comprised two women, one of 
whom was admitted six times) and five were infected through blood products 
(one woman who was admitted four times and one man). In 30 admissions 
CDC staging was 2 or 3, eight were in CDC stages 4.1 and 4.32 and 42 were 
in AIDS defining categories - ten in CDC 4.2 and 32 in CDC 4,31. Total bed 
days used by the City and other hospitals was 1192 and average length of 
stay was 13.1 days. Length of admission was much longer in those patients 
admitted to the City hospital compar ed with the other hospitals - 14.2 versus 
4.8 days. Homosexual men (most of whom had AIDS) had the longest mean 
length of stay at 19.6 days. Length of stay was much longer in patients with 
AIDS compared with those without AIDS - 17.7 versus 10.4 days. Only four 
admissions were for one day or less. Thirty six lasted for ten or more days, 
18 for 20 or more and seven for more than 30 days. The longest admission 
was for 93 days in a homosexual man with cerebral toxoplasmosis. Two 
patients were admitted for 75 days - one with CMV retinitis and 
disseminated Mycobacterium kansasii infection and one with an HIV 
myopathy. One female IDU was admitted for 57 days for investigation of 
blackouts and a second diagnosis of pelvic mflammatory disease.
The most common reason for admission was cerebral toxoplasmosis (18 
admissions). All seven patients were homosexual men apart fiom one 
heterosexual woman who was admitted five times and spent a total of 90 
days in hospital with this diagnosis. One man was admitted five times, one 
man three times, one twice and three men were admitted once. The man 
admitted five times, who had a second diagnosis of Kaposi's sarcoma (KS), 
spent a total of 53 days in hospital and he died in his last admission. The 
man admitted on three occasions later developed cerebral lymphoma 
(diagnosed on brain biopsy) fiom which he died and it is not clear whether
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his admissions for presumed cerebral toxoplasmosis were in fact due to 
cerebral lymphoma. The patient who was admitted twice had a second 
diagnosis of myelopathy. One of the patients admitted once spent 93 days in 
hospital (not only the longest admission but also longer than the total days 
spent in hospital by the two patients who were admitted five times) and 
another patient admitted for 31 days died during that admission.
Two patients had a diagnosis of cerebral lymphoma. One was discussed 
above and the other had a primaiy diagnosis of PCP. In this patient cerebral 
lymphoma was not diagnosed until post-mortem.
Five patients (four homosexual men, one female IDU) were admitted with 
CMV retinitis. CMV retinitis accounted for 101 bed days (range 2-75, mean 
20). The patient admitted for 75 days also had disseminated M  kansasii 
infection and one other patient had a second diagnosis of oral KS.
One patient was admitted with ciyptococcal meningitis and concomitant 
diagnoses of PCP and high grade B cell lymphoma.
One patient was admitted twice with a diagnosis of dementia. Another 
foui* admissions were in patients complaining of memoiy loss for which an 
exact cause was not found.
The above 27 admissions were therefore for AIDS defining conditions. 
Sixty fom admissions were for non AIDS defining events. The most 
common reason was for investigation of blackouts. Fouiteen admissions 
were in this categoiy - nine female and three male IDUs, one heterosexual 
woman and one woman infected from blood products. Total bed days were 
196 with a range fiom one to 57 and average of 14 days. All these 
admissions were in patients with CDC disease stage 2 or 3 except one male 
IDU who had stage 4.32 disease. CD4 counts ranged from 210 to 670 
cells/mm^ In four cases a second diagnosis was recorded (two chest and one 
urinary tract infections and one case of pelvic inflammatory disease). A
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definite diagnosis was not achieved in any of these cases and many were 
thought to be solely drug related. One patient who was admitted for 57 days 
had a caidio-respiratoiy anest dming her admission.
Eleven admissions to the City and six to other hospitals were for seizures. 
Three of these patients had CDC stage 4.31 disease, 11 had CDC stage 2 or 3 
and two had stage 4.32 disease (one unknown). Average length of stay was 
7.4 days. One woman was pregnant and had a diagnosis both of epilepsy 
and of pseudoseizmes.
Eight admissions (five in women, thr ee in men) were for headaches of no 
defined cause. The average admission in this category lasted 10.4 days.
Seven admissions were for nemopathy and one woman was admitted on 
five occasions for symptoms of cervical disc compression and on the third 
admission had a C5/6 foraminotomy. Two admissions were for lymphocytic 
meningitis and one for pneumococcal meningitis. Three patients had a 
diagnosis of myopathy and one of these admissions lasted 75 days.
Psvchiatiic admissions
Thiity eight admissions (721 bed days) were for psychiatric disorders. 
Because the nature of admissions to psychiatric hospitals is very different 
fiom all other hospital admissions, the psychiatric admissions to tire City 
Hospital and those to the Royal Edinburgh Hospital were analysed 
separately.
Eleven admissions with a primary psychiatric diagnosis were recorded for 
the City Hospital. Length of admission ranged from three to 31 days and 
totalled 103 days (mean = 9.4 days). Fom* men were admitted because of 
anxiety - in one patient with two admissions this was described as anxiety 
depression and in one it was described as anxiety psychosis. All these
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patients had CDC stage 4 disease. Four admissions were for depression and 
one of these patients had a further admission with acute hypomania. In two 
admissions there was a secondaiy diagnosis of depression, in one of whom 
the primary diagnosis was of poor memoiy. Two patients were given a 
diagnosis of unspecified psychosis. In one female IDU the admission lasted 
31 days and was thought to have an organic aetiology although the exact 
cause was not identified. One AIDS patient had a primary diagnosis of 
exposure dehydration but this exposure was dhectly precipitated by a 
paranoid depression.
Twelve patients (8 male and 3 female IDUs and one homosexual man) 
were admitted on 27 occasions to the Royal Edinburgh Hospital. These 
admissions accounted for 618 bed days and hospital stays ranged fiom one 
day to 217 days (eight months), mean 23 days per admission. For individual 
patients, who had between one and six admissions each, the range of total 
bed days used was 3 - 224, mean 51.5, median 26.5 days.
Fomteen of these Royal Edinburgh Hospital admissions were for 
detoxification, five for "drug abuse", seven for psychosis and one for 
depression. One patient had six admissions for detoxification and discharged 
herself fiom four of them. There were two other self discharges. One 
admission initially for detoxification lasted for eight months having been 
complicated by "?organic confusional state, ? severe anxiety state, ?functional 
psychosis". Most of the admissions for "drug abuse" had additional 
diagnoses - personality disorder in one, overdose of psychotropics as a 
suicide attempt in one and adjustment reaction to HIV infection in one. Of 
the seven admissions for psychosis, three were in one patient (who had 
diagnoses of hypomania, dmg induced psychosis and par anoia), two in one 
patient (diagnoses of psychotic depression and paranoid psychosis), another 
was a paranoid psychosis and one was an amphetamine induced psychosis.
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Eleven of the Royal Edinburgh Hospital admissions were before 1985, 
two were in the first year* of the admissions study (November 1985 to 
November 1986), two in the second year, three in the third and nine in the 
last year. Five of the admissions for psychosis were in the final year of the 
study. The HIV status of the patient was not known in 13 admissions 
(including all six in the IDU admitted for six détoxifications, the eight month 
admission originally for detoxification and the homosexual patient who was 
admitted with depression). Two patients learnt of their HIV infection during 
their psychiatiic admission. CDC stage was recorded in foui* admissions 
(CDC stage 2/3 in three, stage 4c2 in one) and CD4 count in fom* (two were 
less than 200 cells/mm^ and two were between 250 and 350 cells/mm^).
Other admissions
Haematological admissions
Thiify five admissions to the City Hospital were because of anaemia (17), 
neutropenia (2) or thrombocytopenia (16) and accormted for 229 days in 
hospital. Nineteen were male IDUs, seven were female IDUs and nine were 
homosexual men. One patient with thrombocytopenia was admitted to the 
Royal Infiimaiy for a splenectomy. In a further five admissions there was a 
second diagnosis of anaemia, in fom* there was a second diagnosis of 
thrombocytopenia (in one of these the primary diagnosis was of a black eye) 
and in one there was a second diagnosis of neutr openia (primary diagnosis 
was a chest infection). Not smprisingly patients with haematological 
manifestations also had more advanced disease - 34 of the 36 admissions 
with a primary haematological diagnosis had CDC stage 4 disease (all 
patients with problematical thrombocytopenia were classified as having CDC
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stage 4e disease). Twenty two admissions were for blood transfusion, 15 in 
patients with AIDS.
Admissions for day tr eatments
Foify seven admissions, all to the City Hospital, were for treatment pulses, 
including blood transfusion. Twenty two were for blood transfusion, ten for 
intravenous immunoglobulin, seven for chemotherapy, thr ee for intravenous 
dextran, one for platelet transfusion and three were for pentamidine 
(intravenous in two cases). Two other patients had a blood transfusion and 
one had an immunoglobulin infusion during admissions for other reasons. 
One patient received both intravenous immunoglobulin and pentamidine 
during the same admissions. Most patients were day patients but the total 
days used for "day" treatments was 103. This includes two patients who 
remained in hospital for 18 and 12 days each. Of the 47 admissions, 25 were 
in men, 22 in women, 29 were in IDUs, 12 in homosexual men, four in 
heterosexuals and two were in blood transfusion recipients. In only five 
admissions was CDC disease stage 2 or 3. The mtravenous immrmoglobulin 
was administered in all cases (to five patients) for prophylaxis of recurrent 
bacterial infections, the chemotherapy was for Kaposi's sarcoma in all three 
patients, the pentamidine was for PCP prophylaxis and the dextran was a 
trial tr eatment for thr ombocytopenia.
Admissions for investigations
Forty five admissions were for investigation of HIV symptomatology 
which was thought to indicate advancing HIV disease ie "AIDS related 
complex" symptoms. This categoiy comprised patients admitted for 
investigation of weight loss (16 admissions), fever (3), lymphadenopathy (3), 
non-specific investigations (17) and starting zidovudine (6). The 16
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admissions with weight loss had an average admission of 12 days (total 194, 
range 1 - 3 3 )  and nine had additional diagnoses (diaixhoea, fever, myalgia). 
The 17 admissions for general investigations had an average admission of 7.3 
days (total 125, range 1 - 24) and four had additional diagnoses (pneumonia 
in two and a urinary tract infection in one). Of the thiee admissions for 
lymphadenopathy, one was to another hospital and a biopsy was callied out 
which showed "reactive changes". The six admissions to stait zidovudine 
were all in IDUs with CDC stage 4.32 disease and all between October 1987 
and January 1988, shortly after zidovudine had become available in the UK. 
Most of these patients were involved in pharmacokinetic trials and although 
the trials only involved a short admission, these admissions accounted for 69 
days in hospital. In ten admissions a second diagnosis came under this 
categoiy (weight loss in four*, starting zidovudine in two, fever in two).
Of these 45 admissions, 26 were in men, 19 in women, 34 in IDUs, seven 
in homosexual men, three in heterosexuals and one in a tr ansfusion recipient. 
Twelve patients had CDC stage 2 or 3 disease (and spent 58 days in hospital) 
and 33 had stage 4 disease (384 bed days).
Dermatological admissions
Eight patients were admitted because of herpes zoster and this diagnosis 
accounted for 72 bed days. The site of the zoster was specified in one case 
only and was ophthalmic. One patient had a second diagnosis of non 
Hodgkins lymphoma and one of KS. Two of these patients had CDC stage 3 
disease (the rest being stage 4), one of whom was also known however to 
have chronic liver disease. In one patient the primaiy diagnosis was of 
neutropenia but the second diagnosis was shingles.
Seven patients were admitted with a variety of other miscellaneous skin 
conditions; heel sore (2), erysipelas, seborxhoeic dermatitis, skin ulcer, skin
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"infection" and thiombophlebitis. Four patients also had a second diagnosis 
of skin disease; eczema, psoriasis, orbital cellulitis and wound infection.
Cardiac admissions
Six admissions were for primaiy cardiac reasons. One patient was 
admitted on two occasions (for a total of 38 days) because of 
cardiomyopathy and car diac failure. He was already known to have atypical 
mycobacterial and CMV infection. One patient was admitted because of 
progressive valvular disease and one for tricuspid incompetence. One male 
IDU was admitted for 33 days because of staphylococcal pericarditis. He 
developed renal failure and cardiac tamponade and was transfeired to the 
Royal Infirmary for pericardial aspiration. There were six admissions due to 
endocar ditis, all of which were before 1986; these admissions have already 
been documented in the section on drug related admissions.
Admissions for malignancv
Nine admissions were primarily because of malignancy (apart from those 
already documented for chemotherapy). Five were for KS (two patients died 
during these admissions), thr ee were in one patient who had lymphoma and 
who also died in hospital and one was another lymphoma patient. These 
admissions accounted for 129 bed days. In eight admissions there was a 
second diagnosis of malignancy - seven KS, one lymphoma.
Admissions for septicaemia
In five admissions the diagnosis was of septicaemia (aheady discussed in 
the chest and GU sections). A somce was specified in two cases (urinary
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tract and chest) and an organism in another two - E. coli and pseudomonas. 
This latter patient who already had CDC stage 4.31 disease was hospitalised 
for 81 days. The other admissions with septicaemia were all for less than ten 
days. One patient, who had CDC stage 3 disease, was admitted twice within 
the space of six months with two episodes of septicaemia.
ENT admissions
Four admissions were for sinusitis, one patient requiring a sinus puncture. 
One admission was for tonsillitis.
Social admissions
Three admissions were for primary social reasons and this was a second 
diagnosis in a further two cases.
Tropical admissions
Three patients were admitted because of tr opical conditions - two with 
malaria and one with visceral leishmaniasis.
Miscellaneous admissions
Two admissions to the City Hospital and two to other hospitals were 
because of atypical mycobacterial infection. One was for disseminated 
CMV infection. One was for incision of an abscess following which the 
patient died post-operatively. One admission was solely for terminal care.
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Discussion
Drug, alcohol and tr auma related diagnoses accounted for 220 admissions 
and 1403 bed days. This amounts to 24% of all admissions and 16% of all 
bed days in this study. Only one of these patients had AIDS and in those 
who had a CD4 count recorded at the City Hospital, none were below 100 
cells/mm^.
Whilst admissions to other hospitals for drug related diagnoses were 
relatively short, admissions to the City lasted longer, particularly in patients 
with abscesses, endocarditis and the patient with the hindquarter amputation. 
Admission to the City Hospital in patients with drug related rather than 
purely HIV related diagnoses may have been chosen by the referring 
practitioner because the patient also had a secondary medical problem. Drug 
related problems may have been complicated by non-specific medical 
problems and this may account for the longer stays in the City Hospital. 
Only two patients with overdose (usually short admissions) were referxed to 
the City Hospital. This reflects the policy in Edinbmgh of admitting all 
overdoses to the regional poisons centre in the Royal Infirmary. 
Undoubtedly other patients admitted to the City Hospital had also 
"overdosed" on admission but the medical problems (eg related chest 
infections) overshadowed overdose as a documented reason for admission. 
The short admissions for overdose reflect the types of drugs taken in 
overdose. These were predominantly drugs of abuse readily available, with 
or without a prescription, to IDUs who had "accidentally" taken too much, 
become unconscious and were therefore admitted to hospital. Most of these 
patients had not intentionally meant to "overdose". The short dmation of 
stay also reflects the uncomplicated natur e of the overdoses and that many of 
the patients self-discharged.
Only 29 admissions to the City Hospital and 14 to the Royal Edinburgh 
Hospital were for detoxification. The smaller number of admissions to the
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Royal Edinbmgh Hospital reflects that hospital's policy on admissions for 
detoxification. Dming the year s studied, although drugs of dependence were 
prescribed, the City Hospital RIDU was neither a drug dependency or 
detoxification unit nor was there a psychiatrist attached to the unit. 
Nevertheless some patients were stabilised, even if not completely 
detoxified. Many of the medical admissions amongst the IDUs may have 
been longer than anticipated because of some degree of drug stabilisation and 
detoxification. Even admissions for detoxification which were deemed 
unsuccessful may have resulted in tempormy alleviation of a crisis situation.
Clearly many of the drug related admissions may not have been HIV 
related. This can only be confirmed by a comparative study of HIV negative 
but otherwise matched drug users which unfortunately has not been possible. 
But because these admissions are not purely "HIV related" does not mean 
that they are not part of the HIV epidemic. Patients who are HIV positive 
are likely to be depressed and may have more ready access to prescibed 
drugs cf one overdose of prednisolone and one of zidovudine (in a 
homosexual man).”  ^ Drug users, in whom the usual response to crisis may 
be overdose or further substance misuse, may have taken an overdose in 
reaction to bad news about their HIV infection. They may revert to more 
chaotic injection use and therefore have more injection related injmies. 
Injection related injmies may have become more traumatic because of HIV 
related thr ombocytopenia and a predisposition to infection. Endocarditis has 
been well documented to be a much more serious illness in HIV positive 
patients^® but was not the case in this Edinburgh study. The episodes of 
endocarditis were all before 1986 and therefore occmred very eariy within 
the natural history of these patients' HIV infection. Since 1986 there has 
been a decline in the amount of injection use within Edinburgh.
This study does bear out the changing pattern of drug use in Edinbmgh as 
has been documented e l s e w h e r e . ’‘5.’le Many injection related problems, most 
notably endocar ditis and acute hepatitis B, were treated in the RIDU before
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the advent of HIV in Edinburgh. Indeed it was because of this link that the 
RIDU became the main refenal centre for HIV infection in Edinburgh. 
However no patients were seen between late 1985 and 1989 with acute 
hepatitis B and there were only six admissions with endocarditis. The 
epidemic of injecting was mainly in the ear ly 1980s when there was also an 
epidemic of acute hepatitis B. The pattern of injecting changed initially 
because of the difficulty in obtaining heroin, and later because of the 
widespread knowledge of the HIV epidemic and methadone maintenance 
prescriptions. Edinbmgh IDUs followed their Glasgow colleagues by 
initially tmning to pharmaceutical prepar ations, particularly buprenorphine, 
benzodiazepines, Diconal and latterly c y c l i z i n e . ^ ^ . n s . u ?  Although these tablets 
when injected are less likely to cause problems with infection than street 
heroin they are chemically irritant. Diconal and temazepam can cause a 
char acteristic skin necrosis and r h a b d o m y o l y s i s ^ ^ . !  17-120 which accounted for at 
least two admissions in this study.
Respiratory admissions were the second most common reason for 
hospitalisation, the most common reason for admission to the designated 
HIV miit at the City Hospital and accormted for most hospital bed days 
overall. That only 27% of the respiratory admissions were due to PGP 
contrasts sharply with studies fiom other UK centres where over 50% of 
chest admissions are due to PCP.’^ ” ^^ The preponderance of BCIs in IDUs 
is one of the most str iking findings of the whole Edinbmgh admissions study 
and it is of particular' note that most of these patients had not progressed to 
CDC stage 4 disease.
The annual incidence of chest infections requiring admission to hospital 
within the general population aged 15 to 44 in Edinburgh in 1985-86 was 0.9 
per 1000 (0.3 per 1000 for non pneumonic chest infections and 0.6 per 1000 
for pneumonia). Between 1980 and 1986 there were 20 hospital discharges 
for drug-related pneumonias in Edinbmgh ie 2.85 per year (personal 
communication. Information and Statistics Division, Common Services
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Agency, Scotland). Dming 1985-86 there were an estimated 2000 IDUs 
within Edinbmgh.’'  ^ Thus, before there was any discernable clinical effect 
of HIV (ie before or within the first two years of the epidemic) the annual 
drug-related pneumonia rate was 1.4 per 1000, compared with 0.6 per 1000 
for the general population. In comparison, for HIV positive patients the 
annual number of admissions for pneumonia or non pneumonic chest 
infections was 12. Fifty percent of the estimated 2000 IDUs in Edinburgh 
are assumed to be HIV i n f e c t e d , yielding an estimated annual incidence 
of 12 per 1000 for pneumonia or non pneumonic chest infections in HIV 
positive IDUs in the whole of Edinburgh. This represents an eightfold 
increase in susceptibility to pneumonia compared with other IDUs, and a 
twentyfold increase compared with the general population. At present there 
are no statistics specifically for HIV negative IDUs, but the figure of 1.4 per 
1000 admissions between 1980 and 1986 would seem to be a reasonable 
assumption. Thus the high incidence of BCIs in HIV positive IDUs from the 
above calculations seems to be more a featme of HIV disease rather than of 
drug use. This conclusion is in line with a previous study from New York 
which reported a fivefold increase in the incidence of bacterial pneumonia in 
IDUs with HIV infection but without AIDS compared with then HIV 
negative counterparts in an out-patient methadone maintenance programme.®^
Unfortunately this latter study did not report on the clinical state of the 
patients, ie whether the patients were symptomatic (CDC stage 4 disease 
without AIDS) or had early stage 2 and 3 disease. In fact, although the 14 
HIV positive patients who were admitted with bacterial pneumonia in that 
study did not have AIDS, two had developed AIDS by the end of their study, 
two had oral candidosis, one had significant weight loss and three had 
persistent generalised lymphadenopathy. The Edinburgh study demonstrates 
a very high incidence of BCIs in IDUs who were still in the early stages of 
HIV infection. More than 50% of these patients were otherwise classed as 
"asymptomatic" from point of view of their HIV infection. The associated
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morbidity was not insignificant as 43% were hypoxic, 28% were 
hypercapnie and average admission time was ten days. Nor were the 
manifestations of BCIs in HIV disease typical of those seen in the general 
population. The preponderence of haemophilus infections contrasts with the 
incidence in the general population where Streptococcus pneumoniae is the 
commonest organism to be found in young patients with community- 
acquired pneumonia.’23
Apart from the preponderance of BCIs the other striking featme was of 
only a single case of tuberculosis. This is in matked contrast to other studies 
of IDUs, from Europe and the US, where tuberculosis is one of the most 
common manifestations of HIV disease.^^ ’^  ^ The reasons for these may be 
the low incidence of tuberculous infection in the UK and the protective 
effect of BCG v a c c i n a t i o n . ’26 J q  explore this more fully a fuifher study 
was caiiied out to assess the percentage of HIV positive patients who had 
received BCG vaccination in the schools programme and the percentage who 
had evidence of tuberculous infection as manifest by a positive Heaf test 
when aged 11 (see chapter fom).
Of the 101 admissions with gynaecological and genito-urinary (GU) 
diagnoses, 63 were to hospitals other than the City. These diagnoses 
therefore accounted for the most frequent reason, second to diug-related 
admissions, for HIV patients to be admitted to other hospitals. Gynaecology 
and obstetiic seiwices in Edinbmgh aie mainly based in the Royal Infhmaiy 
and Eastern General hospitals although at the beginning of the study there 
was also a unit in the Western General Hospital. Gynaecological and genito- 
minary admissions accounted for a total of 546 days although if  the two 
longest admissions of 53 and 38 days are excluded, the average length of 
admission is short at 4.4 days. It is of note that the admissions to the City 
Hospital were longer - ten days compared with 2.3 days to other hospitals. 
Most of the admissions under this categoiy to the City were for prostatitis 
and urinaiy tiact infections.
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Altogether 79 of these GU admissions were in women. It is not smprising 
that most of these admissions were due to pelvic inflammatory disease - it is 
only suiprising that out of a total of 359 admissions in women during this 
study, only ten women (26 admissions) were admitted with pelvic 
inflammation. With 12 of the 26 admissions by heterosexually infected 
women, these admissions may reflect the high prevalence of sexually 
transmitted diseases among commercial sex workers. Although data have 
not been collected on the number of women attending the City Hospital 
clinic who were commercial sex workers, our impression is that it is a lot 
lower than in other cohorts of IDUs and heterosexually infected women. 
The admissions with prostatitis and minaiy tiact infection, most of which 
were in patients with CDC stage 2 and 3 disease, reflects the problem of 
recmxent bacterial infections requiixng hospital admission. That more 
women than men were admitted with urinary tract infection is consistent 
with the prevalence of minaiy tract infection among the general population, 
but few women in the general population would requhe hospital admission 
for a minaiy tiact infection. This would suggest that HIV infected women 
were more likely to present with fever and systemic symptoms rather than 
with localised symptoms and signs. Because of the large number of in 
patient requests for mine cultme compaied with the few admissions for 
minaiy tract infection a separate study was caixied out to assess the 
prevalence of bacterimia in these patients (see chapter fom).
The 98 admissions with a primaiy diagnosis of GI disorder accounted for 
984 days in hospital. The longest admission was 85 days in one homosexual 
patient who had a protein-losing enteropathy. In 77 admissions the patients 
were IDUs. Sixty nine admissions were in men and the 29 women were 
disproportionately represented amongst the admissions for cholecystitis and 
oesophagitis. Why so many more men than women were admitted with other 
GI diagnoses is not cleat'. GI related admissions and diseases are much more 
common in other cohorts, particularly in cohorts of homosexual men.’2?
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CMV colitis and cryptosporidiosis aie less common as AIDS defining 
diagnoses amongst IDUs whereas oesophageal candidosis is a more common 
AIDS defining diagnosis in IDUs and in w o m e n . Only six admissions 
were for oesophageal candidosis but this is a condition which is often 
diagnosed and ti eated as an out-patient. It is of note that none of the patients 
in this study were admitted with CMV or ciyptosporidial colitis. In fact very 
few pathogens were identified as a cause of diarrhoea in this study and only 
14 admissions were for diaixhoea of unidentified cause. Most of the patients 
in whom pathogens were identified were homosexual men (four homosexual 
men, thiee IDUs) but most (12/14) of the admissons for diaixhoea of 
unknown cause were in IDUs. In the out-patient setting IDUs presenting 
with diaixhoea aie often diagnosed as having oveiflow diaixhoea secondaiy 
to opiate induced constipation. But fiom this in-patient data only nine 
admissions were for constipation. However constipation is often diagnosed 
and treated as an out-patient and does not usually require hospital admission.
It is also smprising that only 11 admissions were for hepatic diagnoses. 
Most cohorts show a high incidence of liver related disorders since hepatitis 
B and C are often acquired via the same route as HIV and heavy alcohol 
consumption has also been found in homosexual and IDU c o h o r t s .  
Some cohorts of "asymptomatic" HIV patients have shown greater morbidity 
and mortality from hepatic disease than fiom HIV,® ’^®2,i33 hepatitis C is 
thought to pmsue a more aggressive course in HIV infected p a t i e n t s . O f  
the six patients admitted with liver problems, two died within the study 
period (one at home and one in hospital). In the patient who was treated 
with interferon, chronic liver disease was thought to be an important 
contributing factor to his death. Only two patients were admitted with acute 
hepatitis. Many of these patients had acquired hepatitis B during the 
1982/1983 Edinbmgh epidemic and had been admitted before the study 
period.^
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With 80 admissions to the City Hospital, neurological diagnoses were the 
second most common reason for admission there. Only 11 admissions were 
to other hospitals, eight of which were to the Institute for Neurological 
Sciences in the Western General Hospital (one for a brain biopsy, one for a 
cervical foraminotomy and six for seizures). Apart from emergency 
admissons with seizures, patients with neurological symptoms tended to be 
admitted to the City Hospital for initial investigations. The low number of 
patients admitted to the neur ological centre reflects the co-operation between 
the Infectious Diseases and Neurological departments in that most patients 
who required a specialist neur ological opinion were seen in the City Hospital 
by a consultant neurologist who consulted there regularly. CT brain scans on 
in-patients in the City Hospital were caixied out in the Royal Infiimary or 
Western General hospitals.
Although only 27 admissions were with AIDS-defining diagnoses 
(cerebral toxoplasmosis, lymphoma, dementia, CMV retinitis and 
ciyptococcal meningitis) the neurological categoiy contained more 
admissions to the City Hospital in AIDS (42) than in non-AIDS (38) patients. 
However, out of 39 admissions with seizures, blackouts and headaches only 
seven were in patients with AIDS. In many other centres these symptoms 
would raise a high suspicion of an AIDS defining diagnosis - for example 
seizures would generally herald a diagnosis of cerebral toxoplasmosis or 
lymphoma. But in this group of patients, seizures were most likely to be due 
to withdrawal from benzodiazepines and blackouts were also usually dmg 
related. It is also interesting that 59% (23 of 39 admissions) of these 
admissions were in women and this may reflect differential patterns of dmg 
taking between men and women or more readiness to seek medical care for 
symptoms of blackouts.
The long length of hospital stay in this categoiy (13.1 days) reflects the 
more complicated nature of these admissions. Many of the patients with 
long admissions had concomitant AIDS diagnoses and three patients died at
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the end of these admissions. The paiticularly long stay for homosexual men 
(19.6 days) is partly skewed by one patient who remained in hospital for 93 
days, but generally reflects the more advanced disease in that patient group 
compared with the others, paiticularly the IDUs. The 1 1 patients admitted to 
other hospitals had an average length of stay of only 4.9 days. This was 
because patients admitted to the Institute of Neurological Sciences were 
admitted there mainly for diagnostic purposes only and were later transfered 
to the City Hospital for on-going medical care. The admissions with seizmes 
were also short and reflected emergency caie only although one woman with 
status epilepticus was hospitalised for eight days.
It is smprising that in a study of 910 admissions of HIV positive patients, 
many of whom might be likely to develop depression on learning of their 
diagnosis and many of whom were IDUs from socio-economically 
disadvantaged backgrounds, only 38 admissions should be for psychiatiic 
disorders. Admissions for detoxification to all other hospitals other than the 
Royal Edinbmgh Hospital are described in the section on drag related 
admissions. If the Royal Edinbmgh Hospital admissions for detoxification 
are discounted then only 24 admissions were with psychiatiic diagnoses.
Other studies have documented a high level of psychiatiic morbidity in 
IDUs, homosexual men and HIV positive p a t i e n t s . Reasons for the 
discrepancy between the Edinburgh study and other studies is that most 
psychiatiic diagnoses aie made and treated as out-patients and that other 
studies often include drag and alcohol dependency, overdose and drag 
detoxification as psychiatrie disorders. Nevertheless an increased incidence 
of psychoses has been found in HIV infected patients and depression, 
paranoia, dementia and delirium have all been associated with A IDS.’35.137.138 
In a San Francisco study of 60 patients with advanced HIV infection, 60% of 
the patients had their first psychiatric hospitalisation after their HIV 
infection. ’34 The increased number of Edinburgh admissions in 1989 may 
have been as a result of the HIV epidemic. In the two IDUs who had five
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admissions due to psychosis, all were following a diagnosis of HIV 
infection. The other two patients admitted for psychosis both leamt of their 
HIV positivity during that admission.
The low number of admissions for detoxification to the Royal Edinburgh 
Hospital is a reflection of Edinburgh psychiatric policy. Services for drag 
users aie on an out-patient basis and there is no specific ward for drag users 
nor for detoxification. The Royal Edinbmgh Hospital's policy is that one 
drag user at a time may be admitted to each of fom acute sector wmds for 
inpatient detoxification.’®^ Between 1983 and 1988, 538 IDUs were seen at 
the Royal Edinbmgh Hospital, and double that number had been referred to a 
psychiatrist from the self poisoning unit, prison and other agencies.*®® The 
Community Drag Problem Service was therefore established in 1988 to co­
ordinate sei*vices for drag users in the community.*®® In the 18 months after 
the Community Drag Problem Service was instituted, 373 drag users were 
referred there by general practitioners.
All admissions for overdose in Edinbmgh are to the Regional Poisons Unit 
in the Royal Infiimaiy. Overdose inpatients aie offered psychiatric 
consultation with the liaison psychiatiist and any patients requiring fuifher 
psychiatiic in-patient caie aie then tiansfeiTed to the Royal Edinbmgh 
hospital.
From 1985 many IDUs with psychiatiic diagnoses were seen and admitted 
to the Infectious Diseases Unit at the City Hospital, although a psychiatric 
diagnosis may not have been the primaiy reason for admission. Some 
patients who were admitted to the City Hospital for medical reasons turned 
out to have a primaiy psychiatiic diagnosis. Other patients may have been 
admitted with a psychiatiic diagnosis to the City because of easy access to 
the wai'ds or because the patients had previously been admitted and knew the 
staff well. The admissions to the City Hospital were with "softer" 
psychiatiic diagnoses and less were for psychosis - fom admissions were for
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depression, foui' for anxiety, two for unspecified psychosis and one for 
?organic psychosis.
In summaiy, analysis of hospital admissions by HIV positive patients 
between 1985 and 1989 in Edinbmgh showed a preponderance of diagnoses 
which were not classically associated with advanced HIV disease. Veiy few 
of the admissions to the other hospitals were with AIDS. Drug related and 
respiratory diagnoses accounted for 45% of all hospital admissions. Many of 
these admission were in patients with "asymptomatic" HIV disease. To 
further assess the proportion of admissions by patients who had not 
progressed either in tenus of clinical disease or low CD4 count, analysis was 
perfoiined of admissions by CD4 count, CDC stage, by diagnosis of AIDS 
and hospital and yeai' of admission (chapter three). Because risk group and 
sex were likely to account for many of these differences, these also were 
analysed. An analysis was also made of AIDS patients and of réadmissions.
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In tr o d u c tio n  an d  m e th o d s
The analysis of Edinburgh HIV admissions by discharge diagnosis gives a 
useful picture of the early natmal histoiy of HIV infection and the illnesses 
seen in one city within the early yeais of an epidemic. A more formal 
evaluation of these admissions analysed by risk factor, sex and clinical and 
laboratory stage of disease is necessaiy to complete the picture. Analysis of 
these variables along with year and hospital of admission would be of 
immense value as a study of health care utilisation and for planning future 
resources. This chapter documents these analyses. An analysis was also 
performed to assess if the likelihood of réadmissions could be determined 
from patient char acteristics on the first admission. Some predictions of the 
likelihood of readmission could be of use clinically, for preventive strategies, 
and also to assist in predicting short term health car e resour ce requirements.
The database was as for chapter two. Analysis was mainly in the form of 
descriptive epidemiology with statistics calculated using the software 
packages "Epi Info 5.01b" (for chi squared tests) and "GLIM 4" (for logistic 
regression). Possible associations between outcome and variables of interest 
were tested using Yates corrected chi squared tests. Confidence limits for 
odds ratios were calculated at 95%. The models for the logistic regression 
are described stepwise in the section on réadmissions. The readmission 
analysis used was to predict the likelihood of any readmission within the 
study period. The analysis did not determine whether the patient would have 
single or multiple réadmissions, nor the likelihood of readmission over 
shorter time periods. Data for each patient's first admission were extracted 
fi'om the database file and patients were categorised into two possible 
outcomes - of single admission or readmission.
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Results
Synopsis
A total of 910 admissions were recorded; 612 to the City and 298 to other 
hospitals (figure 3.1). These accounted for 8738 bed days. Most admissions 
to the hospitals other than the designated HIV unit were not classically HIV 
related and mainly comprised complications of dmg use and gynaecological 
admissions. The number of admissions per patient ranged fiom 1 to 30. 
Mean length of admission was 9.6 days although this varied markedly 
between risk groups, sex and year of admission. There was a virtual 
doubling of admissions to the City Hospital over each one year period with 
the percentage of admissions by AIDS patients rising from 14% in the first 
year to 42% in the last. The average length of stay for AIDS patients and for 
homosexual men fell over the four year- period. Longer admissions in 
patients with CD4 cormts <200 cells/mm^ or with stage 2 or 3 disease were 
predictors of readmission during the study period.
Analysis by sex did not show great differences between men and women 
other than the differences accounted for by risk factor. Analysis by risk 
factor showed marked differences in admission patterns. Admissions among 
homosexual men were significantly more likely to be for AIDS related 
conditions, admissions among IDUs were significantly more likely to be for 
bacterial infections and admissions among patients with heterosexually 
acquired HIV infection were significantly more likely to be for pelvic 
inflammatory disease and for AIDS related diagnoses when compared with 
IDUs. Of the 611 City Hospital admissions in which CDC staging was 
available, 246 (40%) were in patients with CDC stage 2 or 3, 170 (28%) in 
patients with stage 4 disease but without AIDS and 195 (32%) were in 
patients with AIDS. Analysis by CD4 cormt revealed similar* results with 
48% admissions in which a CD4 count was recorded being over 200
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cells/mm^. As admissions by AIDS patients rose, the average CD4 count fell 
over the four year period.
Analvsis bv risk group
Seven hundred and two (77%) admissions were in IDUs, 136 (15%) in 
homosexual men, 62 (7%) in heterosexuals and 10 in blood product 
recipients (figure 2.1).
Analysis by discharge diagnosis showed veiy different patterns between 
risk groups (table 3.1). For the homosexual men the most striking feature 
was the preponderance of AIDS related diagnoses. Of the 105 admissions 
for purely AIDS related diagnoses (PCP, toxoplasmosis, KS, CMV disease, 
lymphomas, disseminated mycobacteriosis, oesophageal candidosis and 
herpes and AIDS dementia), 65 were in homosexuals, 28 were in IDUs and 
12 in heterosexuals. These 105 admissions were not the only ones in AIDS 
patients but were those specifically related to AIDS (therefore excluding for 
instance an overdose admission by an IDU who had AIDS). Admissions by 
homosexual men were 12 times more likely to be for AIDS specific 
diagnoses than admissions by IDUs (odds ratio (OR) = 22.04, confidence 
limits (cl) 12.91-37.78, relative risk (RR) = 11.98, chi square = 217, 
p<0.0001). The 65 AIDS related admissions in homosexuals included 26 for 
PCP, 14 (in six patients) for toxoplasmosis, five for CMV disease, five for 
KS, five for lymphoma and seven for chemotherapy for either KS or 
lymphoma. Indeed homosexuals were the only risk group to be admitted 
with KS or lymphoma. Homosexuals also accormted for the only admissions 
with disseminated tuberculosis (two admissions in one patient) and atypical 
mycobacteriosis (two admissions). The 26 admissions with PCP compares 
with 16 in IDUs and six in heterosexuals. Therefore admissions among 
homosexual men were seven times more likely to be for PCP compar ed with 
admissions by any other risk group (RR=^6.73, OR=8.08, cl 4.25-15.38,
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p<0.0001). This difference was paiticulaidy marked when comparing 
homosexual with IDU admissions alone (OR—10.13, cl 5.04-20.52, 
p<0.0001) whereas although admissions by homosexuals were twice as 
likely to be for PCP compared with admissions by heterosexuals, tliis did not 
reach statistical significance. The five admissions among homosexual men 
for CMV disease compares with only one other admission by a female IDU 
for this condition (OR=26.76, cl 2.94-1267.17, p<0.0001). The 14 
admissions for toxoplasmosis compares with the five admissions by one 
female heterosexual for cerebral toxoplasmosis; this was not statistically 
significant. Of all the other ("non AIDS") diagnoses there was no 
preponderance of homosexuals. Of the 41 admissions for anaemia, 
neutropenia and blood transfusion, 11 were in homosexuals and 28 in IDUs; 
but of the 27 admissions for thrombocytopenia and immimoglobulin 
tr eatment, 24 were in IDUs and only one in a homosexual (neither of these 
were statistically significant). In conclusion, admissions by homosexual men 
were significantly more likely to be for AIDS related diagnoses when 
compared with admissions by any other risk group and this was mostly 
related to diagnoses of KS, lymphoma, CMV and PCP. The main reason for 
these AIDS related differences is because the homosexual men had been 
infected longer than the IDUs and heterosexuals and were therefore in a 
more advanced stage of disease.
With only 28 of 105 AIDS related diagnoses in IDUs, IDUs were 
significantly less likely to be admitted with AIDS related conditions. In fact 
the only AIDS categories where there were more admissions by IDUs than 
by other risk groups were for oesophageal candidosis (four IDU, one 
heterosexual and one homosexual admission) and AIDS related dementia 
(five IDU, one homosexual). Clearly most of the admissions by IDUs were 
for diagnoses not specifically AIDS related. Although more admissions for 
investigation of headaches, fits, drop attacks, weight loss, pyrexia and 
lymphadenopathy, and for psychiatric and haematological diagnoses were by
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IDUs than other risk groups, the proportion of admissions is as expected 
given the preponderance of IDUs attending the clinic and being admitted. 
The main excess of admissions by IDUs lay in the 220 admissions for drag 
related diseases (injection injuries, overdose, withdiawal) and trauma. The 
other main reason for admission by IDUs was for chest and other bacterial 
infections and it was clear that there was a significant difference between 
IDUs and all other risk groups for these admissions (chi square with Yates 
correction=7.11, p<0.01). This difference was particularly striking for 
bacterial chest infections alone, as was the difference between admissions by 
IDUs and homosexuals for all bacterial infections.
With only 62 admissions by heterosexuals it was more difficult to assess if 
they were any more likely to be admitted with any paiticular diagnoses. 
However their admissions were five times more likely to be with AIDS 
related diagnoses when compared with IDUs (0R=5.78, cl 2.60-12.71, 
RR=4.85, p<0.0001). Admissions for pelvic inflammatory disease (PID) 
were nine times more common amongst heterosexuals than amongst IDUs 
(12 heterosexual and 14 IDU admissions, O R^ll.79, cl 4.81-28.85, 
RR^9.71, p<0.0001) although they were no more likely to have been 
admitted for teimination of pregnancy (one heterosexual, nine IDUs), 
pregnancy (four IDUs only), urinaiy tiact infection (12 IDUs, thiee 
heterosexuals) or other gynaecological disorders.
There was a striking difference among risk groups with respect to lengths 
of admission - ranging from a mean of 16.7 days in the homosexual men to 
8.5 days in the IDUs and 7.6 days in the heterosexual group. This variation 
probably accounted for the difference in length of stay between men (10.1 
days) and women (8.9 days). Analysis by year shows this effect to be even 
more pronounced (table 3.2). Eleven homosexual men were admitted in the 
first year and average length of admission was 30.7 days; in the second year 
it fell to 20.6 days in the 22 homosexual admissions; in the third year it was 
12.3 days for the 42 admissions and in the last year it was 15.7 days for the
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61 admissions. The percentage of admissions among the homosexual men 
rose over the study period. In the fust year 7% (11) admissions were in 
homosexual men, 15% (22) in the second yeai, 19% (42) in the thiid and 
16% (61) in the last. Concomitantly the percentage of admissions amongst 
IDUs fell from 87% (139) in the first yeai' to 78% (117) in the second year, 
76% (168) in the third and 73% (278) in the final year.
Analvsis bv sex
Men accounted for 551 (61%) admissions and women for 359 (39%). 
Most differences between the sexes when analysed by diagnostic categoiy 
were probably related to risk group. Diseases specific to women (PID, 
pregnancy, teimination of pregnancy and other gynaecological conditions) 
accounted for 56 admissions. All the female genito-urinaiy conditions (ie 
adding uiinaiy tiact infections and genital waits to the above list) accounted 
for 79 of the 359 admissions in women. Urinaiy tiact infections were a more 
common reason for admission in women than in men (11 female and two 
male) and another classically female disease - gall bladder disease - 
accounted for six admissions in four women and no men. Investigation of 
fits, headaches and diop attacks were more than twice as common in women 
as in men (24 female and 15 male admissions, OR=2.56, cl 1.27-5.21, chi 
square = 8.32, p<0.005). Women were also over-represented in admissions 
with bacterial chest infections (42 women, 55 men), detoxification (15 
women, 14 men) and overdose (45 women, 55 men) but these differences 
were not statistically significant. Excluding homosexual men, AIDS defining 
admissions followed the general 3:2 pattern except for admissions for 
oesophageal candidosis, the six admissions of which were split equally 
between the sexes.
Of the 220 admissions in women to the City Hospital, 180 were in IDUs, 
33 in heterosexual women and seven in women infected via blood products.
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Almost 52% (113) admissions were in women with CDC disease stage 2 or 3 
and 34% (74) were in women with AIDS. The women with AIDS accounted 
for 36% (903) of the female bed days whereas the women with CDC disease 
stage 2 and 3 accounted for 50% (1258) bed days. O f the 33 admissions in 
heterosexually infected women, 20 (237 days) were in women with CDC 
disease stage 4c 1, two in women with stage 4c2, five in women with stage 2 
and six in women with stage 3 disease. Of the 180 admissions in women 
who were IDUs, 54% (98) were in women with CDC disease stage 2 or 3, 
26% (46) in women with stage 4c 1, thiee with stage 4a, five with 4b, 23 with 
4c2 and five with 4e. The seven admissions in women infected via blood 
products were all in one woman who initially had CDC stage 3 disease and 
later progiessed to stage 4b. Therefore, most (82%) women who were 
admitted were IDUs and most (66%) did not have AIDS. Neveitheless these 
admissions in women without AIDS accounted for 1613 bed days. A greater 
percentage of the admissions in heterosexual women (61%) were in women 
with AIDS compaied with female IDUs (28%) (OR=4.00, cl 1.74-9.28, chi 
squaie with Yates coixection = 12.17, p<0.001). Despite the fact that more 
of the heterosexually infected women had AIDS, lengths of admission were 
similar between the two risk groups (11.8 days for the IDUs, 11.4 days for 
the heterosexuals).
More admissions were in men in almost eveiy categoiy, generally 
following a 3:2 pattern. Of the IDUs, more men than women attended the 
clinic and more male than female IDUs were admitted, added to which were 
the admissions by the homosexual men. Only 11 admissions were for male- 
specific diseases (prostatitis and epididymo-orchitis). Only male 
homosexuals were admitted with KS and lymphoma and only men were 
admitted with liver disease. Men were also over-represented in admissions 
for thi ombocytopenia and immunoglobulin treatment (19 men, eight women) 
but this was not statistically significant.
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Of the 392 male admissions to the City Hospital, 258 (66%) were in 
IDUs, 126 in homosexual men, seven in heterosexual men and one in a man 
infected via blood products. There were maiked differences in CDC 
classification and lengths of stay between risk gioups. One hundied and 
nineteen (46%) admissions amongst the IDUs were in men with CDC disease 
stage 2 or 3, 46 in men with stage 4a, 18 with stage 4b, 21 with stage 4c 1, 34 
with stage 4c2 and 20 with stage 4e. Mean length of admission in male 
IDUs was 9.9 days. This compaies with the 17.1 days for the 126 
homosexual admissions. CDC staging for the homosexual men was; 81 in 
stage 4cl, 22 in stage 4d and only 23 in all the other stages. Thus 82% (103) 
admissions amongst the homosexual men were in men with AIDS. These 
103 men accounted for 1981 bed days (average 19.2 days).
Analvsis bv vear of admission
Of the 910 admissions, 160 (1597 days) were in the first yeai of the study, 
150 (1563 days) in the second, 221 (1863) in the third and 379 (3715) in the 
last year (table 3.3). When the 612 City Hospital admissions are analysed by 
year a slightly different pattern emerges from analysis of the whole study. 
Fifty six admissions (1038 days) were to the City Hospital in the first year, 
85 (1304 days) in the second, 171 (1719 days) in the third and 300 (3241 
days) in the last year (table 3.3). Therefore there was virtual doubling of 
admissions over each year. Concomitantly, lengths of admission fell each 
year fiom 18.5 days in the first year to 15.3 in the second, 10.1 in the thiid 
and a stabilisation at 10.8 in the last yeai (table 3.4). Of the 56 admissions 
before November 1986, 44 (79%) were in IDUs, ten in homosexual men and 
two in the other risk groups; eight admissions were in AIDS patients (who 
accounted for 298 bed days, i.e. mean length of admission = 37 days), 42 
were in patients with CDC disease stage 2 or 3 and the rest were in patients 
with disease stage 4a, 4c2 or 4e. So in this fust yeai’ 14% (eight) of
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admissions were in AIDS patients but they accounted for 29% (298) of the 
bed days (table 3.5). The ten admissions in homosexual men were the 
longest at 31.1 days on average (vs. 16.3 days for the IDUs). Of the 85 
admissions in the second year, 56 (66%) were in IDUs, 22 in homosexuals 
and seven in other risk gioups. Admissions in the homosexual gioup were 
again longer (20.6 vs. 14 days). Almost 24% (20) admissions were in AIDS 
patients and accounted for 41% (535) bed days. In the thhd year, 72% (123) 
admissions were in IDUs, 24% (40) in homosexual men and seven 
admissions were in heterosexuals and one in a blood product recipient. In 
this yeai' 38% (65) admissions were in AIDS patients (accounting for 42% 
(721) bed days) and 40% (68) admissions were in patients with CDC disease 
stage 2 and 3. In the final year the admissions were as follows: 215 (72%) in 
IDUs, 54 in homosexual men, 28 in heterosexuals and thiee in blood product 
recipients. CDC staging was: stage 2 = 1 5  admissions (109 days), stage 3 = 
68 admissions (548 days), stage 4a = 37 (323 days), stage 4b = 18 (244 
days), stage 4cI = 102 (1477 days), stage 4c2 = 38 (378 days), stage 4d = 5 
(58 days), stage 4e = 16 (86 days) and one admission where CDC staging 
was not documented. Therefore AIDS patients accounted for 42% (125) 
admissions and 55% (1779) bed days.
Admissions for most diagnoses, paiticulaily those which were AIDS 
related, followed a stepwise increase (almost doubling) over the years 
studied. However there were some anomalies. Most of the admissions for 
drop attacks were in 1988 (no admissions in the first year, two in the second, 
eight in the third and thiee in the last). Admissions for psycliiatric 
conditions were mainly in the last yeai' as were admissions for investigation 
(10 of 13 admissions) and for anaemia, neutropenia or tiansfusion (17 in the 
thhd year and 24 in the last year). This latter finding is probably due to the 
effect of zidovudine which did not become available in the UK until late 
1987.
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Thus of the 612 City Hospital admissions, not only did the admission 
numbers double eveiy yeai' but the pattern of admissions changed. 
Proportions analysed by risk groups and by sex stayed relatively stable. The 
percentage of AIDS admissions rose yearly fiom 14% (8) admissions in the 
first year to 24% (20) in the second year, 38% (65) in the third and 42% 
(125) in the last (table 3.5). Concomitantly, although the average length of 
stay of AIDS patients fell din ing the study period, the percentage of bed days 
occupied by AIDS patients also rose from 29% (298) in the first year to 41% 
(535) in the second, 42% (721) in the third and 55% (1779) in the last.
The pattern in the 298 admissions to the other hospitals was quite 
different. One hundred and four admissions were recorded in the first year, 
65 in the second, 50 in the thhd and 79 in the last year. Mean length of 
admission was 4.8 days, ranging over the study from 5.4 days in the first 
year to 4 in the second, 2,9 in the third and six days in the last year. Data 
from the first year are skewed by the psychiatric admission lasting 278 days 
and if this is discounted the average in the first yeai' falls to 2.5 days.
The main diagnoses accounting for the decrease in admissions to other 
hospitals over time were overdose and other admissions related directly to 
drug use. O f the 100 admissions to other hospitals with overdose, 38 were in 
the fust year of the study, 29 in the second, 16 in the third and 17 in the last. 
Admissions for overdose, injection injury and detoxification to all the 
hospitals (including the City) decreased fr om 63 in the fust year to 42 in the 
second yeai', 38 in the third year and 43 in the final yeai'. Admissions with 
endocarditis were only in the first year of the study. Other admissions to the 
other hospitals which decreased over the years were admissions for PID, 
teimination of pregnancy and other gynaecological disorders.
82
Analvsis bv hospital of admission
The 612 admissions to the City Hospital were accounted for by 208 
patients. Of these 208 patients, 145 were men and 63 were women; 151 
were IDUs, 42 were homosexual men, 13 had acquired their infection 
heterosexually and two from blood products. Seventy one percent 
admissions (438) were in IDUs, 21% (126) in homosexual men, 7% (40) in 
heterosexual patients and 1% (8) in transfusion recipients (figure 3.2).
The 298 admissions (1436 bed days) to other hospitals were accounted for 
by 121 patients. Most (221) admissions were to the Royal Infirmary, 44 
were to the Western General, 27 to the Royal Edinburgh and six were to the 
Eastern General Hospital (figure 3.1). They were mostly accormted for by 
the 144 admissions for overdose, injection injuries and trauma and by the 63 
admissions for gynaecological and genito-urinaiy diagnoses. Thirty three 
admissions were for gast o-intestinal and 11 for neiuological diagnoses. The 
proportion of women admitted to the other hospitals was much higher at 47% 
(139 admissions were in women, 159 in men). Hospital stays for the women 
were much shorter (2.4 vs. 3.6 days). In 264 of the admissions the patients 
were IDUs, 22 were in heterosexuals, ten were in homosexuals and two in 
blood transfusion recipients (frgme 3.3). Apart from one admission in 1986, 
the homosexual men were not admitted rmtil the last two year s of the study 
period. CDC classifications were not available for patients admitted to the 
other hospitals but most of the admissions (mainly because of the nature of 
the admission) were in patients without symptomatic HIV disease. Of the 
105 admissions with AIDS specific diagnoses, only six were not admitted to 
the City Hospital.
Analvsis bv CDC stage
The 612 admissions (7302 days) to the City Hospital were analysed in 
more detail by CDC stage and CD4 count. Forty percent (246) admissions
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were in patients with "asymptomatic" HIV disease i.e. CDC disease stage 2 
and 3. Thhty six percent (218) admissions were in AIDS patients, 
accounting for 46% (3333) bed days. CDC staging was available for 611 of 
the 612 admissions and was as follows (figure 3.4): stage 2 = 59 admissions 
(711 days), stage 3 = 187 admissions (1875 days), stage 4a = 58 admissions 
(517 days), stage 4b = 26 admissions (325 days), stage 4cl == 170 admissions 
(2806 days), stage 4c2 = 63 admissions (656 days), stage 4d = 22 admissions 
(202 days), stage 4e = 26 admissions (192 days).
Clearly the AIDS specific admissions accounted for most of the 218 
admissions in patients with AIDS. Of the 105 admissions with AIDS 
specific diagnoses, 99 were to the City Hospital. Admissions in patients 
with CDC stage 4 disease were also significantly more likely to be for 
haematological diagnoses (38 admissions in patients with CDC stage 4, three 
admissions in patients with CDC stage 2 and 3 disease, OR=9.41, cl 2.93- 
48.10, chi square wiüi Yates correction = 18.39, p<0.0001).
Of the 65 admissions to the City Hospital for detoxification (28), overdose 
(two) and injection related injuries (35), 52 were in patients with CDC 
disease stage 2 or 3 and 13 in patients witli CDC stage 4 disease (OR=7.26, 
cl 3.72-14.39, chi square with Yates correction, p<0.00001). Admissions in 
patients with CDC stage 2 or 3 disease were significantly more likely to be 
for drop attacks (OR=20.3I, cl 3.60-865.39, chi square with Yates correction 
= 14.32, p<0.0005) but not for fits or headaches. Admissions in patients 
with CDC stage 2 or 3 disease were also significantly more likely to be for 
bacterial infections. Of the 110 admissions to the City Hospital with 
bacterial chest and urinary infections, 64 were in patients without stage 4 
disease and 46 had stage 4 disease (OR=2.44, cl 1.59-3.79, chi square = 
17.01 with Yates correction, p<0.0001). This effect was even more 
pronounced on analysis of all 144 admissions to the City Hospital for 
bacterial infections (89 in CDC stage 3, 55 in stage 4, OR=3.20, cl 2.13- 
4.80, chi square with Yates correction = 35.19, p<0.00001).
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Admissions bv patients with AIDS
There were 218 admissions to the City Hospital in patients with disease 
stages 4c I (170), 4d (26) and 4b (26). However only thr ee of the admissions 
in stage 4b were AIDS defining (AIDS dementia). The other admissions by 
patients in this stage were for patients with memory loss (13 admissions by 
two patients), peripheral neuropathy (five admissions by two patients), HIV 
related myopathy (four admissions by one patient) and organic psychosis 
(one admission by one patient). Therefore a total of 195 (32%) City Hospital 
admissions were in patients with AIDS. These admissions were made by 57 
patients whose number of admissions with and following their AIDS 
defining diagnosis ranged from one to 20 per patient (figure 3.5). Of these 
57 patients, 33 were homosexual men, 20 were IDUs and fom' were 
heterosexual women. Homosexual men were significantly more likely to be 
admitted with AIDS than any other risk group (011=28.88, cl 13.20-64.05, 
chi square with Yates collection = 127.39, p <0.00001). Ten of the AIDS 
patients were women, 47 were men. AIDS defining diagnoses were; PCP 
(34), PCP and lymphoma (one), PCP and KS (one), PCP and cryptococcal 
meningitis and lymphoma (one), oesophageal Candida (five), KS (foui), 
cerebral toxoplasmosis (two), toxoplasmosis and KS (one), CMV (two), 
lymphoma, candidal pneumonitis, oesophageal heipes, AIDS dementia, 
disseminated TB and atypical mycobacteriosis (one of each). Therefore PCP 
was the AIDS defining diagnosis in 65% of patients, with oesophageal 
candidosis the second most common diagnosis. All the heterosexual AIDS 
patients presented with PCP (including one African woman who had both 
PCP and KS), 14 of the IDUs presented with PCP (including one man with 
both PCP and lymphoma) and 19 of the 33 homosexual men presented with 
PCP. Of the other AIDS defining diagnoses amongst the IDUs, four were 
with oesophageal candidosis, one with AIDS dementia and one with 
disseminated TB. Of the ten women with AIDS, eight presented witli PCP 
and two with oesophageal candidosis. None of these differences between
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risk groups and between sexes were statistically significant. Mean CD4 
count at diagnosis of AIDS was 77 cells/mm^ (range 4-270). Patients lived 
on average 11.3 months (range two days to 45 months) and spent 71 days 
(range 2 - 208) in hospital fiom a diagnosis of AIDS to death. Nineteen 
patients died from AIDS (see chapter five).
Analvsis bv CD4 count
Analysis by CD4 count was restricted to the 612 City Hospital 
admissions, in 563 of which (92%) a CD4 count was recorded. CD4 count 
was less than 50 cells/mm^ in 167 admissions, between 50 and 100 cells/mm^ 
in 42 admissions, between 100 and 200 cells/mm^ in 86, between 200 and 
500 cells/mm^ in 166 and above 500 cells/mm^ in 102 admissions (figure
3.6). CD4 counts cleaily became more routine as the years progressed since 
no CD4 count was available in 43% of admissions in the first year of the 
study but this had decreased to 4% in the last yeai'. CD4 count conelated 
with clinical markers of disease progression as defined by CDC staging and 
presence or absence of AIDS. Of the 99 admissions to the City Hospital 
with AIDS specific diagnoses, 65 (66%) had a CD4 count of less than 50 
cells/mm^ and all but 6 (6%) had a CD4 count of less than 200 cells/mm^ 
The diagnoses in the AIDS related admissions with CD4 counts of more than 
50 cells/mm^ were; PCP (17 of 47 admissions), cerebral toxoplasmosis (three 
of 17 admissions), AIDS related dementia (three of six admissions), CMV 
disease (two of six admissions), oesophageal candidosis (five of six 
admissions), KS and lymphoma (two of 11 admissions) and the only 
admission to the City Hospital with tuberculosis. Of admissions in patients 
with disease stage 4.31, 70% (119 of 170 admissions) had a CD4 count of 
less than 50 cells/mm^. Ten (6%) had a CD4 count of over 200 cells/mm^. 
Of the 246 admissions in patients with stage 2 and 3 disease, 76 (31%) had 
CD4 counts of over 500 cells/mm^, 94 (38%) had CD4 counts between 200
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and 500 cells/mm^, and interestingly, 18 (7%) had CD4 counts of below 100 
cells/mni3. Of the admissions in patients with symptomatic HIV disease but 
without AIDS (i.e. CDC stages 4a and 4c2), 42 (35%) had a CD4 count of 
less than 100 cells/mm^ and 78 (64%) had a CD4 count of above 100 
cells/mm^.
When the AIDS specific admissions are excluded, most of the admissions 
are in patients with higher CD4 counts. Of the 65 admissions to the City 
Hospital for detoxification, overdose and injection injuries, 48 (74%) were in 
patients with a CD4 count of above 200 cells/mm^. Of the 144 admissions to 
the City Hospital for bacterial infections, 75 (52%) were in patients with a 
CD4 count of above 200 cells/mm^ and 38 (26%) in patients with a CD4 
count of less than 100 cells/mm^.
Of the 135 City Hospital admissions by homosexual patients, 75 (55%) 
were in patients with a CD4 count of less than 50 cells/mm^ (12% were in 
patients with a CD4 count of over 200 cells/mm^). By comparison a CD4 
count of less than 50 cells/mm^ was found in 11% of City Hospital 
admissions by IDUs and in 24% of admissions by heterosexuals, and a CD4 
count of above 200 cells/mm^ was found in 35% of admissions by IDUs and 
in 18% of admissions by heterosexuals.
Analysis of CD4 count by year of admission reveals similar results to 
analysis by any other measurement of disease progression (CDC stage, 
percentage of admissions in patients with AIDS) in that more admissions 
towaids the end of the study were in patients with more advanced disease. 
Patients with a CD4 count above 200 cells/mm^ accounted for 43% of 
admissions in the first year, 60% in the second, 54% in the third yeai' and 
34% in the last yeai'. In the last year only 8% of patients had a CD4 count 
above 500 cells/mm^ (compared with 27% just one year before) but 37% of 
patients had a CD4 count of less than 50 cells/mm^.
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Analvsis of readmissions
Analysis was peifoimed on the likelihood of readmission with relation to 
patient characteristics on the initial admission. The 612 admissions to the 
City Hospital were accounted for by 208 patients, 89 of whom were admitted 
on one occasion only and 119 who were admitted more than once. Of the 
119 patients readmitted, 83 were male and 36 were female; therefore 57% of 
all men and 57% of all women were readmitted. Initial vaiiables used were 
sex, risk factor, CDC stage and CD4 count. Infoimation on CDC stage in the 
initial database was divided into two categories for comparison (CDC stages 
2 and 3, compared with CDC stage 4) as was that on CD4 counts (CD4 coimt 
of <200 cells/mm3 compared with CD4 count >=200 cells/mm^). Single 
vaiiable analysis was peiToimed using "Epi-Info" to test for associations 
between outcome and these variables. None of these were significantly 
associated with readmission (table 3.6). Although 71% of homosexual men 
were readmitted compai ed with 54% of both IDUs and heterosexual patients, 
this difference was not statistically significant (p=0.2). Variables of age and 
days were analysed as continuous variables, testing for differences in means 
among the two outcomes and no significant difference was seen with age, 
nor with the number of days spent in hospital during the first admission. This 
single variable analysis was also earned out for tluee diagnostic categories. 
The categories chosen were of all respiratoiy admissions (the commonest 
reason for admission by HIV positive patients to the City Hospital), bacterial 
chest infections and PCP (two salient resphatoiy diagnoses which can be 
difficult to differentiate clinically). The results showed that patients 
admitted with respiratoiy conditions were no more likely to be readmitted 
than patients admitted for any other reason. There was also no significant 
likelihood of readmission for patients with PCP or with bacterial chest 
infections compaied with patients without these conditions.
All of the above vaiiables were then used in a multi-variable logistic 
regression analysis using the "GLIM" statistics package. Because of some
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missing data (on CD4 count, CDC stage), 186 obseivations were used in this 
initial model. The significance of the variables in the model were assessed 
by fitting the model with and without each variable in turn and using the 
difference in deviance as a likelihood ratio chi squared test statistic (table
3.7). Again, none of the variables were associated with readmission.
A second model was fitted with all two way interactions. In this 
model, days were not tieated as a continuous variable but initial admissions 
of seven days or less were compared with those lasting over seven days. 
This model was then compaied with the initial model (table 3.8) with a 
resultant p=0.017I suggesting that there were some factors whose effects 
were mediated by those of another. This was investigated using a further 
model (table 3.9). From this, the interactions between days and age 
(p=0.0792), between all respiratoiy admissions and days in hospital during 
the initial admission (p=0.0499) between CDC stage and days (p=0.0377) 
and between CD4 count and days (p=0.0133) were the interactions which 
tended towards statistical significance. A final model was constructed by 
removing all the non-significant (p>=0.05) interactions (tables 3.10, 3.11). 
From this final model, statistical significance was reached for the interaction 
between CD4 count and days, and between CDC stage and days, on the 
likelihood of readmission. The interaction was such that patients with a CD4 
count >=200 cells/mm^ who were admitted initially for more than seven days 
were less likely to be readmitted than those with a CD4 count <200 
cells/mm^ (table 3.12). The interaction between CDC stage and days in 
hospital was in the opposite direction from the CD4 count results. Patients 
with CDC stage 2 or 3 disease who were admitted initially for more than 
seven days were more likely to be readmitted than patients with CDC stage 4 
disease (table 3.13).
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Discussion
The oveiwhelming finding from the above analyses is that despite the 
rising percentage of admissions due to AIDS over the four year period, the 
vast majority of admissions were in patients who did not have AIDS and, by 
CDC staging, many of these patients were classed as having "asymptomatic" 
HIV infection. Of the 611 City Hospital admissions where CDC staging was 
available, 40% of admissions were in patients with CDC stage 2 and 3 
disease. It is likely that most of the 298 admissions to the other hospitals 
were also in patients with disease stage 2 or 3 because most of the 
admissions to other hospitals were for drag related or gynaecological 
diagnoses (and only six were for AIDS specific diagnoses). Therefore a 
figme of 40% of admissions in patients with "asymptomatic" disease stage 2 
or 3 is probably a vast underestimation for the whole 910 admissions. This 
large percentage of admissions by patients with "asymptomatic" HIV 
infection has not been documented in other studies and clearly reflects the 
early yeai s of an epidemic and the laige number of admissions in IDUs. The 
propoitions of admissions in CDC stage 2 and 3 patients fell from 75% to 
62% to 40% and then to 27% over the four years studied. It might be easy 
on first glance to surmise that this was merely due to the effects of drag use 
in the eaily years of the study. However the actual number of admissions in 
patients with CDC stage 2 and 3 disease rose over the course of the study 
(42, 53, 68 and 83 admissions in the consecutive years of the study) and 
these admissions were to the City Hospital where few of the admissions were 
solely drag related and most were due to bacterial infections.
But the effects of drag use on hospital admissions can clearly be seen. 
Fiistly, one stiiking feature of the analysis of admissions to the other 
hospitals is the higher number of admissions to the other hospitals in the first 
years of die study. Indeed in the first year, there were nearly double the 
admissions to the other hospitals than to the City Hospital. This may be 
related to local knowledge about the City Hospital unit. It is possible that in
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the later yeais, once the City Hospital became well known as an admission 
centie for HIV positive patients, that patients with HIV infection and a 
related or nnielated problem were immediately refened up to the City 
Hospital. In eailier yeais it is possible that HIV positive patients were 
refen ed to the usual hospitals and through the usual channels. In some of the 
admissions the patients may not even have been known to have been HIV 
positive at the time of their admission. However, most of the admissions to 
the other hospitals were as a consequence of drag use and the most likely 
explanation is that the amount of injection drag use by HIV positive patients 
decreased over the foui* years. This is also reflected in the fact that the 
percentage of admissions amongst IDUs fell steadily over the four yeais fiom 
87% in the first year to 73% in the last. No admissions for endocaiditis were 
recorded after die first year of the study. Admissions for blackouts were 
almost entirely in IDUs in 1988 which would suggest that these admissions 
were related to a paiticular type of sheet drag which was only available for a 
short time. Admissions for detoxification and for overdose decreased over 
the foui yeai period and only a small cohort of patients accounted for the 
overdose admissions in later years of the study. Duiing the time of the study 
period, changing patterns of drag using behaviour were recorded in 
Edinburgh and it may have been that less injecting and more awaieness of 
the risks of injecting accounted for the fewer admissions due to overdose as 
the yeais progressed.^^-’i^ .ne
Apart from drag use the other main factor accounting for the high number 
of patients admitted with "asymptomatic" HIV disease are the admissions for 
bacterial infections. Bacterial infections accounted for 21% of all 
admissions (189 admissions). Most patients admitted with bacterial 
infections did not have advanced disease. Of the 144 admissions to the City 
Hospital with bacterial infections, 62% had "asymptomatic" HIV disease and 
52% had a CD4 count above 200 cells/mm^. There is however a clear 
interaction between the effects of drag use and bacterial infections. IDUs
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were significantly more likely to be admitted with bacterial infections than 
any other risk group, particulaiiy for BCIs. The large number of admissions 
for bacterial infections could be due to the difficulty in differentiating BCIs 
from oppoitunistic infections in IDUs and lack of physician familiaiity with 
HIV related diseases. But this is not the entire explanation since the 
"asymptomatic" patients with bacterial infections admitted to the City 
Hospital spent longer in hospital than the "symptomatic" patients and 
admissions for bacterial infections continued to rise over the four years 
despite improved physician familiarity with HIV disease. Bacterial 
infections cannot be ascribed solely to the effects of drug use. Admissions 
for PID were significantly more common amongst heterosexual women than 
among female IDUs, although this may be more related to the prevalence of 
sexually transmitted diseases among women who may have a higher number 
of sexual paitners or aie commercial sex workers. It is not cleai' why the 
number of admissions for PID fell over the foui* year period. The 
concomitant fall in the number of admissions for teimination of pregnancy 
may be related to more widespread adoption of safer sex techniques and the 
deshe to keep a pregnancy before the advent of more advanced disease.
Among admissions to the City Hospital, it was expected that the 
percentage of admissions in patients with AIDS should rise (from 14% in the 
first yeai* to 42% in the last) as the epidemic progressed. It is interesting that, 
although bed days for AIDS patients also rose duiing the four years, the rise 
was not in parallel and the mean admission time for AIDS patients fell. This 
probably reflects physician familiarity with the disease and more out patient 
üeatments and caie. Admissions in AIDS patients were usually with AIDS 
specific diseases but admissions for haematological diagnoses were also 
significantly more common amongst AIDS patients and these were mainly 
related to the use of zidovudine which became available for patients with 
AIDS in late 1987. Admissions with bacterial infections were less common 
among patients with AIDS. This may be mainly because most AIDS patients
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were homosexual men who were significantly less likely to be admitted with 
bacterial infections. PCP was the most common AIDS defining diagnosis 
(65% of AIDS defining illnesses) and remained so throughout the four yeai* 
period without any concomitant fall in length of admission. In general, CD4 
count con elated with clinical HIV staging although it is of note that in 7% of 
admissions in patients with CDC stage 2 or 3 disease the CD4 count was less 
than 100 cells/mm^ and that in 6% of admissions in patients with CDC 
disease stage 4c 1 the CD4 count was above 200 cells/mm^. The 
multivariable analysis of réadmissions with reference to CD4 count and CDC 
staging is difficult to explain. That patients with a CD4 count <200 
cells/mm^ and admitted initially for more than seven days were more likely 
to be readmitted than those with a CD4 count >=200 cells/mm^ is 
presumably because the foimer patients had more advanced disease and were 
more likely to be readmitted. That patients with CDC stage 2 or 3 disease 
who were admitted initially for more than seven days were more likely to be 
readmitted than those with stage 4 disease could be explained by these 
patients being less likely to die and therefore having more chance of being 
readmitted during the study period. An admission of more than seven days 
in these patients might also suggest that they were about to progress to stage 
4 disease.
Most differences by sex were related to risk group and most differences 
by risk group were related to the more advanced stage of illness of the 
homosexual men. This is because most of the admissions in homosexual 
patients were in men who had AIDS. Whereas none of the IDUs had 
seroconverted before 1984, many of the homosexual men (whose 
seroconversion dates are unknown) already had advanced HIV infection 
before the stait of the study period. The percentage of admissions in the 
homosexual group rose steadily over the study period from 7% in the fiist 
yeai to 16% in the last. This again reflects the more advanced stage of HIV 
infection and earlier séroconversions in these men. If City Hospital
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admissions only are analysed (i.e. excluding puiely drag related admissions) 
it is seen that a gieater proportion of homosexuals were admitted compaied 
with the proportion attending the clinic; 78% clinic attenders were IDUs and 
12% were homosexual but 72% City Hospital admissions were in IDUs, 21% 
in homosexuals. The mean length of hospital admission was longer for 
homosexuals than for other risk groups. Many of these longer admissions 
were also in the eaily pait of the study when patients with AIDS had longer 
admissions perhaps paitly due to less physician familiaiity with the disease 
and paitly because of less community caie support for AIDS patients. 
However, although mean length of stay amongst homosexual men had 
decreased from 31 days to 16 days over the fom* years of the study, even at 
the end of 1989 the mean of 16 days was considerably longer than the mean 
of nine days for all the other risk groups. This is also largely the effect of 
more advanced disease among the homosexual men, although the length of 
admission for IDUs is skewed by the 100 admissions for overdose which 
were usually less than 24 hours.
There were some differences in admission patterns by sex and by risk 
gi'oup which were not entirely accounted for by disease staging nor by the 
effects of drag use. The admissions for bacterial infections have aheady 
been described. Women were significantly more likely to be admitted with 
fits, headaches and diop attacks and with bacterial infections. The latter 
difference is not entirely accounted for by admissions with PID which was a 
significantly more common reason for admission amongst heterosexual 
women than amongst female IDUs. Women who acquired their HIV 
infection heterosexually might be more likely to have a higher incidence of 
PID because of previous sexually ti ansmitted diseases and higher number of 
sexual paiiners (or vice versa) or a genetic or other predisposition to both. 
Heterosexual women had more advanced stage of disease and were also 
significantly more likely to be admitted with AIDS related diseases than 
female IDUs. The reasons for this aie not entirely cleai*. One heterosexual
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woman with AIDS had acquired her infection in Africa hut most of the 
others had acquired their infection from male IDUs in Edinburgh. Therefore 
many of the heterosexual women seemed to have progressed faster than their 
IDU counteipaits. However since only ten women had progressed to AIDS 
by the end of the study it is not possible to attach any significance to the 
differences between the fom* heterosexual and the six IDU women. No 
significant differences were found for AIDS defining diagnoses by risk gioup 
or by sex as a whole, even for KS and lymphoma, although these admissions 
were significantly more common amongst homosexual men.
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Table 3,1
Comparison of admission diagnoses by risk factor
Diagnosis Homosexual
men
IDUs Hetero­
sexuals
All others Confidence
limits
p value
All AIDS
specific
diagnoses
OR 22.04 NA NA 12.91-37.78 <0.0001
NA - OR 5.78 NA 2.60-12.71 <0.0001
PCP OR 10.13 - NA NA 5.04-20.52 <0.0001
KS/lymphoma undefined NA NA _ undefined <0.0001
CMV OR 26.76 NA NA - 2.94-
1267.17
<0.0001
Bacterial
infections
NA OR 1.82 NA - 1.16-2.87 <0.01
- OR 3.05 NA NA 1.59-5.96 <0.0005
Pelvic
inflammatory
disease
NA OR 11.79 NA 4.81-28.85 <0.0001
Table 3.2
Analysis by year of admission and by risk factor
Homosexual
men
IDUs Other Total
1st year 11 (7%) 139 (87%) 10 (6%) 160
2nd year 22 (15%) 117 (78%) 11 (7%) 150
3rd year 42 (19%) 168 (76%) 11 (5%) 221
4th year 61 (16%) 278 (73%) 40 (11%) 379
Total 136 (15%) 702 (77%) 72 (8%) 910
Table 3.3
Analysis by year and by hospital of admission
City Hospital Other hospitals Total
1st year 56 (1038 days) 104 (559 days) 160 (1597 days)
2nd year 85 (1304 days) 65 (259 days) 150 (1563 days)
3rd year 171 (1719 days) 50 (144 days) 221 (1863 days)
4th year 300 (3241 days) 79 (474 days) 379 (3715 days)
Total 612 (7302 days) 298 (1436 days) 910 (8738 days)
Table 3.4
Average length of hospital admission by year
City Hospital Other hospitals Total Homosexual
men
1st year 18.5 days 5.4 days 9.9 days 30.7 days
2nd year 15.3 days 4 days 10.4 days 20.6 days
3rd year 10.1 days 2.9 days 8.4 days 12.3 days
4th year 10.8 days 6 days 9.8 days 15.7 days
Mean for all 
years
11.9 days 4.8 days 9.6 days 16.7 days
Table 3.5
Admissions by patients with AIDS to the City Hospital analysed by year
Number (%) 
admissions
Number (%) 
bed days
Average length 
admission per 
AIDS patient
1st year 8 (14%) 298 (29%) 37.2 days
2nd year 20 (24%) 535 (41%) 26.8 days
3rd year 65 (38%) 721 (42%) 11.1 days
4th year 125 (42%) 1779 (55%) 14.2 days
Total 218 (36%) 3333 (46%) 15.3 days average
Table 3.6
Subject characteristics and réadmissions to the City Hospital - results from 
single variable analysis
Variable Admitted
(89)
Readmitted
(119)
Percent
readmitted
Total p value
(Yates
corrected)
Sex
male 62 83 57.2 145
female 27 36 57.1 63 0.889
Risk
heterosexual 6 7 53.9 13
blood product 1 1 50.0 2
homosexual 12 30 71.4 42
IDU 70 81 53.6 151 O.I9 7 F
CDC stage
stage 2 or 3 35 55 61.1 90
stage 4 54 64 54.2 118 0.395
CD4 count
<200 28 46 62.2 74
>=200 51 61 54.5 112 0.375
All respiratoiy 
admissions
no 63 85 57.4 148
yes 26 34 56.7 60 0.957
BCIs
no 77 105 57.7 182
yes 12 14 53.9 26 0.874
PCP
no 80 106 57.0 186
yes 9 13 59.1 22 0.969
F = Fisher's exact test
Variable p value*
age 0.253
days 0.208
* based on F test for difference in mean age/days among admitted and readmitted 
group
Table 3.7
Multivariable analysis - initial model, including all variables from table 3.6
Variable Odds ratio 95% confidence 
interval
p value
Age 1.0039* 0.9574, 1.053 0.8732
Days 1.0045* 0.9860, 1.023 0.6283
Sex
male 1.00**
female 1.0502 0.5233,2.108 0.8905
Risk
heterosexual 1.00**
blood products 0.7713 0.0376, 15.826
homosexual 2.2564 0.5251, 9.696
IDU 0.9874 0.2967, 3.286 0.4171
CDC stage
stage 2 or 3 1.00**
stage 4 1.0063 0.4642, 2.182 0.9871
CD4 count
<200 1.00**
>=200 0.8729 0.3811, 1.999 0.7477
All respiratory
admissions
no 1.00**
yes 0.7180 0.1988, 2.593 0.6143
BCIs
no 1.00**
yes 1.3637 0.3054, 6.09 0.6848
PCP
no 1.00**
yes 0.8966 0.1828, 4.397 0.8929
* odds ratio for the change in risk per daily increase in admissions
** baseline category
Table 3.8
All two way interactions from table 3.7
Model
(79 admissions 
107 réadmissions)
Deviance Degrees of 
freedom (df)
Change in 
deviance/df 
from initial 
model
p value
Initial model 192.03 138
Current model 
testing for 
interactions 248.25 174 56.21/36 0.0171
Table 3.9
Fitting main effects plus all significant interactions from table 3.8
Model
(79 admissions 
107 réadmissions
Deviance df Change in 
deviance/df 
from initial 
model
p value
Initial model 234.43 169
Days/age 237.51 170 3.081/1 0.0792
Sex/age 237.02 170 2.593/1 0.1074
CDC stage/days 238.75 170 4.320/1 0.0377
CD4 count/days 240.56 170 6.129/1 0.0133
All respiratory 
admissions/days
238.28 170 3.845/1 0.0499
Table 3.10
Removing all non significant interactions from the model in table 3.9
Model
(79 admissions 
107 réadmissions
Deviance df Change in 
deviance/df 
from initial 
model
p value
Initial model 240.51 171
All respiratory 
admissions/days
242.18 172 1.673/1 0.1959
CDC stage/days 244.33 172 3.827/1 0.0504
CD4 count/days 247.31 172 6.802/1 0.0091
Table 3.11
Removing the non significant interactions from table 3.10
Model
(79 admissions 
107 réadmissions
Deviance df Change in 
deviance/df 
from initial 
model
p value
Initial model 242.18 172
CDC stage/days 246.54 173 4.359/1 0.0368
CD4 count/days 248.18 173 6.005/1 0.0143
Table 3.12
The significant interactions relating to réadmissions
CD4 count/days; Patients with CD4 counts above 200 cells/mm^ and initially 
admitted for more than seven days were less likely to be readmitted than those with 
a CD4 count less than 200 cells/mm^.
CD4 count <200 cells/mm^ >=200 cells/mm^
Admission status admit readmit admit readmit
Days/count
<= 7 days 14 18 29 31
> 7 days 14 28 22 30
Odds ratio 1.6 1.3
Table 3.13
CDC stage/days: patients with stage 2 or 3 disease and initially admitted for more 
than seven days were more likely to be readmitted than patients with stage 4 
disease
CDC stage Stage 2 or 3 Stage 4
Admission status admit readmit admit readmit
Days/CDC stage 
<= 7 days 
> 7 days
21 22 
14 33
29 31 
25 33
Odds ratio 2.25 1.2
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Intfoduction
Twenty one percent of all admissions were due to bacterial infections. 
These comprised: all bacterial chest and upper respiratory infections 
(excluding cases with concomitant PCP); all urinary tract infections, 
prostatitis, epididymo-orchitis and pelvic inflammatory disease; colitis due to 
Campylobacter, salmonella and Clostridium difficile', appendicitis, sinusitis, 
osteomyelitis; pericarditis and endocarditis; cellulitis, abscesses and 
septicaemia. Admissions for all bacterial infections were therefore analysed 
more fully and further studies arising from these results were conducted.
A total of 189 admissions (1931 days) were found for bacterial infections. 
A further 49 admissions to the City Hospital had a second diagnosis of a 
bacterial infection. Most (144) of the admissions were to the City Hospital, 
where the median length of stay was 12.1 days compared with 4.2 days for 
the 45 admissions to other hospitals. The admissions because of bacterial 
infection to the other hospitals were mainly due to pelvic inflammatory 
disease (22 admissions) and direct complications of injection drug use i.e. 
skin abscesses, cellulitis and endocarditis (12 admissions). A total of 15% of 
admissions to other hospitals were therefore directly due to bacterial 
infection.
Eighty five percent of the admissions (160) were in IDUs, 17 were in 
heterosexuals and 12 were in homosexual men whose average length of stay 
at 16.5 days was longer than that of the IDUs (10.3 days) and the 
heterosexual patients (4.5 days). Men accormted for 103 admissions (and 
1163 days) and women for 86 (and 89 days). Therefore whereas 77% of the 
total 910 admissions were in IDUs, IDUs were disproportionately 
represented and homosexual men disproportionately rmderxepresented among 
these admissions with bacterial infections. This was a significant difference, 
such that admissions among IDUs were three times more likely to be for 
bacterial infections compared with admissions by homosexual men
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(OR==3.05, confidence limits 1.59-5.96, chi square -  13.63, p<0.0005). There 
was no difference when IDUs were compar ed with heterosexuals, the main 
reason for this being the greater number of admissions for pelvic 
inflammatory disease in heterosexual women. Of the 12 admissions m the 
homosexual group, four were the only four' admissions with bacterial colitis, 
one was the only admission with epididymo-orchitis, one was with 
appendicitis, one a urinary tract infection, one prostatitis, two were 
rmspecified septicaemia and two were primary bacterial chest infections. 
Most (73%) of the 189 admissions with bacterial infections were in the 
categories of chest and ur ological infections and pelvic inflammatory disease 
(135 admissions). The admissions with pelvic inflammatory disease were 
mainly to other hospitals but further information is available on the 110 
admissions (1037 days) with chest and urinary tract infections to the City 
Hospital. One hundred and one of these were in IDUs, six in heterosexuals 
and three in homosexual men (chi square = 15.35 with Yates conection, 
p<0.0001). Fifty eight admissions were in men, 52 in women. Admissions 
in women to the City Hospital were significantly more likely to be for 
bacterial chest and genito-urinary infections when compared with the men 
(OR=1.78, confidence limits 1.15-2.76, chi square = 6.88, p<0.01). The 
average length of stay was also longer for the women (10.5 vs. 8.5 days). 
Sixty four (58%) of these admissions were in patients with CDC stage 2 and 
3 disease and 46 admissions were in patients with CDC stage 4 disease. 
Mean length of stay was the same, regar dless of CDC stage (9.4 days).
Of the total 144 admissions with bacterial infections to the City Hospital, 
62% (89/144) were in patients who did not have CDC stage 4 disease. 
Interestingly, in total the "asymptomatic" patients spent longer in hospital 
(12.9 days vs. 10.7 days).
Chest infections accounted for the largest number of admissions with 
bacterial infections. In many other patient groups, PCP and not bacterial 
infection, would account for most admissions with respiratory s y m p t o m s . ^^2
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BCIs concomitant wMi PCP were excluded fiom this section of the analysis 
but accounted for seven admissions. Diagnosis of both infections together is 
difficult. The diagnosis of PCP is fuifher complicated in the IDU because of 
poor pre morbid pulmonary f u n c t i o n , t h e  lack of specificity o f chest X- 
rays and arterial blood gases and the difficulty in assessing oxygen and 
opiate requirements for bronchoscopy. A separate study was therefore 
performed to assess the usefulness of sputum induction techniques in the 
diagnosis of PCP in this patient group.
Despite the preponderance of respiratory infections, there was only one 
admission with tuberculosis. Most other studies of IDUs and those in which 
a high incidence of BCIs have been recorded have also documented a high 
incidence of tuberculosis.®® A study was therefore canied out to assess 
whether the low incidence of tuberculosis is due to the low rate of 
tuberculous infection in the UK population or to the schools BCG 
vaccination programme.
Urinary tract infections accounted for a primary diagnosis in 13 and a 
secondary diagnosis in 15 admissions. Because bacteriuria is often 
asymptomatic and because its prevalence has been reported at much higher 
rates in other s e r i e s , a  separate study was conducted to assess the 
prevalence of bacteriuria in Edinburgh patients and the usefulness of routine 
screening mine samples.
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Study on diagnosis of Pneumocystis carinii pneumonia with particular 
reference to sputum induction and fluorescent antibody techniques.
Introduction
The finding of most clinical significance fiom the study of admissions in 
Edinbmgh was the high percentage of admissions due to chest infections. 
Although in this study 54% of respiratoiy disorders were due to BCIs and 
only 27% to PCP it is important that the two should be distinguished 
clinically and tr eated appropriately. A missed diagnosis of PCP (for example 
in an IDU who had suffered frequent previous BCIs) could have serious 
implications. Differentiating BCIs from PCP in IDUs is difficult and neither 
chest X-rays, arterial blood gases nor culture of sputum are specific. For 
example, in Edinbmgh patients admitted with BCIs, 43% were hypoxic and 
28% were hypercapnie. The position is further complicated by the fact that 
in 15% of episodes of PCP a concomitant BCI was diagnosed. Diagnosis of 
PCP is confirmed by identification of the organism in respiratory 
secre tio n s .S ecre tio n s can be obtained by bronchoalveolar l a v a g e , b u t  
reliance on bronchoscopy would be demanding both for the health service 
and individual patients particularly because so many IDUs have fiequent 
réadmissions because of chest infections. In many centr es in the late 1980s, 
sputum induction techniques replaced bronchoscopy as first line 
investigation in cases of suspected PCP.*'^ ® ’^® Experience was gained at the 
City Hospital in both bronchoscopy and sputum induction for making a 
diagnosis of PCP and the latter technique was foimd to be so useful that fi om 
1989 sputum induction replaced bronchoscopy as the initial investigation to 
confirm a clinical diagnosis of PCP.
A study was therefore rmdertaken to assess the value of sputum induction 
with particular reference to sensitivity, specificity and patient acceptability
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of the technique, and thereafter to make recommendations for the 
management of respiratoiy infections in IDUs.
Consequently all sputum inductions performed over a one year period 
between June 1990 and May 1991 in the City Hospital were reviewed.
Methods
The medical case records of all patients on whom sputum induction was 
requested during the study year* were retrospectively reviewed.
All sputum inductions were supervised by an experienced physiotherapist. 
Sputum was induced by inhalation of 2.7% hypertonic saline using an 
ultrasonic nebuliser (Devilbiss ultraneb 99, Devilbiss Health Care UK Ltd, 
Heston, Middlesex, UK) with patients breathing for ten minutes through an 
open mouth. Patients were then encouraged to cough deeply. If little or no 
sputum was produced, chest physiotherapy was canied out with postural 
drainage and percussion. The whole procedure took 30 minutes including 
ten minutes spent on the nebuliser. If  a poor sample was produced, the 
procedure was repeated up to thr ee times and the results were pooled.
The presence of Pneumocystis carinii (PC) in respiratory secretions was 
demonstrated using a combination of a fluorescent antibody test (FAT) 
employing a fluorescein isothyocyanate conjugated monoclonal antibody 
(PC Immunofluorescence Test Kit, Genetic Systems, Syva UK, 
Maidenhead, Berks, UK) which recognises an antigen, considered to be a 
glycoprotein, in the 40KD band, and diamidinophenylindole (DAPI).’^  ^ In 
addition in 1990 all samples were stained with a modified toluidine blue O 
stain.'50 The induced sputa were transported rapidly to the laboratory where 
they were processed immediately (in class 1 containment safety cabinets 
imtil the fixation stage was completed) or stored at 4°C for up to 24 horns. 
The sample was mixed wiüi an equal volume of sputolysin (Behring
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Diagnostics, Hounslow, Middlesex, UK) in a "V" bottomed container. After 
vortexing the sealed container with glass beads the sample was incubated in 
a water bath at 37°C. 15mls of phosphate buffered saline were added and 
the sample centrifuged at 600rpm for 30 minutes. The supernatant was 
discarded and the pellet resuspended in 1ml of buffered saline. Cytospin 
preparations were made using a cytocentrifuge (Shandon). In 1990 one slide 
was stained with toluidine blue O and the other by FAT following 
manufactur ers instr uctions with the addition of DAPI in the mountant. From 
1991 onwar ds the toluidine blue O was omitted because it had no benefit 
over FAT. Slides were viewed at a magnification x400 using a Zeiss 
Axioskop 20 fluorescence microscope with a reflector slide with two filter 
sets, 450-490mm for the conjugated monoclonal antibody and 355-450mm 
for DAPI. This allowed examination of each field with both stains without 
moving the preparation. Pooled samples were regarded as positive when two 
to three cysts with or without trophozoites were seen in a preparation. All 
slides were read by experienced staff. Consultant time for this was on 
average five minutes to check each slide - less time for good positives and 
more for negatives. The conventional method of silver staining was not used 
for identification of PC dining this study period since FAT had already been 
chosen by the City Hospital laboratory staff as being a more useful technique 
(faster, at least as sensitive and specific and less labom intensive) than silver 
staining. These two techniques were therefore not compared in this sputum 
induction study although most published papers on sputum induction used 
silver staining as their laboratory method of choice.
Results
Over the one year period from June 1990 until May 1991 inclusive, 220 
requests were made for PC FAT tests on induced sputa. One hundred and 
sixty four sample results were negative, 2 0  were unsuccessful (no sputum
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was obtained despite physiotherapy) and 36 were positive. All patients 
tolerated the procedure and no adverse events, such as worsening dyspnoea, 
were reported by the supervising physiotherapist.
Positive Samples
A total of 38 diagnoses of PCP were made during this one year period in 
the Infectious Diseases Unit. PC was found in 36 by FAT testing of induced 
sputa. One fur ther positive PC sample was a nasopharyngeal aspirate (taken 
following a recent successful diagnosis of PCP in a child by this method"®), 
and one patient was tr eated on clinical grounds alone. Tliis latter patient had 
consistently negative FAT for PC on the induced sputum samples, did not 
have a bronchoscopy and died two months later of pulmonary Kaposi's 
sarcoma. In retr ospect the illness for which he was treated with three weeks 
anti-PCP therapy may have been puhnonaiy Kaposi's rather than PCP.
O f the 38 episodes of PCP (in 26 men and seven women), 29 occurred in 
IDUs, seven in homosexual men and two in patients with heterosexually 
acquired disease.
In 19 cases this was the AIDS-defrning diagnosis and in the remaining 19 
the patient's clinical staging was already CDC 4c 1. In 17 episodes the 
patient had received no prior PCP prophylaxis, in 16 prophylaxis had been 
with monthly nebulised pentamidine (five patients were known to be poor 
compliers), one patient received regular intravenous pentamidine, one patient 
was taking cotrimoxazole and three patients were on clindamycin and 
pyrimethamine for Toxoplasma gondii infection.
In 17 of the 38 episodes of PCP (45%) chest X-rays were reported by the 
radiologist at the time of admission as normal (18 were abnormal and three 
were not X rayed) and in 12 (32%) the p02 was >10kPa (20 (53%) were 
<10kPa and in six cases the results were not available). In seven (18%)
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cases both chest X-ray and p02 were nonnal. Of the 38 episodes, 35 were 
thought likely to be PCP by die admitting team, but one was thought to be 
solely a BCI, and two were found in die course of investigations in patients 
who initially presented with jaundice and back pain. The final diagnosis in 
these last three patients was of PCP. In 14 episodes of PCP (37%) a 
concomitant BCI was found. No patients died nor required ventilation 
although one patient (who had taken nebulised pentamidine as PCP 
prophylaxis) developed bilateral pneumothoraces. Median CD4 count at 
diagnosis of PCP was 10 cells/mm® (range 0-330, mean 52 cells/mm®). 95% 
of CD4 counts were <250 cells/mm® and in 28 cases the CD4 count was <30 
cells/mm® (normal range 500-1500 cells/mm®).
Unsuccessful Samples
Twenty samples (9%) were "unsuccessful". In 15 cases this was because 
no sputum was produced. Two patients who were demented were unable to 
co-operate with the procedure and three patients were considered too unwell 
to have the procedure carried out. No patients became unwell as a direct 
result of the procedure. In none of these 20 cases was further investigation 
for PCP carried out and no patient was diagnosed with clinical PCP during 
that admission. All patients received regular* follow up. One patient (5%) 
had a positive induced sputum sample three months after his unsuccessful 
attempt.
Negative Samples
Of the 184 unsuccessful or negative samples there was only one possible 
false negative result (the patient with Kaposi's sarcoma described above). 
One patient rmderivent bronchoscopy (the only bronchoscopy carried out on 
an HIV positive patient dining the study period). This IDU who did not have
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AIDS and who had not taken any PCP prophylaxis had unexplained 
symptoms of weight loss and malaise. He had a CD4 count of 50 cells/mm®, 
his chest X ray showed interstitial shadowing and he had a p02 = 9.4 kPa. 
Haemophilus influenzae had already been isolated on microbiological 
examination of his sputum, FAT for PC was negative on five occasions and 
no fmther information was gained after bronchoscopy and bronchoalveolar 
lavage. An AIDS-defining diagnosis of AIDS dementia complex was made 
four months following his bronchoscopy.
Of the remaining 162 negative sputum results final diagnoses were; BCI in 
77, bacterial pneumonia in 16, atypical mycobacterial infection in nine, 
puhnonaiy tuberculosis in one and non respiratoiy diagnoses in 59. CDC 
staging was; 2 and 3 = 17, 4a == 16, 4b = 2, 4cl = 69, 4c2 = 38, 4d = 3, 4e = 
11, not recorded = 6 . Median CD4 count in this group was 50 cells/mm® 
(range 0-570, mean 101 cells/mm®). In 142 cases (8 8 %) the CD4 count was 
<250 cells/mm®. The tieatment schedule in these patients did not include 
cotrimoxazole nor pentamidine.
All patients were followed up regularly in the clinic. In 154 cases PCP did 
not occur over the ensuing three months. However in five patients (nine 
negative sputum inductions) PCP was diagnosed within the next three 
months. One patient had negative induced sputum samples in July, 
September and January and positive samples in October, December and 
February (the latter was the nasopharyngeal aspirate documented above). In 
this patient repeated samples were being taken because of recunent 
admissions with respiratory symptoms usually due to BCIs. In the remaining 
four patients at the time of diagnosis of PCP (by positive FAT on induced 
sputum samples) only one patient had a p02 <10kPa (9.2 kPa). All five of 
these patients already had advanced AIDS (CDC 4c 1) and CD4 coimt <30 
cells/mm^ and none appeared disadvantaged by any possible delay in 
diagnosis. Therefore, of the 184 unsuccessful or negative samples, ten (5%)
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progressed to induced sputum confirmed PCP within the ensuing three 
months.
Discussion
Although only 36 (16%) samples of 220 were positive on FAT, the 
sensitivity was 95% and specificity was 100%. If one assumes that a 
positive FAT within three months of a negative FAT represents failed 
detection of PCP, the sensitivity falls to 75% (the specificity remains 1 0 0 %). 
The occuiTence of a positive result witliin three months of a negative one 
continues to represent early detection of PCP rather than a failure of sputum 
induction and FAT for PC. Because of the good patient acceptability of the 
induced sputum procedure it was used in the City Hospital as an early 
screening test. Patients may tolerate the procedure better when it is canied 
out in the early stages of disease and therefore have not suffered the adverse 
events such as nausea and vomiting which have been documented in other 
c e n t r e s . Arterial desaturation in HIV positive patients undergoing 
sputum induction has been documented in one study.'®® Arterial blood gases 
were not directly measured in this study but none of the patients became 
more dyspnoeic nor cyanosed during the procedure. Other possible reasons 
for good acceptability of the procedure and the low number of unsuccessful 
samples compared with other studies'®' are the use of a dedicated 
physiotherapist and the fact that the patients were mainly IDUs who often 
have smoking related chronic obstructive pulmonary disease with resultant 
chronic productive cough. Conversely, the procedure of bronchoscopy is 
perhaps more complicated in IDUs compared with other patients because of 
the difficulty in assessing the pre-medication and oxygen requirements of 
patients who are already taking large amounts of opiates and 
benzodiazepines and who are chronically hypoxaernic. Since IDUs rarely
107
suffer from Kaposi’s sarcoma, direct visualisation of the bronchoscopic tree 
is less frequently indicated compared with other patients.
What has been saved by peifoiming so many sputum inductions? Of the 
184 negative and unsuccessful samples, in 82 cases the patient aheady had 
AIDS and in a further 67 the patient had CDC stage 4 disease without AIDS. 
In 97 cases the CD4 count was below 50 cells/mm^, in 54 of whom the 
diagnosis was thought likely to be PCP on clinical grounds. Therefore using 
the criteria of a high clinical suspicion of PCP (weight loss, fever, cough or 
breathlessness) and a CD4 count of less than 50 cells/mm^ if sputum 
induction had not been available in the City Hospital then at least 54 cases 
would have required bronchoscopy and bronchoalveolai* lavage. In seven 
patients this would have necessitated more than one bronchoscopy. Since 
PCP may occur with increasing frequency in patients with CD4 counts <250 
cells/mm^, 142 bronchoscopies might have had to be undertaken (the number 
of negative induced sputum samples in patients who also had a CD4 count 
<250 cells/mm^), excluding those patients with positive results.
By 1991 local pricing the cost of 54 bronchoscopies was £13,500 (£250 
per bronchoscopy excluding £7,000 for the initial puichase of the 
bronchoscope). By compaiison the cost of 220 induced sputa was £1,840 
(nebuliser £1,000, 110 hours of physiotherapy time £840). FAT testing cost 
£2,500 (20 hours of consultant virology time £300, reagents and laboratory 
time £2 ,2 0 0 ).
A more recent Edinbuigh study analysed all episodes of PCP in the 11 
yeai' period horn Januaiy 1984 until December 1994 (Dr RLS Laing, 
unpublished data). During this period 176 episodes of PCP were treated in 
126 patients. Although this indicates that there has been an increasing 
number of admissions since November 1994, the incidence of PCP as the 
AIDS indicator diagnosis has declined remarkably in recent years (Dr CLS 
Leen, personal communication). This is likely to be due to systematic use of
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PCP prophylaxis. Despite increasing numbers of patients with PCP the 
method of diagnosis has not changed. Few patients undergo bronchoscopy 
and induced sputum samples are still examined by FAT (Dr CLS Leen, 
personal communication).
Although BCIs are a more common reason for respiratoiy symptoms and 
hospital admission than PCP amongst IDUs, it is worthwhile excluding PCP 
in an IDU with any suspicious symptoms and a CD4 count of <250 
cells/mm^ because of the possibility of both infections occuning 
concomitantly. In this study 37% episodes of PCP were associated with a 
BCI. Diagnosis and tieatment of these 14 patients might have been delayed 
by the finding of a BCI if sputum induction had not been available in the 
RIDU; bronchoscopy would not have been peifoimed until after tieatment of 
the BCI.
If yield of positivity of sputum inductions is analysed by CD4 count alone, 
25% of samples sent in patients who had a CD4 count <50 cells/mm^ were 
positive compared with 10% positive yield in patients with CD4 count >50 
cells/mm^.
A management stiategy for investigation and tieatment of HIV positive 
IDUs presenting with respiratoiy symptoms was therefore drawn up (figme
4.1). All patients with symptoms of cough or breathlessness with or without 
fever and weight loss aie heated initially with broad-spectrum antibiotics 
(not cotimoxazole) whilst awaiting results of sputum cultmo. 
Bronchodilators are added to the regime if there is any evidence of 
broncho constriction. Patients who aie known to be receiving opiates and 
benzodiazepines (with or without a prescription) and who have a p0 2  < 1 0  
kPa ai e closely monitored and aie advised to voluntaiily restrict their intake 
of diugs whilst in hospital. If the p02  falls to < 6  kPa, a naloxone infusion is 
stalled with the aim of increasing the respiratoiy rate and p02. Fuither 
action would then depend on the results of the patient's most recent CD4
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count. If this was <250 cells/mm^ or if the patient was not responding to 
broad spectium antibiotics, a sputum induction sample for PC FAT would be 
taken. All positive results would be tieated with a thi ee week course of anti- 
PCP medication. In patients with negative results, further investigations 
would be cairied out only if the patient was not responding to antibiotics, 
bronchodilators and oxygen. This plan obviates the need for bronchoscopy 
in most cases although it is not mled out for patients with negative sputum 
induction and poor clinical progress.
Whilst the acceptability of bronchoscopy was not specifically assessed, 
induced sputum techniques proved safe, were well tolerated by patients, and 
were reasonably fast and inexpensive. FAT was also found to be as sensitive 
and specific as histochemical staining and has the additional advantage of 
being faster.
no
Figure 4.1
Management plan for HIV +ve IDUs with respiratory symptoms
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Non-cotrimoxazole antibiotics +/- bronchodilators
p02 (kPa)
6-10 >10
naloxone infusion limit opiates observe
CD4 count (cells/mm- )^
<250 >250
induced sputum for PC
clinical recovery
reassess in 48 hours
no yes
clinical concern
yesI
start anti-PCP treatment
no
Iawait result
continue
continue
-ve
seek alternative diagnosis
I
deteriorate
+ve 1start treatment
-ve
continue
bronchoscopy
Study of previous tuberculous infection and BCG status in HIV infected
patients
Introduction
One of the stiiking findings fiom the study of admissions was the low 
number of admissions recorded for tuberculosis (TB). Only one patient (a 24 
year old IDU) was admitted with pulmonaiy and disseminated TB. He was 
sputum smear positive for AAFB on admission, and Mycobacterium 
tuberculosis was later grown on culture of his sputum and bone maiiow. It 
was his first presentation with HIV infection, he had no other concomitant 
AIDS defining illness and his CD4 count on admission was relatively well 
maintained at 130 cells/mm^ It would be unlikely that any patients would be 
diagnosed with TB in the community without a hospital admission. 
Therefore one out of 702 admissions in IDUs represents a very low incidence 
of TB when compared with other cohorts.
From American data, the incidence of TB in patients with AIDS is almost 
500 times the incidence of the general p o p u l a t i o n . A l t h o u g h  
extrapulmonary TB was an AIDS defining condition by the 1987 CDC 
classification, pulmonary TB alone was not.^ Pulmonary TB is a common 
disease in HIV positive IDUs and in heterosexual African, Haitian and 
Hispanic patients and often occurs at a relatively early stage of HIV 
infection, preceding an AIDS defining diagnosis by many months, if not 
years.^^’’24.i56-i58 The incidence amongst homosexual and haemophiliac 
patients is much lower. *24.157 Two mechanisms may account for this 
discrepancy between risk groups. Firstly it may reflect tlie different natural 
history of HIV disease in different risk groups. IDUs ar e more likely than 
the rest of the population to have had previous exposure to M  tuberculosis 
and to have particularly poor living c o n d i t i o n s . B u t  secondly the 
incidence of TB may not be a feature of the risk category but instead may be
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a feature of the incidence of TB in the countries from which most HIV 
positive IDUs and African heterosexuals have been reported. Most reports 
of the high incidence of TB in HIV positive IDUs and African heterosexuals 
come from Africa, Spain, Italy and New York - all areas with a higher 
incidence of TB among the general population than the UK.^ ® *24,i56,i57 gpain 
and Italy exemplify the European north/south divide with respect to HIV; in 
Southern Europe spread via IDU is more c o m m o n , '*2.^ 2,72,124 whereas in 
Northern Europe most patients affected have been homosexual men. 
Edmbru’gh, which has a pattern of spread more akin to Southern Europe, is in 
a Northern European country with a low incidence of TB.
Another feature peculiar to the Edinburgh cohort is the social stability of 
the IDUs, In many other countries HIV infected IDUs are chaotic and often 
difficult to access because of their ûequent changes of address (if they have 
one) both within towns and between different towns and c o u n t r i e s . T h e  
Edinburgh IDUs, by contr ast, have mainly been born and brought up in the 
same ar ea of Edinbrugh - one of the reasons why it has been an ideal cohort 
to follow prospectively.^ One other point of note is that almost all the 
Edinburgh HIV positive patients me white Caucasians and none me from the 
Indian subcontinent.
The UK has a programme of BCG in schools for all children aged between 
ten and 1 4 . The mass BCG immrmisation programme is one reason why 
the UK has a low incidence of TB. Other reasons are effective 
chemotherapy, contact tracing and chemoprophylaxis.*^*** '^ The aim of this 
study was to assess the interaction between BCG and TB in the context of an 
HIV cohort which has a low incidence of TB.
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Methods
Records of all BCGs given thr ough the schools vaccination programme in 
Edinburgh since 1954 are kept in the Edinburgh Chest Clinic at Spittal 
Street. Records ar e kept in box files, filed alphabetically by date of birth. 
Information on each child's car d includes name, date of birth, result of Heaf 
test, date of BCG, any reactions to BCG, reasons why any childr en had not 
received BCG, and follow up with chest X-ray results on children who were 
Heaf positive. Permission was given by the chest clinic to access these files.
A list was made of the names, dates of hirth and risk factor of all patients 
attending the City Hospital HIV clinic. Maiden and other previous names 
were included where available. The data were obtained fr om the Chest clinic 
box files and matched with the City hospital list. Data therefore finally 
obtained and entered on to a database file were: identifier, date of birth, risk 
factor, sex, whether Chest clinic records had been found for that patient or 
not, whether BCG had ever been given and if not why not, result of Heaf test 
where recorded, and any follow up.
Results
By the time the study was canied out in 1991, 523 HIV positive patients 
had attended the City Hospital HIV clinic and another 24 yeai' old male IDU 
had been admitted with TB, presenting with a pleural effusion. Risk factors 
of the 523 patients were IDU in 394 (66%), homosexual intercouise in 72 
(14%), heterosexual intercourse in 53 (10%) and blood transfusion in 4; 350 
were men and 173 were women. Dates of bhth ranged from 1927 to 1973 
but most were between 1955 and 1967.
Matching was achieved with chest clinic records for 310 (59%) of the City 
Hospital group. Records were found for 223 men and 87 women; 270 were
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IDUs, 21 were heterosexual, 18 homosexual and one patient was infected 
from blood products.
Of the 310 patients whose records were available (figure 4.2), 243 had 
received BCG; 229 at age 11 in the schools programme and before this in 15 
cases (one patient had BCG twice). The main reason for BCG prior to age 
11 was because of contact with a case of TB. The childien who were given 
BCG at age 11 included botli patients who later developed TB. BCG was 
aiTanged for a fuifher 46 childien who did not receive the vaccine as planned 
for valions reasons; absence from school, school exclusion, refusal by the 
child or their patents, and, in a minority, that the child had left school and 
moved away fr om the area. Of these 46 children, 43 were to become IDUs. 
This refusal rate therefore accounts for 15% of the 310 whose records were 
found. In 17 cases the child was Heaf positive without having received a 
previous BCG; follow up in all these cases, with at least one chest X-ray, 
was normal. None of these childi en developed active TB during their period 
of follow up by the chest clinic and none received later BCG. In a further 
fbui cases, BCG was not given for different reasons. In one case the child 
had developed TB when aged nine and was still under régulai' follow up, the 
chest X-ray showed calcified primaiy lesions in another, bad eczema was 
cited as the reason in a third and in the last the reason is not clear.
Discussion
Although the incidence of TB in the UK has been falling steadily over the 
past 100 yeai's and is now at a veiy low level, there has been a slowing in the 
decline of notifications in the 1980s with a possible rise in cases since 
1987,125,162 Groups at risk for TB in the UK are immigrant populations 
(particulai'ly from the Indian sub-continent), alcoholics and the homeless, the 
elderly, the poor and the immunosuppressed including those infected with 
y iY  125,163-165 TEe reason for the slight rise in UK figures is not yet cleai*.
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Although most UK cases aie in Asians, there has been concern that the rise 
in cases may be directly related to HIV infection. But preliminaiy studies 
have suggested that aieas with a rise in notifications aie not those with 
higher numbers of HIV cases but rather aieas with higher numbers of 
immigrants; and that the rise has not affected the age and sex groups 
associated with HIV infection but instead young females and older men and 
w o m e n .  *25.163,166,167 This contrasts with the pictuie in the United States where 
the rise in reported cases has been particularly rapid amongst younger men, 
particularly black people and Hispanic populations, in which both poverty 
and HIV have a high prevalence.'®
In this study 0.4% of the HIV positive clinic population (and 0.5% of the 
IDUs) had developed TB. By cunent reporting, 5% of AIDS patients in 
England and Wales develop tuberculosis.'®*® This clearly may 
underestimate the size of the problem since by the CDC 1987 definition, TB 
was not an AIDS defining disease,^ nor aie all patients who present with TB 
tested for HIV infection. But even taking this into account, 5% is a low rate. 
Why is this so? One reason is that the overlap between the population with 
HIV infection in Britain (mainly young white men) and the population with 
previous tuberculous infection (mainly the elderly and people from the 
Indian sub-continent) is limited and that most UK HIV positive patients have 
never previously been infected with M  t u b e r c u l o s i s The other may be 
the effect of BCG immunisation.
Historically BCG has had a high and consistent efficacy in the UK.'2<5 A 
latge randomised contiolled trial of BCG in 14 yeai- olds showed protective 
efficacy of 77% over 20 years of follow up.'2' The efficacy in a study of 
Edinburgh school children between 1970 and 1983 was over 60%. *22 
Although contioversy exists about the continuing value of the schools BCG 
immunisation programme in the face of the cun ent low national incidence of 
TB,'® the Joint Committee on Vaccination and Immunisation has advised 
continuation of the programme until at least 1995/1996 because of the
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possibility of the HIV epidemic causing a futuie increase in cases of TB in 
the UK.'®
BCG had been given to 243 of Edinbuigh patients whilst they were 
childien, i.e. to at least 46% of the 1991 HIV clinic population. Two 
bundled and eight of these were IDUs. Therefore at least 53% of the 1991 
clinic (208/394) IDU population had received BCG, two of whom developed 
TB dining the study period. Because the chest clinic records were complete, 
the only reason for not matching records was because of incorrect 
infoimation of date of biith or name, or because the child did not attend 
school in Edinburgh. Many of these patients would have received BCG 
elsewhere. Matching was obtained with Chest clinic records for 59% of the 
City hospital group. The likelihood for matching was not equal for sex or 
risk group. Matching was obtained for 64% of the men but only 50% of the 
women; for 69% of the IDUs, 40% of the heterosexuals and 25% of the 
homosexuals. The lower rate of case finding for women was probably due to 
change of name on maiiiage and for homosexual men because they were on 
average older and more likely to belong to a more mobile population.
It is interesting that BCG uptake and refusal rate amongst IDUs, the group 
most likely to have been economically and socially disadvantaged as school 
children, was similar to that of the general population. BCG was given to at 
least 53% of the IDUs and 46% of the 1991 clinic population. Uptake rates 
of the school BCG programme have been documented at 75% over the past 
decade.'® Uptake rate amongst this matched cohort was 78% and the refusal 
rate was 15%. Amongst IDUs the uptake rate was 77% and the refusal rate 
was 16%.
There is no published epidemiological evidence on whether BCG is 
effective in UK patients who later acquire HIV infection. BCG is contia- 
indicated in patients (both children and adults) already known to be HIV 
positive because of the risk of disseminated BCG infection.'® But
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theoretically BCG should be effective if given before HIV infection and 
before the fust contact or infection with tuberculosis.'® BCG has also been 
to shown to provide most protection in stopping haematogenous spread of 
mycobacteria and has generally provided high protection against TB 
meningitis.'22 These properties should be of paiticulai* value in HIV positive 
patients since TB is more often extiapulmonaiy and disseminated in HIV 
positive than in HIV negative patients. '24 The efficacy of BCG may reduce 
with time as the immune system becomes progiessively impaired.'® In a 
study from Tower Hamlets, an aiea in the east end of London with high 
levels of poveity, homelessness, immigrant populations and HIV infection, 
10 (7%) of 150 HIV positive patients screened for TB were found to have 
active disease. '25 Five patients (four British whites and one African) had 
received BCG immunisation. Although this might suggest that BCG is not 
always protective, this paper does not state whether these patients had 
received BCG before or after acquisition of HIV infection. A paper fiom 
Austria has suggested that BCG immunisation before HIV infection could 
have untowai'd effects. In the case documented, disseminated BCG infection 
in an HIV positive patient was ascribed solely to BCG immunisation 30 
yeai's beforehand.'2^
In this Edinbuigh study it is of note that the two patients who developed 
TB during the period of follow up had received BCG as schoolchildi en only 
12 yeai’s before. It is difficult to deteimine the efficacy of BCG in any 
population and even more so in an individual but further follow up of this 
cohort may give some intimation of the protective value of BCG to HIV 
positive patients.
None of the 19 children with evidence of previous tuberculous infection 
(17 Heaf positive and two with X-ray evidence of TB), developed TB during 
the study. The prevalence of previous tuberculous infection in this cohort 
was 6% (19/310), exactly the same as found in the study of all Edinbuigh 
schoolchildien.'22 Applying this figure to the 523 clinic attenders or to the
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estimated 1000 HIV positive IDUs in Edinbmgh"® suggests that 31 to 60 
might have dual infection with M. tuberculosis and HIV. Assuming that dual 
infection leads to active TB at a rate of about 10% per year,® then thiee to 
six cases of TB would be expected annually in this population. This is a rate 
considerably lower than the finding of less than one case a yeai’ and suggests 
that primaiy tuberculous infection may play an important role.
Some follow up of this study has already been perfoimed (Dr AG Leitch, 
unpublished data). By 1994 none of the 19 tuberculin positive patients had 
developed TB. A further tluee patients had developed TB, two male IDUs 
and one homosexual man, none of whom had a scai’, nor a histoiy of BCG 
vaccination. By 1994 1030 cases of HIV infection in Edinburgh had been 
recorded, 60% of whom were IDUs. Five cases of TB among 1030 HIV 
infected patients, 60% of whom were IDUs, still represents a low rate 
compared with other cohorts.
In conclusion, die incidence of TB in HIV infected patients in Edinbmgh 
is much lower than has been described in almost any other cohort. This is 
largely due to the low incidence in the UK, but even in those previously 
infected with M  tuberculosis^ no cases of reactivation had been found. 
Primaiy tuberculous infection may therefore be important in cohorts with a 
high incidence o f  TB.*’? The protective value of BCG was not proven in this 
small study. Fuifher long teim follow up will be of the utmost importance.
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Figure 4.2
BCG vaccination and tuberculin reactivity in Edinburgh HIV +ve patients
523 HIV positive clinic attenders
310 BCG records traced 213 records not traced
243 BCG 67 no BCG
229 aged 10-14 14 younger
17 heaf +ve46 DNA 2 previous/current TB 2 other
Study of bacteriological screening of urine samples from HIV infected
patients.
Intioduction
Urinary tract infections (UTIs) have been described as one of the 
manifestations of recunent bacterial infections in HIV positive p a t i e n t s .
In the admission study only 13 admissions (in two men and 11 women) had a 
primary diagnosis of UTL There were two admissions (in the same male 
IDU) for septicaemia secondary to a UTL Perhaps more interestingly UTI 
was a second diagnosis in 15 patients suggesting that a larger spectinm of 
UTIs exists which may cause significant morbidity but not being life 
threatening is not deemed a primary diagnosis. It was thought that screening 
for these might be of value. Bacteriological examination of urine samples 
was part of the routine investigations earned out on all HIV positive patients 
admitted to the City Hospital and was thought to add significantly to the 
workload of the bacteriology depaiiment. A reti'ospective analysis of the 
results of bacteriological examination of all urine samples fiom adult HIV 
infected patients admitted to the City Hospital duiing the year from 1 April 
1988 to 31 March 1989 was therefore earned out. The aims of this study 
were to assess the usefulness of this investigation in HIV positive patients 
without evidence of UTI and to document the prevalence of bacteriuria.
Methods
The results of urine samples received for bacteriological investigation 
fiom all HIV positive inpatients in the City Hospital between 1 April 1988 
and 31 March 1989 were conelated with clinical infoimation obtained fiom 
the medical casenotes.
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Urine samples were considered to be "screening samples" in the absence 
of: (1) symptoms and signs of cystitis or pyelonephiitis or (2) clinical "septic 
shock" or (3) pregnancy. If pyrexia was present without any of the above the 
samples were also considered "screening samples" but were analysed in a 
separate subcategoiy. All other samples were classified as "non-screening 
samples".
Results
During the year studied, 106 patients accounted for 181 admissions. One 
hundred and seven of the admissions were men aged 16-58 years (average 32 
yeais) and 74 were women aged 22-41 yeai's (average 27 yeai's). Two 
pregnant women had five admissions between them. Sixty percent of the 
patients had CDC stage 4 disease, 50% of whom had AIDS, 31% had stage 3 
and 9% had stage 2 disease. Altogether 30% of the 106 patients had AIDS.
Foul' hundred and foity samples were received during the study period. Of 
these, 279 were considered "screening samples" and were derived from 118 
admissions (72 men and 46 women). There were two positive urinary 
cultmes from the men and six from the women. The two men had CDC 
stage 4 disease. Two women had CDC stage 4 disease, two had stage 3 and 
two had stage 2 disease. Eighty one of the 279 samples were fiom patients 
with pyrexia and were derived from 36 admissions (26 men and ten women). 
There were two positive urinaiy cultuies within this subgroup (one man and 
one woman). A positive cultuie was obtained with two or fewer samples in 
all but one patient. In the single exception the positive culture was the tenth 
sample and was almost certainly a hospital-acquired infection.
One hundred and sixty one "non-screening" samples were received fiom 
63 admissions (35 men and 28 women). There were two positive uiinaiy 
cultures fiom the men and 12 from the women, one of whom was pregnant.
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One of the men had CDC stage 4 and the other had stage 3 disease. Nine of 
the 12 women had CDC stage 4, two had stage 3 and one had stage 2 
disease. The number of samples required to obtain a positive cultui e ranged 
fiom one to five. The one episode which required five samples was probably 
due to a urinary tr act infection acquired after admission to hospital.
The organisms isolated from both screening and non-screening urine 
samples were the common urinary tract pathogens. Escherichia coli was 
isolated in 11 of the 22 positive cultures, Enterococci were found in six and 
there was one episode each of UTI due to Enterobacter species, gr oup B beta 
haemolytic streptococci, Klebsiella oxytoca, Klebsiella pneumoniae and 
mixed organisms.
Discussion
The prevalence of asymptomatic bacteriuria in tliis group of HIV positive 
patients was 13% in women and almost 3% in men, considerably higher than 
the normal figure of 3-5% in women and 0.5% in men.’^® In women this 
difference is statistically significant (p < 0.05 by chi-square test with Yates' 
correction). No significant differences were found between CDC stages. Of 
the non-screening samples, bacteriuiia was detected in 6% of samples from 
men and 43% from women. The numbers involved are very small (14 
positive samples in 63 admissions) but in ten of the 14 cases the patient had 
CDC stage 4 disease.
The prevalence of bacteriuria in HIV positive men in other reported 
studies is even h i g h e r . T h e r e  are two reasons for this. Firstly, the 
percentage of homosexual men among Edinburgh admissions is much lower 
than in many other studies. Bacteriuria was found in 17% of urine samples
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fiom a Netherlands study of 98 men, 89 of whom were hom osexual. ’^ 3 
Although the authors did not find a conelation between the prevalence of 
UTI and specific sexual practices there was no non-homosexual group for 
comparison. In a study from Rio de Janeir o of 58 male patients without 
other local risk factors for UTIs, bacteriur ia was found in 1 4 %.
Although the study did not find a significant association between risk 
factor and bacteriuria and the numbers were small, 75% of the patients were 
homosexual men. Secondly, the Edinburgh patients had less advanced 
disease than in other reported studies; dining the year studied 40% of the 
admissions were in patients who had not reached CDC stage 4 disease. The 
Netherlands study correlated the presence of bacteriuria with a lower CD4 
count: bacteriuria was significantly more common in men with a CD4 count 
of less than 200 cells/rmn^ compared with men who had a CD4 count 
between 200 and 500 ceils/mmL In Pinho's Rio de Janeiro study all the men 
had CDC stage 4 d i s e a s e . j n  ^ later study by Pinho in which the 
prevalence of bacteriuiia in a group of 245 HIV positive men was 9.4%, not 
only was the prevalence rate of bacteriuria much higher in patients with 
AIDS compared with those with asymptomatic infection, but the only 
patients with symptomatic UTI were those who had AIDS.*^^
All the asymptomatic bacteriurias in the Edinburgh study were detected in 
the first or second samples received. The high incidence of asymptomatic 
bacteriuria would suggest that screening urine samples should be sent in 
similar groups of asymptomatic HIV positive patients but that negative 
cultures from two specimens can reasonably exclude urinary tr act infection. 
Following this policy would have reduced the number of urine samples in 
this study by 56 (13%). Screening urine samples should be sent only in 
patients who have been admitted. In many cases it may transpir e that non­
specific symptoms ar e secondary to a minary tr act infection. Because of the 
associated immune deficiency, even if at an early stage, and the
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predisposition to bacteraemia, these patients should be tieated with the 
appropriate antibiotic.
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Introduction
Studies of hospital admissions aie at present one of the best methods of 
assessing the morbidity of HIV infection, even although they cannot give a 
full picture. Studies of mortality complement those on morbidity. Official 
figures of AIDS deaths might seem to be more accurate than any figures 
relating to morbidity but these figures are only available when a diagnosis of 
AIDS or HIV infection was made before death.*®'’ Additionally, deaths in 
HIV positive patients which are not specifically related to HIV infection aie 
not always included in HIV statistics.*®* *®^ From the Edinbuigh admissions 
study, fomteen patients died in the City Hospital and four patients died in 
other Edinburgh hospitals. Because patients with AIDS may choose to die at 
home and because deaths due to overdose aie likely to be at home, the 
admissions study was unlikely to give a complete record of all deaths in the 
cohort. Therefore a separate study of all the deaths in the Edinburgh cohort 
before November 1989 was canied out. Paiticular attention was paid to post 
mortem results since deaths ascribed to overdose might be due to HIV 
disease.
Methods
The names of all patients who had attended the City Hospital outpatient 
clinic and who had died before November 1989 were obtained from the City 
Hospital computer files. Details were obtained from the City Hospital 
casenotes of date of death, place of death, postulated cause of death, whether 
post mortem was canied out and the results if so, CDC stage and CD4 count 
before death, previous hospital admissions and AIDS defining diagnoses, sex 
and risk factor. Since all post mortems performed may not have been 
recorded in the City Hospital notes, a list of names of sudden deaths at home 
where no post mortem was recorded was sent to the University of Edinburgh 
Forensic Medicine Unit, to the Procurator Fiscal for Edinburgh and to the
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General Register Office for Scotland. Full details of four post mortems were 
obtained from the Forensic Medicine Unit. In addition, for two patients, the 
general practitioner's notes were checked.
Results
Thiity four deaths were recorded by November 1989. Thirteen patients 
were homosexual, 19 were IDUs and two heterosexual; 28 were male and six 
were female (five IDUs and one heterosexual). One death was recorded in 
1984, four in 1986, seven in 1987, nine in 1988 and 13 in 1989. Of the 34 
deaths, 19 were due to AIDS, two to liver disease and 13 were thought to be 
ding related.
Deaths due to AIDS
Of the 19 AIDS related deaths, 13 were homosexual men, four were IDUs 
and two were heterosexual. Only two of these deaths were in women (one 
IDU and one heterosexual). Fourteen of the patients died in the City 
Hospital, two died in other hospitals (both patients were tmnsfened from the 
City Hospital to the two other hospitals, one of which was in Fife, during 
their teiminal admission), one patient died in an Edinburgh hospice and two 
patients died at home (one in Edinburgh and one in Spain).
AIDS had been diagnosed between two days and 45 months before death 
and the average time alive with AIDS in these 19 patients was 11.7 months. 
Eleven patients had died within one yeai’, and 17 within two years of their 
AIDS diagnosis. Two patients died during their initial HIV hospitalisation 
and a fuilher two patients died dming their admission for tlieir AIDS 
defining illness. AIDS defining diagnoses for these 19 patients were PCP 
(six patients), oesophageal candidosis (two patients), KS (three patients),
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cerebral toxoplasmosis (two patients), and, in one patient each, CMV 
encephalitis, AIDS dementia, ciyptococcal meningitis, PCP with KS, 
toxoplasmosis with KS and PCP with cerebral lymphoma (table 5.1). 
Lifetime HIV related admissions per patient ranged fiom one to 20 (mean 5.7 
admissions). The 19 AIDS patients had a total of 44 AIDS related 
conditions- 14 episodes of PCP, six of CMV, five of KS, five of 
mycobacteriosis, four of oesophageal Candida, four lymphoma, foui 
toxoplasmosis, one ciyptococcal meningitis and one AIDS dementia. 
Average CD4 count at death was 41 cells/mm® in the 18 patients in whom it 
was recorded (range 0-255 cells/mm®). The CD4 count was less than 30 
cells/rum® in 14 patients, between 30 and 100 cells/mm® in two and between 
100 and 300 cells/mm® in two patients (who died in 1986 and 1987).
It was often difficult to assess what was the principal cause of death. Dual 
(or multiple) pathology was found in at least seven cases. Disseminated 
CMV was implicated in six deaths, KS in five, PCP in four, cerebral 
toxoplasmosis in four, lymphoma in thiee and mycobacteriosis in two (table
5.1).
Post mortem studies were canied out in nine patients. Of the other ten, a 
refusal for post mortem was documented in thiee casenotes, no mention of 
post mortem was made in thiee casenotes and post mortem was not requested 
in the two patients who died at home, the patient who died in the hospice nor 
in the patient who died in the Fife hospital.
Post mortem revealed unexpected findings in eight of the nine cases (table
5.2). Multiple pathology was detected in all of them. Diagnoses which were 
made only at post mortem (and not suspected clinically ante mortem) were 
CMV disease in thiee, disseminated mycobacteriosis in two and lymphoma 
in one. In addition, one patient who had initially been tieated for cerebral 
toxoplasmosis (which was his AIDS defining diagnosis) but whose ante
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mortem brain biopsy showed evidence of cerebral lymphoma had no 
evidence of cerebral toxoplasmosis on post mortem.
Deaths due to hepatitis
Two men died of IDU related hepatitis which may have been exacerbated 
by concomitant HIV infection. One man died at home of a massive 
haematemesis. He was known to have chionic hepatitis B infection, 
ciiThosis, portal hypertension and oesophageal varices and had been admitted 
on six occasions to the City Hospital (for diagnoses including bacterial 
pneumonia, Escherichia coli septicaemia, urinaiy tiact infection, 
haematemeses and ascites). His CD4 count just before death was 20 
cells/mm® and he had CDC stage 3 disease. The other man with chronic liver 
disease was known to have chronic hepatitis B and D infections but was not 
admitted until the day of his death when he developed peritonitis. Post 
mortem revealed a primaiy E, coli peritonitis with subphrenic and pelvic 
collections, macronodular ciiihosis and a 4cm hepatoma. Hepatitis C was 
demonshated by EIA in his stored serum in 1990. He had CDC stage 3 
disease and a CD4 count of 221 cells/mm® at death.
Deaths due to overdose
Thirteen deaths were assumed to be due to overdose. Eleven patients 
were found dead at home and two died in hospital. Post mortem studies 
were peifoimed on seven patients. In the six patients who did not have post 
mortems (four were reported to the Procurator Fiscal and were examined by 
the forensic doctor without a full post mortem), there was good 
circumstantial evidence of overdose which in all cases seemed accidental 
rather than deliberate. Tluee had CDC stage 2 or 3 disease, two had stage 4e 
and one had disease stage 4c2. Average CD4 count at death was 363
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cells/mm® (range 135-840 cells/mm®). One patient died fiom injecting 
Diconal (dipipanone and cyclizine) the day after his release from prison, one 
patient died in police custody, one patient was found dead in the bath with 
fresh needle marks, one patient had had three admissions for overdose and 
one other patient had had two previous IDU related admissions.
Of the seven IDUs who had post mortems canied out, five were in patients 
found dead at home. In four cases there was likely evidence of recent drug 
use and this was confiimed on post mortem when asphation pneumonia was 
also found in thiee and acute pulmonary oedema in one (table 5.3). 
Significant lymphadenopathy was found in two patients, one of whom (who 
was known to have hereditaiy spherocytosis) also had marked splenomegaly 
with prominence of the white pulp. In these four cases the brain was not 
examined. The fifth death in this categoiy was in an IDU who had had one 
previous admission for pneumococcal pneumonia, who was in CDC stage 4a 
and whose CD4 count was 155 cells/mm®. He was found dead at home, 
thiee days after being seen in the City Hospital out patient clinic and one day 
after being seen by his general practitioner. He had been assessed at both 
clinics as being in his usual state of health. When found dead at home he 
had fallen out of bed and petechial haemoii'hages were seen on his buccal 
mucosa. The death was thought to be ding related but post mortem revealed 
a florid meningoencephalitis of uncertain aetiology and maiked cerebral 
oedema. The pathologist remarked that he could not conceive how this 
patient had been walking around the day before his death.
The two other post mortems were caixied out in IDUs who died in 
hospital. One was an IDU who was admitted unconscious and died after two 
days artificial ventilation in the Intensive Care Unit. The diagnosis on the 
death certificate was of self poisoning and bronchopneumonia. Post mortem 
revealed moiphine in post mortem blood, a bilateral confluent pneumonia 
secondary to a viral pneumonitis, evidence of septicaemia and generalised 
lymphadenopathy. The other patient had been admitted for drainage and
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packing of an IDU related antecubital abscess. He later had a respiratoiy 
an*esf ascribed to the effects of IDU, horn which he died. A post mortem 
dmgs screen was completely negative and death was due to acute pulmonaiy 
oedema. Splenomegaly was also found but the abdominal organs were only 
examined supeificially and the cranium not at all.
Discussion
The most stiiking finding hom this study was that although there were 
more deaths due to AIDS (19) there were almost as many deaths not due to 
AIDS (15), All 15 of these other deaths were in IDUs. Two of these deaths 
were due to chionic liver disease, one to a meningoencephalitis of unknown 
cause and the remaining 12 were likely to be related to drug use. Of these 
12, six had post mortems canied out confiiming overdose in foui’, overdose 
with bronchopneumonia in one and acute puhnonaiy oedema in one. Acute 
pulmonaiy oedema is a recognised complication of opiate use®*’’®^ although a 
toxicological screen was negative in one patient with this diagnosis. 
Bronchopneumonia is a recognised complication of both drug use*’ and HIV 
i n f e c t i o n . C h i  onic liver disease is also a recognised complication of drug 
s^e8U86,i85 with, in the case of hepatitis C, a synergistic effect with HIV 
in fec tion . ’32 Therefore of the 34 deaths, 19 were due to AIDS, one to 
meningoencephalitis, two to liver disease and 12 were principally due to the 
effects of ding use.
Was there an increase in non-AIDS deaths due to the impact of HIV? This 
phenomenon has been seen in some other countiies. In Italy the mortality 
rate for non-AIDS related deaths was 1.7/100 person yeais for HIV 
séropositives compared with a rate of 0.8/100 person yeais for 
seronegative s . D e a t h s  from overdose and endocai'ditis were higher in these 
HIV séropositives than in the seronegatives. In this Edinburgh study there 
was a rise thioughout the yeais studied for both AIDS and non AIDS deaths.
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For AIDS deaths, after one death at the end of 1984, there were two deaths 
in the first year of the study (1986), two in the second, six in the third and 
eight in the final year. For non-AIDS deaths there was a viitually parallel 
rise at one death in the first yeai', four in the second, four in the third and six 
in the final yeai. These figures might suggest a rise in non-AIDS related 
deaths but it is probable that deaths due to overdose in IDUs in the eaiiy 
yeai s of the study were in IDUs who had not been HIV tested either ante or 
post mortem. There is therefore a likely underestimate of deaths due to 
overdose in HIV positive patients in the early pait of the study period. This 
underestimate would not have occuired in the later yeais because a policy of 
HIV screening all sudden deaths in patients with a histoiy of dmg use was 
instituted in Edinbuigh in 1 9 8 7 . None of the patients in this study were 
identified by this method - all IDUs had been known to be HIV positive 
before death.
The annual expected mortality for all causes in IDUs in the UK before the 
advent of HIV infection was calculated at 18.4/1000 in 1980.^4 This figure is 
taken from a study of deaths of notified dmg addicts in the UK fmm 1967- 
81, Although this study included deaths from all causes (the causes were not 
specified but drags were specifically implicated in 74%) it was a study of 
notified drag addicts and is therefore likely to be an underestimate of the true 
IDU related mortality. This study also showed a fall in mortality in drag 
addicts when compaied with eailier studies, due to the decreased availability 
of bai'bitmates,*3 and that the mortality figuies for the UK were much higher 
than for the US. Other estimates of the mortality in IDUs in the immediate 
pre AIDS era are of 13.3/1000 in 1984 in New York, half of these deaths 
being due to cinhosis, overdose and t r a u m a . B y  November 1989, 319 HIV 
positive IDUs had attended the City Hospital clinic. Fourteen deaths in this 
cohort due to overdose and liver disease gives a death rate in this cohort of 
43/1000 over the fom* year period, an annual death rate of 10.75/1000. If 
one assumes that 14 deaths over four years is the death rate of the estimated
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1000 HIV positive IDUs in Edinburgh’^ '* then the annual death rate due to 
overdose and liver disease drops to 3.5/1000. These figures, although cmde, 
suggest that the deaths due to overdose and liver disease in this study are 
those expected as the results of IDU and are not increased. This is in 
keeping with other studies where, although there is an excess of deaths in 
IDUs due to overdose, tiauma and liver disease, the mortality due to these 
diseases has remained stable since the advent of HIV i n f e c t i o n .
What this Edinburgh study has not shown is a rise in non-AIDS mortality 
not specifically related to dmg use. Studies fiom the US have shown a 
marked increase in deaths due to septicaemia, pneumonia, tuberculosis, 
endocarditis and suicide in HIV positive p a t i e n t s . studies from the 
UK of death entries at the Office of Population Censuses and Surveys have 
also suggested by inference that this is the case in the UK.’®^ A substantial 
increase in deaths in HIV positive haemophiliacs without AIDS (including 
fiom pneumonia, cirrhosis, poisoning, suicide and dmg abuse) has been 
shown in the UK study o f  haem ophiliac s .' 9^ Whilst the Edinbuigh deaths due 
to overdose could be ascribed to suicide there was absolutely no evidence to 
suggest that they were suicidal in natui’e. No deaths were due to endocarditis 
or tuberculosis. Although the final cause of death in some of the AIDS 
patients was ascribed to pneumonia, as were four of the overdose deaths, no 
deaths were recorded due to septicaemia or pneumonia in HIV positive 
patients without AIDS who did not have a likely underlying overdose. This 
seems in direct contrast to the marked morbidity found in the admissions 
study due to chest and other bacterial infections which concuis with US 
data.®5 This phenomenon of increasing morbidity without a rise in non-AIDS 
mortality has been described among IDUs in A m s t e r d a m .  y  tie authors of
this paper suggest that the reason for this is the easy access to medical caie 
and consequent early detection and heatment of bacterial pneumonias in 
Amsterdam. Access to medical care in Edinburgh is veiy similar to that in 
Amsterdam and the Amsterdam explanation is probably very relevant to the
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Edinburgh findings. More UK data on deaths in HIV positive patients 
without AIDS should be available from the confidential repoiting system 
which, since mid-1989 has asked doctors to report deaths in HIV positive 
patients without AIDS.'^")
This study has shown the importance of post mortem examinations in HIV 
positive patients. Clearly post mortems aie important in patients dying of 
AIDS and will usually show multiple, often unexpected pathology. But post 
mortem studies aie less often canied out in HIV infected patients who have 
not progressed to AIDS. In this study one IDU who was thought likely to 
have died of overdose was found to have a florid meningoencephalitis, a 
previously undiagnosed hepatoma was found post mortem and one patient 
who probably did die of an overdose was also found to have a post viral 
pneumonitis. In addition lymphadenopathy and splenomegaly were found. 
Post mortem studies aie essential for a full description of the eaily natural 
histoiy of HIV infection. In a Geiman series of 53 post mortems in IDUs 
who died from dmg related causes (20% were HIV positive), hepatitis was 
found in 40%, foreign body granulomas in 30% and myocarditis in 18%.’^ ’ 
Although most of the patients whose death was ascribed to overdose in this 
study probably did overdose, this is not always the case. In a later case 
report from Edinburgh an HIV positive dmg user was found dead in a room 
in which were discovered tablets of dihydrocodeine and a m i h y p t i l i n e . ’^^  
had had past episodes of dmg overdose which was the suspected cause of 
death. However post mortem revealed a severe desquamative interstitial 
pneumonitis and HIV encephalitis, and toxicological screen was negative. 
The points made in Jones' Edinburgh p a p e r ’ were that the sudden onset of 
illness (such as HIV encephalitis or a chest infection) might alter the 
tolerance of IDUs to their usual dose of prescribed or recreational dmgs.
The brain was not examined in any of the patients with sudden non-AIDS 
related death except in the patient who turned out to have 
meningoencephalitis. It is cleaily important to do this to assess whether
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cerebral disease was a causative factor in the patient's death and to describe 
the eaiiy features of HIV related brain disease. This has since been done in 
E d i n b u r g h . Histological examination with polymerase chain reaction for 
HIV of the brain was done in 23 IDUs who died suddenly some yeais after 
seroconversion but while still in the presymptomatic stages of infection. The 
findings were that significant HIV infection of the brain does not occur in the 
presymptomatic stages of infection and that invasion of the centi al neiwous 
system may be delayed until the transition to symptomatic AIDS. This is in 
contrast to an eailier similai' study from Germany which suggested that 
invasion of the centr al neiwous system was an early f e a t u r  e .
So that full and relevant infonnation can be sought at post mortem, HIV 
infection has to be recognised ante mortem. In Scotland 8.5% of all deaths 
come to medico-legal n e c r o p s y . hIV  testing of sudden or diug related 
deaths has been instituted in many centius.’^ '^^ ’^^  ^ This is primarily for 
epidemiological assessment of HIV seroprevalence in that community. 
Much more use could be made of this if more detailed post mortems were 
carried out. In one study from Dundee routine post mortem HIV serology 
was instituted on deaths selected for medico-legal e x a m i n a t i o n . I f  the 
patient was found to be seropositive, a post mortem was not carried out 
"except for compelling legal reasons".
In the AIDS patients, post mortem studies revealed additional multiple 
pathology to that diagnosed ante mortem. In particular, previously 
undiagnosed CMV disease was revealed in three patients and disseminated 
mycobacteriosis in two. Treatment of these infections would have been 
unlikely to have prolonged life or achieved symptomatic benefit, but the 
knowledge of then local prevalence would increase physicians' awareness 
when treating other patients. Neither the patient whose AIDS defining 
diagnosis was CMV encephalitis, nor the two patients who developed CMV 
retinitis had post mortems.
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Sui*vival differences in AIDS patients have been clearly linked to the 
initial AIDS defining diagnosis and some studies have found this to be the 
most important factor determining s u r v i v a l . A g e ,  sex and year of 
diagnosis of AIDS are also important predictors of survival.^^-’o^ .ioi.ige 
Unfortunately the numbers in this Edinburgh study ar e too small to make any 
meaningful comparisons on survival with reference to AIDS defining 
diagnosis, year of AIDS diagnosis, sex, risk factor or age.
As patients are living longer and are less likely to die of their AIDS 
defining illnesses, they are developing and are dying of different and 
multiple diseases, many of which ar e refractory to crurent t r e a t m e n t s . I n  
this study, three patients died with lymphoma, three with disseminated 
mycobacteriosis and six with probable disseminated CMV infection. It is 
important to have continuing surveillance on the prevalence of different 
AIDS related diseases as well as on AIDS defining diseases, and post 
mortem studies are one way of doing this. Eight five percent of AIDS 
patients die in hospital (although this figure may change with better 
community care) so higher post mortem rates should be a c h i e v a b l e .  
Clinicians caring for HIV positive patients should make every effort to 
obtain permission for post mortem examinations and should liaise closely 
with pathologists to ensure tliat all relevant information is obtained.
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Table 5.1
AIDS defining diagnosis, survival time and cause of death in 19 patients
AIDS defining diagnosis AIDS survival time Cause of death
PCP 16 months Disseminated 
mycobacteriosis + CMV
PCP 29 months CMV
PCP 20 months Toxoplasmosis + CMV
PCP 7 days PCP + CMV pneumonitis
PCP 4 months PCP
PCP 2 months Toxoplasmosis
PCP + lymphoma 2 days PCP + lymphoma
PCP + KS 18 months KS
KS 11 months KS
KS 15 months KS + mycobacteriosis
KS 14 months KS
KS + toxoplasmosis 8 months KS + toxoplasmosis + 
CMV + mycobacteriosis
Toxoplasmosis 5 months Cerebral lymphoma
Toxoplasmosis 1 month Toxoplasmosis
Oesophageal Candida 19 months Disseminated
mycobacteriosis
Oesophageal Candida 45 months Lymphoma
CMV encephalitis 11 months CMV
AIDS dementia 3 months AIDS dementia
Cryptococcal meningitis 2 months PCP + lymphoma + 
cryptococcosis
Table 5.2
Ante mortem and post mortem causes of death in nine AIDS patients
Ante mortem Post mortem
AIDS dementia + 
bronchopneumonia
AIDS dementia 
Bilateral bronchopneumonia
Atypical mycobacteriosis Mycobacterium avium pneumonia 
Adrenocortical haemorrhage 
Micronodular cirrhosis 
Early HIV encephalitis
Cerebral lymphoma Cerebral lymphoma 
B ronchop neumo nia 
Prostatitis 
Splenomegaly
Viral encephalitis Cerebral toxoplasmosis 
Bronchopneumonia
Cerebral toxoplasmosis Cerebral toxoplasmosis 
Pulmonary microabscesses 
Disseminated CMV 
Disseminated mycobacteriosis 
Cutaneous KS
KS +
bronchopneumonia
KS
Rectal mycobacteriosis
Cerebral toxoplasmosis + 
bronchopneumonia
Cerebral toxoplasmosis 
Bronchopneumonia 
Disseminated CMV
PCP PCP
Cerebral lymphoma 
Leucoencephalopathy
PCP PCP
CMV pneumonitis
Table 5.3
Post mortem results in seven patients in whom death was thought to be due
to overdose
Presumed cause of death Post mortem result
Overdose Temazepam + alcohol in post mortem 
blood
Aspiration pneumonia 
Generalised lymphadenopathy
Overdose Aspiration pneumonia
Overdose Temazepam in post mortem blood
Overdose Acute pulmonary oedema 
Aspiration pneumonia 
Splenomegaly 
Lymphadenopathy
? Overdose 
? Head injury
Florid meningoencephalitis 
Marked cerebral oedema
Overdose
Bronchopneumonia
Morphine in post mortem blood 
Bilateral confluent bronchopneumonia 
Post viral pneumonitis 
Septicaemia
Generalised lymphadenopathy
Respiratory arrest 
? Overdose
Acute pulmonary oedema
Post mortem drugs screen negative
Splenomegaly
CHAPTER SIX
DISCUSSION
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The study of Edinburgh hospital admissions and of deaths in a cohort of 
HIV positive patients over a four yeai period must be one of the most 
comprehensive studies of morbidity, hospital use and mortality within the 
early years of an HIV epidemic. Apart from obstetiics, all hospital 
admissions in one city were studied, and different methods of case finding 
were used. It is therefore a complete record for the 409 patients attending 
the City Hospital out patient clinic and can be extiapolated to represent the 
1000 drug users estimated to have been HIV infected in Edinburgh at that 
time. It is not confined to one hospital, one diagnostic category, one risk 
group nor one sex. It provides a complete picture of the early phase of an 
epidemic. The results have been used for planning resources within the city 
of Edinburgh and can used by other cities who aie assessing health service 
resoui'ces required for an HIV epidemic. The results show that planning for 
AIDS related admissions five to ten years after the introduction of HIV 
infection into a population is not appropriate, and that exha resouices aie 
needed at all stages, paificularly in a population of HIV infected IDUs, 
because of the early rise in morbidity and mortality.
Had the City Hospital admissions alone been studied, not only would 
details have been missed on 30% of the total admissions but the disease 
spectium would have seemed veiy different. It would have been skewed 
towards admissions in patients with symptomatic disease and admissions for 
BCIs. None of the gynaecological admissions and only a very small 
proportion of the dmg related and psychiatiic admissions would have been 
analysed. Veiy few of these admissions were in homosexual men or AIDS 
patients. Therefore the early natuial histoiy of HIV disease in women, 
heterosexuals and IDUs and the large number of admissions in patients with 
CDC stage 2 and 3 disease would not have been so accurately documented. 
Also, a lai’ger number of psychiatiic admissions might have expected in this 
community, whereas only 38 occuiTcd.
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This thesis did not include obstetric admissions. The natuie of these 
admissions is quite different from any medical, surgical or psychiatric 
admissions and they have already been extensively d e s c r i b e d . N o  
admissions outwith Edinbuigh were analysed. Most of the admissions 
among the IDUs and heterosexual patients were likely to have occuned 
within Edinburgh since these patients aie known to belong to a socially 
stable g r o u p . A  minority of the homosexual men attended for medical care 
in other cities before or after attending in Edinbuigh. It was not necessary to 
study these admissions to provide a pictuie of the seivices used in 
Edinburgh.
There was a change in the disease spectium over the years studied so that 
by the end of the study, although only six years after the intioduction of HIV 
into the Edinburgh IDU community, more IDUs (and patients from all risk 
groups) were developing symptomatic disease and more admissions were 
AIDS related. By 1989 this was aiguably no longer the "early natural histoiy 
of HIV infection". But the advantage of studying up until 1990 was that it 
gave a cleai’ pictuie of admissions within the first fom years of the 
introduction of the City Hospital clinic and within the first six years of the 
Edinburgh epidemic. Even in late 1989 many of the admissions were in 
patients without CDC stage 4 disease. It also documents the changing face 
of an epidemic with the consequent change in seivices required.
Comparisons of different risk groups can give rise to criticism of this 
thesis. The natme of the patients from different risk groups are not directly 
comparable. The homosexual men aie, as a group, older and the 
heterosexual patients younger than the IDUs. Older age is one of the most 
important cofactors for progression of HIV d i s e a s e , g Q  progression of 
HIV in these Edinburgh patients from different risk groups cannot be directly 
compaied. Furtheimore, accurate dates of seroconversion are only known 
for the IDUs. Although the homosexual men as a group seroconveited 
earlier, and the heterosexual patients later than the IDUs, seroconversion
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dates for these risk groups can only be suimised. Length of time since 
seroconversion and yeai* of presentation with AIDS are also important 
predictors of s u r v i v a l . ’"’ ’ 3.34 the primaty aim of tliis thesis was not to
investigate progression of, nor survival with, HIV infection. To have studied 
each risk group independently would not have produced a picture of the 
inpatient seivices required for a city with a laige number of HIV infected 
patients, many of whom aie at different stages of HIV disease and have 
differing needs for HIV care. Although compaiisons aie drawn between 
different risk groups, these are only with relation to different health caie 
needs.
The thesis has obviously focused on IDUs because they aie the lai'gest 
gi'oup requiring medical and other care in Edinburgh. One of the most 
difficult problems facing the study was in assessing how much morbidity 
was due to the effects of HIV infection, how much was due to the effects of 
drug use per se and how much was additive. Unlike the US methadone 
maintenance programmes,®^ ®^ tliere was no cleai* compaiison cohort of HIV 
negative IDUs. Many studies in Edinburgh aie following up gioups of IDUs 
regai'dless of HIV s t a t u s . But in these groups the IDUs who are not 
known to be HIV positive aie not necessaiily negative and may have chosen 
not to be HIV t e s t e d . ^ ^  Projections of IDU-related HIV in Edinburgh would 
suggest that many of these IDUs are in fact HIV positive. Other IDUs in 
Edinbuigh are therefore not a suitable compaiison group. Additionally, no 
comprehensive data are available on admissions of these IDUs. There is no 
"flagging" system of these IDUs nor would a diagnosis of IDU always be 
recorded on discharge summaries and SMR-1 foims. Because of this 
problem, data were found on admissions in Edinbuigh for BCIs from the 
immediate pre HIV era and from the first two yeais following the 
intioduction of HIV into IDUs - when it was veiy unlikely that any 
admissions, even in patients already HIV positive, would be HIV related. 
This is the most suitable compaiison gioup. Admissions for dmg related
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disease aie compared with published data from Glasgow for the immediate 
pre HIV era (see below). A prospective study comparing HIV positive and 
negative IDUs in Edinburgh would be invaluable.
Most published studies on admissions and health care utilisation were not 
relevant to planning resources for IDUs and other HIV-infected patients in 
Edinburgh, This is not to say that compaiisons between study groups are not 
valid, nor that this thesis is not applicable to any gioup out of Edinbmgh. 
But compaiisons are best drawn between similai groups of patients in similar 
health care environments. Most studies aie from America where the health 
care system is quite different from that in the UK. This is home out by 
numerous American studies which suggest inequalities within the American 
health caie system such that women, IDUs and certain racial groups have 
more difficulty in accessing health caie, 202 and that in-patient survival is 
better in hospitals more experienced in tieating AIDS patients.203 One major 
advantage of American studies is the large number of patients studied and the 
consequent validity of statistically significant results. CDC studied 43,000 
admissions in 1988,204 and 222,200 admissions from the National Hospital 
Dischaige Suivey between 1983 and 1988.205 The 1987 US hospital AIDS 
suiwey reported on 14,145 patients, 22,088 admissions and 371,768 bed 
days. But the veiy size of these studies does limit detail.
Of necessity many studies on admissions have focused on bed utilisation 
and on costings of hospital sei'vices .205 Widely different lengths of hospital 
stay for HIV positive patients have been reported (tables 6.1, 6.2). For 38 
IDUs with AIDS in Brooklyn the annual number of admissions was 1.13, 
annual days in hospital was 38.5 and average length of stay was 34 days.205 
In Cleveland in 1987 and 1990 the average length of stay for a group of 50 
homosexual AIDS patients was around 16 days.202 In the Kaiser Permanente 
study, 863 Californian AIDS patients had a mean 40 lifetime inpatient days 
and 3.3 hospitalisations with average length of stay of 17 days in 1983, and 
11 days in 1 9 8 7 .20» Tfle 1987 US hospital AIDS suiwey of 276 hospitals and
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14,145 AIDS patients gave an average length of stay of 17 days.204 Between 
1984 and 1987 in San Francisco the average length of admission for an AIDS 
patient was 11.6 days.209 From European data, mean lifetime bed use in 
AIDS patients in Geneva was 56 days in 2.4 admissions with an average 
length of stay of 22.5 days.2’0 Johnson's 1985 study of 33 London AIDS 
patients gave a mean length of admission per AIDS patient of 17 days with a 
total of 50 hospital days whilst alive with AIDS.2” In Dublin in 1987 the 
average length of stay for patients with CDC stage 2 or 3 disease was 8.5 
days and 13.5 days for patients with stage 4 disease. 212 The average length of 
stay in Edinburgh was 9.6 days. This paiticulaily low length of stay is due 
to a number of factors. Patients were included at all disease stages, all 
admissions (including overdose) were studied and there was a good system 
of out patient caie, thereby relieving some burden from inpatient ward care. 
IDUs often lead such chaotic life styles that they tend to present in crisis. 
Community caie and out patient seiwices aie often not able to accommodate 
this so that problems which might be resolved by earlier out patient 
attendance require admission in IDUs. Tailoring of out patient seiwices to 
the needs of the local community is important and walk in and methadone 
clinics have been shown to reduce the number of crisis admissions in 
I D U s . ”2,213-215 The availability of out patient seiwices is therefore an important 
factor to take into account when assessing the literature on hospital 
admissions, and paiticulaily when comparing European and US studies.2’6
Lengths of hospital stay have decreased since the early yeais of the 
epidemic,204,2os partly due to physician familiaiity and partly due to better out­
patient, prhnaiy caie and hospice sei'vices.2°^ '2i4 Despite this, lifetime bed 
days post AIDS may not have changed and may be a feature of longer life 
expectancy with more, albeit shorter, admissions.20  ^ A decrease in length of 
stay was clearly found in Edinburgh. Average length of stay in the City 
Hospital fell fiom 18.5 to 15.3 to 10.1 and then 10.8 days over the four years 
studied, while the length of admissions to the other hospitals (usually not
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classically HIV related), stayed relatively stable. This fall in lengtli of stay 
was despite a rising number and percentage of admissions in patients with 
symptomatic stage 4 disease and AIDS. Physician familiarity with HIV 
disease was an important factor but even more influential was the 
development of good out patient facilities and of home caie support teams.2‘5 
Out patient facilities which were "IDU fiiendly" decreased the percentage of 
admissions in IDUs over the years, the other factor being the decline in 
injecting in Edinburgh and admissions consequent to IDU.^ .^ns.ne
Some studies have found lengths of stay to vaiy between risk groups. In 
the US this may be due to different health caie needs, and the longer 
admissions in IDUs have been related to housing problems.20=^ No difference 
between risk groups was found in Geneva.^’” In Edinburgh there was a clear 
difference between risk groups with homosexual men having significantly 
longer admissions than any other risk group. This was partly because of the 
many short admissions for overdose by the IDUs and partly because most of 
the homosexual men were likely to have seroconveited some yeais before the 
IDUs and had more advanced disease.
Another problem when compaimg admission studies is that most studies 
have focused on homosexual m e n , 2 0 s  and some studies have actively 
excluded women from analysis because of "marked differences in types and 
intensity of health cai e resource utilisation" . 205
That women were included in this Edinburgh study and that women 
comprised 39% of admissions is of epidemiological importance. The 
medical problems of HIV in women did not receive much attention until 
some years after the onset of the HIV epidemic. A flmiy of studies in the 
late 1980s tiied to rediess tliis balance. These were mainly epidemiological 
studies, many of which suggested that the natmal histoiy of HIV infection 
showed much faster progression in women.'^o^oo o f  5833 New York patients 
who developed AIDS before 1986 the poorest prognosis was found among
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women.’0’ Gender was an independent predictor of smwival in this study 
(and only 9% of the study patients were women) but contiibuting factors 
were black race, that women did not present with KS and that more women 
than men had a zero survival (which accounted at that time for 11% of the 
cohort). There was concern that women presented with later stage disease,^’? 
had poorer access to medical care,^’» were less likely to be emolled in clinical 
tiials,2’9 and received less zidovudine.220 Physicians were less likely to 
consider an HIV related diagnosis in female patients.22’ In a study of gender 
difference in suivival of 2,526 men and 544 women with first episode PCP, 
although analysis for gender alone revealed that women were not 
significantly more likely to die during the initial hospitalisation than men this 
was only when analysis was adjusted for the confounders of admission 
thiough the emergency room, not having private health insurance and 
receiving medical care in hospitals with less experience in treating PCP .221 
Women were significantly more likely to belong to all of these categories 
and were also more likely to be non-white. Women were also less likely to 
undergo bronchoscopy than men but were more likely to be intubated for 
respiratoiy failure suggesting that women with PCP may be tieated less 
aggressively than men. Studies have since shown little difference in 
progression to AIDS and to death in women if adjustment is made for 
confounding f a c t o r s . -222-225 The main confounders are underlying risk 
factor, ethnicity and socioeconomic status.225
An important indicator of suiwival is presenting illness at diagnosis of 
AIDS and this has implications for suiwival of w om en .'2.'01 Women are less 
likely to present with KS, the most benign of the AIDS defining 
i l l n e s s e s . ’01.222,227 Women are more likely to present with oesophageal 
c a n d i d o s i s , 06-128.217.228 -wasting syndrome,2i'? and chionic muco-cutaneous herpes 
simplex.06-217 Some studies have reported tliat women are also less likely to 
present with PCP.22s.229 Some recent studies have even suggested enhanced 
suivival in women compared with men .222 In the European study of 6578
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patients diagnosed with AIDS before 1990, no significant difference in 
survival was found between men and w om en .”
This thesis has, almost uniquely, been able to compare veiy similar gioups 
of men and women with HIV infection. Excluding the homosexual men, 
who as a group were on average older and more likely to be of a higher 
social class, the male and female IDUs came from veiy similai backgrounds. 
The heterosexual patients also came fiom very similar backgrounds since 
many of them had acquired their infection from Edinburgh IDUs.^^o The 
heterosexual group did differ, but only by route of infection, later date of 
seroconversion and younger age. By November 1989 only thiee 
heterosexually HIV infected African patients (two women and one man) had 
been admitted to Edinburgh hospitals. The rest of the patients were 
Caucasians with the same access to health caie and, excluding the 
homosexual men, of the same social class. This makes this thesis veiy 
different from most American studies where women are more likely to be 
black or Hispanic and socio-economically disadvantaged. A study of women 
attending for out-patient follow-up in London hypothesised that women from 
sub-Sahaian Africa may even have difficulty in accessing health care in the 
UK.23' Some European studies have compaied similai* socioeconomic and 
racial groups of women and men but most of the patients are IDUs and 
compaiison groups with heterosexuals are less valid. Although by November 
1989 the numbers of progiessions to AIDS and of deaths were too small in 
this study for valid statistical compaiisons between men and women, 
different risk groups and different indicator diseases, fuither follow up of 
this cohort of 409 patients will be invaluable. Of the ten women who 
developed AIDS during the study, eight presented with PCP and two with 
oesophageal candidosis. One African heterosexual woman had KS (although 
this was not a reason for admission) and the 13 admissions for KS or 
lymphoma were all in homosexual men. Admissions among heterosexual 
women were significantly more likely to be for AIDS related conditions and.
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since thi'ee of these four women (one was African) had acquired their 
infection fiom Edinburgh IDUs and had later dates of seroconversion, this 
would suggest faster progression among heterosexual women.
Studies of clinical disease in women have focused on AIDS defining 
diagnoses, the effect of pregnancy on progression and on women-specific 
d i s e a s e s . 224.232.233 Edinburgh studies on pregnancy have shown a small 
increase in spontaneous abortion but otheiwise no adverse effect on the 
outcome of the pregnancy in 50 seropositive women compaied with 64 
seronegative contiols.234 The same seropositive cohort has also been studied 
for progression to AIDS and, compaiing women who became pregnant pre 
HIV seroconversion, women who became pregnant post HIV seroconversion 
and HIV positive women who had never been pregnant, found that 
intercuiTent pregnancies did not affect progression.236 Similar post AIDS 
survival has also been documented in Edinburgh among five women with 
AIDS who had been pregnant compared with 17 women who had not.’^®
Women-specific diseases reported in the literature are genital tiact 
infections and malignancy. There is a significant association between HIV, 
ceivical intiaepithelial neoplasia (CIN) and ceivical cancer. The summaiy 
odds ratio of five studies (of 628 women) on CIN indicated that the odds of 
HIV-infected women having CIN were five times that of matched HIV- 
negative women.236 Ceivical cancer is more rapidly invasive in HIV positive 
women.232 Despite this, most women with HIV infection and ceivical cancer 
aie more likely to die of HIV related diseases than of ceiwical cancer. In 
Chu's study of 1157 death certificates in US women with any mention of 
HIV or AIDS, ceivical cancer was listed as a cause of death in five.23? But 
studies in this area aie difficult to inteipret because of confounding and 
because closer smveillance of HIV positive women may identify more 
pathology.223 Pelvic inflammatoiy disease has also been studied, but to a 
lesser degree, and has been found to be more coimnon in HIV positive 
women.238 Chu's study reported that pelvic inflammatoiy disease was listed
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as a certified cause of death in two HIV positive women.23? A small study by 
Kom compaiing 23 HIV-seropositive women with a conü'ol group of 108 
sero-negative women admitted for pelvic inflammatoiy disease showed that 
the altered immune response in the HIV positive women affected their 
clinical presentation.23« HIV positive women had significantly lower
abdominal tenderness, lower white cell counts and requhed more suigical 
intervention and were less likely to have gonococcal infection.
In this thesis no women were admitted for ceivical cancer and no deaths 
were due to this. The routine assessment of women attending the out-patient 
clinic included at least yearly ceivical smears with colposcopy for any 
abnonnalities. CIN is more likely to be an out-patient diagnosis but patients 
with ceivical cancer would be admitted at some point in their illness and 
therefore the figure for ceivical cancer is probably true. Pelvic inflammatoiy 
disease accounted for 26 admissions in ten women (and 100 days in hospital) 
and was a significantly more common reason for admission among 
heterosexual women. Many of the women may have been commercial sex 
workers and it is suiprising that only 26 of 359 admissions in women should 
be for pelvic inflammatoiy disease and that, in general, these admissions 
should be short and uncomplicated. Gonococcus was cultmed in two cases 
(8% of admissions) which is even lower than Kora's figure of 27%.
Few studies have assessed gender differences for other clinical 
presentations in HIV positive patients. A Rhode Island study of 200 women 
found recunent vaginal candidiasis to be the most common initial 
manifestation of HIV infection (43 of 117 women) as well as the most 
frequently obseived infection duiing the course of HIV infection, and 
bacterial pneumonia was the initial presentation in 15.'2» The authors 
comment that these sentinel diagnoses rarely prompted HIV testing, even if 
the patient had a histoiy of IDU. Twenty patients died in this study 
including five from PCP, four from bacterial pneumonia, two from 
staphylococcal endocarditis, two from liver failure and one from sepsis of
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unknown aetiology, Chu's study of causes of death due to HIV infection in 
US women identified that in addition to deaths related to "classical" HIV 
related conditions there was an increase in deaths due to chionic liver disease 
and cinhosis, pneumonia, pulmonaiy tuberculosis and septicaemia.^^? From 
the US National Hospital Dischaige Suivey analysis of HIV related 
admissions, women were more often admitted with non-AIDS related illness 
than AIDS and were more likely to be admitted than men with non- 
oppoitunistic infections.205
This thesis differs importantly fiom other studies of women in that it 
examines all clinical presentations in women, not just diseases specific to 
women or AIDS defining diagnoses. Women-specific diseases (pelvic 
inflammatory disease, pregnancy, teimination of pregnancy and other 
gynaecological conditions) accounted for only 56 of the 359 admissions by 
women in this study. The most common clinical presentation among this 
group (among both men and women) was with bacterial infection. Urinary 
tiact infections were a more common reason for admission among women 
than men (11 women, two men) and appealed to be complicated in that the 
average length of admission was five days. It is interesting that published 
studies on uiinaiy tiact infections in HIV positive patients have focused on 
m e n . ’42. 143.179 Women were over-represented among admissions for bacterial 
chest infections but the difference did not reach statistical significance. 
Admissions for detoxification, overdose and investigation of fits, headaches 
and di'op attacks were also more common amongst women.
This thesis has focused on another group, which like HIV infected 
women, has not been the subject of enough research attention - namely HIV 
infected patients without AIDS. Most published studies have only reported 
on AIDS p a t i e n t s . 204.208 Data are easier to obtain on AIDS patients but to 
focus solely on AIDS patients vastly understimates the total resouices needed 
for HIV caie. Foity percent of admissions to the Edinburgh City Hospital, 
accounting for 2586 bed days, were in patients with CDC disease stage 2 or
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3. Some studies have described admissions in HIV infected patients without 
AIDS,®  ^but few have described admissions in patients without "symptomatic 
disease". Since most of the admissions to the other Edinburgh hospitals were 
likely to have been in patients with "asymptomatic" HIV infection (only six 
AIDS exclusive diagnoses were recorded in the other hospitals) it is likely 
that over 50% of all Edinburgh admissions were in patients with 
asymptomatic disease. Cleaily there were also many asymptomatic patients 
who did not require admission - both those already attending the clinic who 
were not admitted and those aheady infected who had not yet attended the 
clinic or learned of their HIV positivity. If the admissions in asymptomatic 
patients are extrapolated to represent all Edinburgh asymptomatic HIV 
positive patients then a figme of 20% may be more representative of the 
whole city. Although many of the admissions would have occuned 
regai’dless of the HIV status of the patient it is likely that there was a real rise 
in the number of IDUs admitted with overdoses and other conditions diiectly 
attiibutable to dmg use. There was also a real increase in admissions due to 
bacterial infection in asymptomatic patients. HIV positive IDUs suffered an 
eight fold increase in the incidence of bacterial chest infections compared 
with figures in IDUs immediately before the Edinburgh epidemic. That these 
IDUs with BCIs required hospital admission (i.e. admissions were not due to 
increased hospital refenal as a result of known HIV status) is shown by the 
long average hospital stay of ten days. Of all admissions to the City Hospital 
with bacterial infections, 62% were in patients who had not progressed to 
CDC stage 4 disease. The average length of admission was longer for the 
asymptomatic patients (12.9 days) compared with the symptomatic patients 
(10.7 days). Conelated with the analysis of admissions by CDC stage is the 
analysis by CD4 count. Eighteen percent of admissions to the City hospital 
were in patients with a CD4 count above 500 cells/mm^ and 48% were in 
patients with a CD4 count above 200 cells/mm^.
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But the data from AIDS patients in this study must not be ignored. Thiity 
two percent of admissions were in patients with AIDS and 60% in patients 
with CDC stage 4 disease. These admissions were more common in 
homosexual men and in the last year of the study accounted for a larger 
percentage of bed days. PCP was the commonest AIDS defining diagnosis 
(in all risk groups) and principal diagnoses of KS and lymphoma were only 
found in die homosexual men. Nineteen patients died of AIDS, 17 of whom 
had died within two years of their diagnosis. Post mortem studies on nine 
patients revealed multiple pathology with unexpected findings in eight cases.
The AIDS related diagnoses highlight the main differences in clinical 
presentation between risk groups. Homosexual men were more likely to be 
admitted with AIDS and less likely to suffer bacterial infections. 
Heterosexual patients were also more likely to have AIDS and were also the 
group which suffered most episodes of pelvic inflammatoiy disease. IDUs 
were less likely to be admitted with AIDS and more likely to be admitted 
with chest infections, overdose and drag related conditions. Of the 34 deaths 
studied, all 15 which were not due to AIDS were in IDUs. Two were due to 
chronic liver disease, one to acute meningoencephalitis and 12 were likely to 
be due to drag use. Post mortem studies were particularly important in this 
group of patients to document the eaily natuial histoiy of HIV infection. 
Meningoencephalitis, hepatoma and pneumonitis were all diagnoses which 
were not suspected clinically ante mortem.
Some published studies have examined the whole spectram of HIV related 
illnesses. One such is Rosenblum's study of 222,200 hospitalisations from 
the US National Hospital Dischaige Suivey.^os Admissions were AIDS 
related in 69%, and 90% admissions were in men. Women were less likely 
to have an AIDS defining illness. For the AIDS related admissions 30% 
were for PCP, 20% for candidosis and 13% for KS although the proportion 
of admissions for PCP and KS declined from 34% to 28% and from 13% to 
9% respectively over the five yeai* period. Among non AIDS related
150
illnesses, infections accounted for 39% and drug abuse for 9%. Infections 
were more common among women, blacks and younger patients, most (28%) 
were bacterial and most (25%) were pneumonia. "Sepsis" accounted for 
17%, enteritis for 16% and uiinaiy tiact infections for 8% of the infectious 
disease admissions. In another analysis of the US National Hospital 
Discharge Suivey, HIV-infected patients had an average of 3.6 diagnoses in 
addition to their HIV diagnosis.239 In the 1988 CDC suivey of 43,000 
admissions, patients with HIV related diagnoses other than AIDS accounted 
for one thiid of all HIV-related admissions and slightly less than one thud of 
the hospital day s .240 The ALIVE study recmited 1881 Baltimore IDUs and 
estimated that the presence of two or more AIDS-related symptoms had the 
strongest influence on the use of both inpatient and outpatient health care 
s e i v i c e s . ’®  Neither HIV positive serostatus alone nor low CD4 counts in the 
absence of symptoms were associated with increased health seivice 
utilisation (i.e. asymptomatic HIV positive IDUs were no more likely to use 
seivices than their HIV negative counteipaits). However even among 
individuals with symptoms, the absence of health insurance was associated 
with a lower probability of receiving inpatient ti eatment.
UK studies should be more comparable with the data from Edinburgh 
because of the same health caie system. But most UK studies aie from 
London where most patients are homosexual men and any women and 
heterosexually infected patients aie likely to be A f r i c a n , 241-242 ajid most focus 
on AIDS patients.211-242 in a study of admissions to a London hospital 
between 1983 and 1988, 84 men, 71 of whom had AIDS, accounted for 371 
admissions.241 Over two thirds of admissions were day cases and blood 
ü'ansfusions accounted for 43% of all admissions. Blood transfusions 
decreased by 25% in a follow-up study.242.243 Median length of admission for 
AIDS patients, excluding day cases was 8.5 days. Pulmonaiy infections (37 
due to PCP, nine due to pyogenic infections) accounted for 12% of all 
admissions. The follow-up study assessed 1541 admissions in 338 AIDS
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patients and 121 HIV positive patients without A I D S . 243 Between 1983 and 
1989 the number of day case admissions increased while the number of 
planned admissions decreased. This paper did not report on admission 
diagnoses. Admission diagnoses were recorded in a 1988 study from another 
London hosp ita l.” ? Of the 221 admissions, blood tiansfusion accounted for 
47, gasti’o-intestinal investigations for 24, AIDS related pneumonias for 20 
(with an average length of stay of 15.4 days), teiminal care for ten and social 
reasons for eight. The 20 patients admitted with pneumonia required the 
lai'gest proportion of bed days (310). Approximately half of all the medical 
admissions stayed for less than a week.
Only two UK studies have been reported from outside London. One from 
Newcastle was an elaborate costing study of 24 patients.244 The other from 
Oxford describes a predominantly haemophiliac cohort of 83 patients 
between 1986 and 1990.245 o f  the 2,446 days spent in hospital, 1,533 were 
by patients who did not have AIDS. The average length of hospital 
admission decreased from 16.8 days in 1986 to 8.6 days in 1989 although 
there was no significant difference in the median length of stay. Although 
this study did not include discharge diagnoses, the causes of death in 28 
patients is documented. Eighteen deaths were due to AIDS, thiee to 
septicaemia, one each to bronchitis, suicide, lung cancer and a wasting 
disease and the cause was unknown for three.
Edinburgh studies are perhaps more comparable with studies fi om Ireland 
and Italy. In both countiies the predominant mode of tiansmission is via 
IDU and both have a universal health caie system.
Of 644 Italian AIDS patients, those diagnosed before 1986 spent about 
half of their life span in hospital compaied with patients diagnosed between 
1987 and 1988 who spent a quarter of their life in hospital.2^6 This was due 
to an increased life span (from seven to 12 months) rather than due to a
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decrease in lifetime hospital days (which declined only slightly from 109 to 
91 days).
A veiy compaiable study to the study of admissions in Edinburgh was 
published fiom Dublin in 1991. '^^ Over a four yeai' period between 1987 and 
1990, 179 patients were admitted 409 times to St James's hospital (table 6.3). 
IDUs accounted for 74% of admissions, 23% were homosexual, 3% were 
heterosexual and overall 73% were male. The annual number of admissions 
increased tenfold over the four yeai period. One hundred and foity five 
admissions were for patients with CDC disease stage 2 or 3 and 263 for 
patients with stage 4 disease. Mean lengths of stay were 8.5 and 13.5 days 
respectively. Bacterial pneumonia accounted for 21% admissions, PCP for 
11%, cellulitis for 7%, chronic hepatic disease for 4%, tuberculosis for eight 
admissions, drug overdose or withdrawal for eight, urinary tract infection for 
five and seizures for four admissions. The high percentage of admissions in 
patients with eaily stage disease was mainly attiibuted to the effects of IDU 
(cellulitis, skin abscesses, endocarditis, hepatitis, dmg overdose and opiate 
withdrawal). The lower mean length of stay when compared with other 
studies was ascribed to the large number of admissions due to bacterial chest 
infections. It is not clear from this paper whether St James's is the only 
hospital which would admit HIV positive patients in Dublin and whether this 
is fully representative of the whole spectium of admissions by HIV positive 
patients in Dublin. It is possible that there is another psychiatric institution 
or poisons unit which would admit IDUs with primaiy ding related 
problems. If not, then eight admissions for overdose or withdrawal is a very 
small number compared with the Edinburgh study.
A study of Accident and Emergency (A & E) department attendances 
published by the same group suggested that there is a much larger spectrum 
of IDU related disease in D u b l i n . ^ '  ^ y  w o  hundred and sixty of 600 known 
HIV positive patients attended the A & E depaitment of St James's Hospital 
between 1990 and 1992. There were 709 visits with a mean annual
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attendance rate of 2.7, twice that for the general A & E population. Bacterial 
respiratoiy tiact infection was the single most common reason for attending 
A & E and for admission to hospital. BCIs (37%) and AIDS defining 
illnesses (31%) accounted for over two-thirds of all admissions. Only 12% 
of admissions by IDUs were for problems atùibutable to IDU but nearly 30% 
of A & E attendances by IDUs were directly related to drug use. Eighteen 
percent of these patients had infective conditions (abscesses and cellulitis) 
related to the site of a recent injection. These figures are lower than those 
fiom a 1986 study of IDUs presenting to a Glasgow A & E department 
where, of 488 attendances, 50% were for "smgical conditions" (mainly 
abscesses, cellulitis and trauma but also including acute abdominal pain, 
gynaecological and dental problems) and 30% were for "psychiatiic 
conditions", mainly alcoholic and narcotic i ntoxi ca t ion.But  this, like other 
studies of A & E attendances and admissions by IDUs,^“-24s was largely 
before the HIV era and so the Glasgow and Dublin studies are not diiectly 
comparable.
The usefulness now of these studies is in the background incidence of 
admissions directly related to drag use. The immediate pre HIV era is the 
best period for studying this, unless clear distinctions are drawn between 
HIV positive and negative patients as in tlie studies from methadone 
maintenance clinics in New York.*  ^ This Edinburgh study was not able to 
compare admissions by HIV positive IDUs with HIV negative IDU controls. 
The incidence of BCIs were compared with figures from the general age 
matched population and from IDUs from the pre HIV era giving a markedly 
increased incidence of BCIs in HIV positive IDUs compared not only with 
the general population but also, by extiapolation, with HIV negative IDUs. 
Figures for admissions for drag related disease in Edinburgh for the pre HIV 
era or for HIV negative IDUs aie not available. This is because most 
patients admitted with overdose are not IDUs.^ '^ ® It is difficult to tell whether 
the figure of 220 admissions over a foui’ yeai' period is in excess of what
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would be expected. Certainly, only one admission was in a patient with 
AIDS. But more admissions might be expected in patients with early HIV 
disease because of the psychological effects of an HIV diagnosis and the 
"crisis" response of IDUs. Also, HIV positive IDUs who had repeated BCIs 
and abnomial pulmonaiy function tests might be more susceptible to the 
adverse respiratoiy effects of their usual quantities of recreational dings. 
On the other hand, the HIV epidemic in Edinbmgh has been associated with 
a decrease in injection ding use, and the number of ding related admissions 
decreased remaikably over the four year period.^^ ''  ^”  ^ More patients may 
request detoxification on learning of their seropositivity. In the Glasgow 
study of admissions by IDUs over a five year period between 1980 and 1984, 
39 admissions were for overdose, 14 for thiombophlebitis and deep venous 
thrombosis and 35 for abscess and cellu litis .S ince  only one admission was 
recorded in the first year of the study it is reasonable to discount the first 
year and consider 122 admissions in four years. Denominator data are not 
available from this paper other than that the hospital serves a population of 
240,000. At least 5,000 drag users were estimated to be in Glasgow at that 
time, although not evenly distributed about the city and the catchment 
population of IDUs for the hospital concerned might be almost the 2,000 
IDUs estimated in E d i n b u r g h . The Edinbuigh figures of 102 admissions 
for overdose and 49 for abscesses and cellulitis aie therefore far in excess of 
this. There aie cleai' differences in IDU behaviom* between Glasgow and 
Edinbmgh,'°5249 but these figmes suggest that there aie more drag related 
admissions in Edinbuigh patients who are HIV infected compaied with those 
who aie not. The 220 admissions diiectly related to drag use made this 
categoiy the commonest duiing the four yeai' period. The figure of 220 does 
not even include those for fits and black outs which were likely to be drag 
related. These could have caused some diagnostic confusion and used 
considerable resources. Fits and blackouts in HIV positive patients would 
noimally require CT or MRI scanning and a lumbar puncture to exclude the 
diagnoses of cerebral toxoplasmosis, lymphoma or ciyptococcal meningitis.
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Therefore health sem ce resoui ces in the face of HIV infected IDUs need to 
consider not only admissions for classic AIDS related conditions, for 
symptomatic HIV positive patients without AIDS and for bacterial infections 
which can occm' at eaily stage HIV infection, but also an increase in 
admissions for what appeal' to be umelated conditions such as injection 
related injuries, overdose, detoxification and fits and blackouts. These 
patients often requiie inpatient and outpatient counselling. Trauma in an 
HIV positive patient will requhe more resouices because of different surgical 
techniques, additional theatre time and the greater likelihood of an HIV 
positive patient developing infectious and other complications. Despite the 
appaient increase in admissions due to overdose and other complications of 
IDU, the 12 deaths directly attiibutable to drug use aie unlikely to represent 
an increase due to HIV.
Although admissions for dmg related diseases were the commonest, most 
bed days occupied were for respiratoiy conditions. PCP was the commonest 
AIDS defining diagnosis and requhed the most bed days (1065 total days, 
average length of admission 23 days) but the most stiiking finding in this 
study was the high number of admissions for bacterial chest infections. Not 
only was the incidence of these infections much increased compared with the 
general population, but it was also increased in HIV positive IDUs compared 
with other risk groups and in HIV positive IDUs compaied with presumed 
negative IDUs. These were infections which, even given an increase in 
incidence, might be thought to have responded to out patient treatment yet 
requiied admission with an average length of admission of ten days. Some 
of this admission time may have been because of diagnostic confusion with 
PCP and therefore the algorithm was drawn up for clinical use. Another 
stiiking finding was that despite the increase in incidence and morbidity 
associated with BCIs, there was no associated mortality. This is in direct 
contrast to US studies but in keeping with Amsterdam studies where early
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diagnosis and tieatment may the reason for the lower BCI related 
mortality.
Chest infections accounted for 51% of all the admissions for bacterial 
infections. A total of 189 admissions for bacterial infections were recorded 
and these accounted for 21% of all admissions. Urinaiy tiact infections and 
pelvic inflammatoiy disease were the other common sites for bacterial 
infections. Admissions amongst IDUs were significantly more likely to be 
for bacterial infections when compared with homosexual men and 
admissions by women to the City Hospital were significantly more likely to 
be for bacterial chest and genito-urinaiy infections. What was also stiiking 
about bacterial infections in this study was that 62% of these admissions 
were in patients who did not have CDC stage 4 disease. Despite the high 
number of admissions due to bacterial infections and the reports fiom other 
IDU studies of the high incidence of T B , ' 24,251 only one case of TB was 
recorded during this study. From the study of BCG records, the low UK 
prevalence of T B  is the most likely reason for this difference with other 
cohorts.
Bacterial infections have long been recognised to be a complication of 
IDU.^  ^ In papers from the pre AIDS era on the medical complications of 
heroin abuse, tetanus, abscesses, endocaiditis, pneumonia and septicaemia 
were often quoted as major reasons for increase in mortality and morbidity 
among dmg a d d i c t s . «5 Endocarditis was primarily right-sided with 
consequent problems of septic pulmonaiy emboli and tiicuspid 
incompetence.’'  ^ Pneumonia presented with typical symptoms, the 
predominant organism was the pneumococcus and it usually responded 
quickly to penicillin. It was also recognised to be a common sub-clinical 
finding and was partly thought to be responsible (along with foreign particle 
emboli) for the alterations in pulmonaiy function seen in IDUs - the most 
common being reduced carbon monoxide diffusing c a p a c i t y . I n  a 
Scottish review of admissions by IDUs to a district general hospital.
157
abscesses accounted for over half of the surgical admissions, most commonly 
in the groin due to repeated injection into the femoral vein.^ *^  This increase in 
bacterial infections in IDUs is due to poor dental hygiene, poor 
tracheobronchial cleaiance of bacteria during periods of intoxification, 
decreased cell-mediated immunity as a result of IDU and repeated injections 
of unsterile drags with diity needles and syringes by people who aie often 
carriers of Staphylococcus aureus.
HIV cleaily has an additional effect. Selwyn's prospective study of 144 
HIV positive and 289 HIV negative IDUs emolled in a methadone 
maintenance programme estimated a cumulative yearly incidence of 
pneumococcal pneumonia of 35 per 1000 for séropositives and 3.5 per 1000 
for séronégatives compared with 2.6 per 1000 for the general US 
population.®^ Morbidity and mortality were both increased in the 
seropositive gi oup in which two patients died and average length of hospital 
stay was 10.4 days compaied with 6.1 days for the seronegatives. In another 
New York study of IDUs attending a MMP, the prevalence and incidence of 
tuberculous infection (as measured by positive PPD skin testing) were found 
to be similar for HIV positive and negative IDUs but the risk of active 
tuberculosis was increased only for the positive subjects.®® Likewise, 
endocarditis seems to have a greater than expected mortality in HIV positive 
IDUs, is associated with a greater diversity of organisms, prolonged duration 
of fever, more persistent bacteraemia and a higher rate of embolic
abscesses.^®'’®^'252
An increased risk of bacterial infections has been documented in patients 
fiom all risk groups. In 1984 Simberkoff reported a 26 fold increase in 
incidence of pneumococcal pneumonia in 35 hospitalised homosexual AIDS 
patients compared with other patients in the same hospital.253 A population 
based study fiom San Francisco, where most cases of HIV infection are in 
homosexual men, found a 100 fold increase in incidence of pneumococcal 
bacteraemia following the onset of the AIDS epidemic.254 Of 294 patients
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with pneumococcal bacteraemia in the age group 20 to 55, 75 (26%) were 
known to be HIV positive. In patients with pneumococcal bacteraemia and 
AIDS, 24 (75%) were bacteraemic dming the six months before or after the 
diagnosis of AIDS. Seven (22%) of these patients had concomitant PCP and 
réadmissions for pneumonia occun ed in 16% of HIV positive patients. In a 
similar study from the Bronx, New York (where there is a greater proportion 
of IDUs), pneumonia hospitalisations are thought to be a sentinel indicator 
for HIV infection.255 Indeed such is the association between invasive 
pneumococcal disease and HIV infection (tables 6.4, 6.5, 6 .6 ) that 
pneumococcal sui*veillance is now being used in some areas as a smxogate 
maiker to assess the size of the HIV infected population.^s^ The excess in 
pneumococcal infection is due to impahment of humoral immunity related to 
functional B cell defects. Although HIV positive patients characteristically 
mount a hypergammaglobulinaemia, low IgG2  levels have been found in 
patients with pyogenic infections.252.258 Antibody to polysaccharide (the 
major component of most bacterial cell walls) is predominantly of the IgG2  
subclass and appeal's to be essential for adequate opsonisation of 
encapsulated organisms. Another manifestation of B cell dysfunction is the 
poor response to pneumococcal vaccination in patients with AIDS who 
mount low post vaccination tihes and in whom clinical vaccine failure has 
been reported.253.259.260 But patients may mount a reasonable response to 
pneumococcal vaccine in the eai ly stages of HIV infection.259
In some series, including in this Edinburgh study, Haemophilus influemae 
chest infections are more prevalent than pneumococcal BCIs.® 2^6i Presenting 
symptoms of pneumonia aie usually similai* to those of the 
immunocompetent population but fever may be absent even in the presence 
of bacteraemia, the diagnosis may be confused with PCP or the two 
infections may occui* c o n c o m i t a n t l y . 2 ' > 2 - 2 6 4  Because of the considerable 
mortality and morbidity associated with recunent pneumonia this was 
included as an AIDS indicator diagnosis in the 1993 CDC AIDS
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d e f i n i t i o n . ®’®2.265 HIV infected patients also have an increased incidence of 
sinusitis, skin infections, gingivitis and periodontitis, pelvic inflammatoiy 
disease, prostatitis and urinaiy tiact in fections.252
Some bacterial infections aie associated with the T cell 
immunodeficiency. These include salmonella species. Cryptococcus 
neoformans. Listeria monocytogenes and Histoplasma capsulatumP' '^'^^ '^'^^  ^
Recmxent salmonella bacteraemia and ciyptococcal meningitis are AIDS 
defining c o n d i t i o n s . I n  a study fiom Nairobi, Kenya of 506 consecutive 
hospital admissions, 19% of whom were HIV positive. Salmonella 
typhimurium was the most common cause of bacteraemia.2^8 This contrasted 
with the HIV negative patients in whom S. typhi was a more common cause 
of bacteraemia. S. typhimurium isolates exceeded those of S. typhi in HIV 
positive patients by a factor of ten. Mortality was significantly higher in the 
HIV positive patients with salmonella bacteraemia, despite tieatment with 
appropriate intiavenous antibiotics.
Neuti'openic patients are at paiticular risk of nosocomial staphylococcal 
and pseudomonal infections and these have a high m o r t a l i t y .253.266.269 Patients 
with neuti’openias, central venous lines, nosocomial infections and infections 
associated with T cell deficiencies aie more likely to have advanced HIV 
disease and AIDS: these infections are unlikely to present within the eaily 
natural histoiy of HIV infection.259 it is the infections associated with 
functional B cell defects, predominantly bacterial chest infections and 
pneumonias, which may present eai ly in the course of the disease.
The importance of documenting admissions for bacterial infections lies 
not only in knowledge of the natural histoiy of HIV infection, nor simply in 
the plaiming of resources. It is because this knowledge can be used in 
clinical decision making. Patients with early stage disease are unlikely to be 
suffering from a classic oppoitunistic disease and therefore eaily diagnosis of 
a likely bacterial infection and tieatment with an appropriate antibiotic.
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usually as an outpatient, can be instituted. On review, fuither investigations 
and hospital admission need be considered only if the patient fails to respond 
to this initial treatment. And it leads on to the question of prophylaxis. 
Antibiotics can afford prophylaxis against bacterial infections and a decline 
in bacterial infections has been seen with the use of antibiotic prophylaxis 
for PCP when compaied with pentamidine. 220 Immunisation can be offered 
against Streptococcus pneumoniae and Haemophilus influenzae. Despite 
reports of clinical failure of pneumococcal vaccine,253 of poor B cell function 
and low antibody levels both pre and post vaccination,221-273 immunisation 
cleaily has a role to play. It is likely to have greatest efficacy when given to 
patients as eaily as possible in their HIV infection but even late stage 
patients can mount some response to some of the antigens.259.260.275 
Pneumococcal vaccine has now been recommended for all HIV positive 
patients by the UK Joint Committee on Vaccination and Immunisation.22^
In conclusion, this thesis has demonstrated the value of a study of hospital 
admissions in determining the morbidity associated with HIV infection. 
Data on admissions are available in the UK and can be collated to give a 
picture of a city wide HIV epidemic. That IDUs, a group usually described 
as chaotic and difficult to access, can be followed up and a picture drawn of 
the spectium of IDU associated HIV infection has been shown. The study of 
IDUs especially has highlighted the morbidity associated with bacterial 
infections and the morbidity and mortality associated with drag use 
combined with HIV infection. The most important results aie of high 
morbidity and mortality even within the eaily yeai's of an epidemic as 
demonstrated by many admissions in patients otheiivise classified as having 
"asymptomatic" HIV infection. These results are vital for allocating health 
care resources and for improving the remaining life of those infected with 
this lethal viras.
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Table 6.1
Reported studies of the average length of hospital admission in AIDS patients
Country 1983 1984 1985 1986 1987 1988 1989 1990
California
(Chen209)
17 11
San Francisco 
(Quesenbery2o®)
11.6
US
(Andmlis2°4)
17
US
(Andrulis24o)
17
Cleveland
(Sharp202)
16
Brooklyn
(Bennett2()5)
34
London
(Johnson^”)
17.5
Geneva
(Vanhems^’o)
22.5
Oxford
( 0 ’Brien245)
10 13 9 6 12
Table 6.2
Reported studies of the average length of hospital admission in HIV positive
patients without AH)S
Country 1983 1984 1985 1986 1987 1988 1989 1990
US
(Andrulis24o)
14
Dublin
(Murphy2'2)
8.5
13.5
Oxford
(0'Brien245)
17 10 8 9 12
Edinburgh 18 15 10 11
Table 6.3
Reasons for hospital admission in Diibliipi^ and Edinburgh HIV positive
patients
Dublin
1987-90
Edinburgh City
Hospital
1985-89
All Edinburgh
hospitals
1985-89
Number of admissions 408 612 910
CDC stage 2/3 145 (36%) 246 (40%)
CDC stage 4 263 (64%) 365 (60%)
BCI 84 (21%) 97 (16%) 100 (11%)
PCP 46 (11%) 48 (8%) 49 (5%)
Cellulitis/abscess 27 (7%) 29 (5%) 49 (5%)
Bacterial endocarditis 8 (2%) 6 (1%) 6 (<1%)
Overdose/withdrawal 8 (2%) 31 (5%) 131 (1%)
Anaemia 24 (7%) 39 (6%) 39 (4%)
Chronic hepatitis 17 (4%) 11 (2%) 11 (1%)
Oesophageal Candida 16 (4%) 6 (1%) 6 (<1%)
KS/lymphoma 19 (5%) 13 (1%)
Headaches 13 (3%) 8 (1%)
Tuberculosis 8 (2%) 2 (<1%) 2 (<1%)
Cerebral
toxoplasmosis
8 (2%) 18 (2%)
Urinary tract infection 5 (1%) 13 (1%)
CMV retinitis 4 (1%) 5 (<1%)
Seizures 4 (1%) 11 (2%) 17 (2%)
Table 6.4
Published studies on the incidence o f pneum ococcal bacteraem ia
Study
period
Reference Place Population Incidence
pneumococcal
bacteraemia
1/82-7/83 Selwyn®^ New York 35 AIDS patients
General medical 
patients
57/1000/year 
3.5/1000/year
1/83-8/85 Witt259 Boston 59 AIDS/ARC pts
Adult hospital 
patients
22.6/1000/year 
2.67/1000/year
11/83-11/87 Redd254 San
Francisco
San Francisco AIDS 
patients
3417 person years
9.4/1000/patient 
years
1986 Schuchat255 New Jersey New Jersey AIDS 
patients
age 25-44 only
"pre AIDS" patients
"pre AIDS" patients 
age 25-44 only
General population
General population 
age 25-44 only
11.2/1000/year
10.7/1000/year
4.5/1000/year
5.3/1000/year
0.176/1000/year 
0.03 3/1000/year
1986-7
1974-6
Breiman227 South
Carolina
All Charleston 
County residents 
(294,830)
0.187/1000/year
0.085/1000/year
1989 Winter228 Scotland All 5m residents 0.0622/1000/year
Table 6.5
Published studies on the incidence o f pneum ococcal pneum onia
Study period Reference Place Population Incidence
pneumococcal
pneumonia
10/85-10/86 Selwyn®^ New York MMP IDUs 
144 HIV+ve 
289 fflV-ve
35/1000/year 
3.5/1000/year
1/80-4/85 Polsky25J New York 336 AIDS 
patients
17.9/1000/51
months
1/83-8/85 Witt259 Boston 59 AIDS/ARC 
patients
45.5/1000/year
1/88-4/90 Garcia-Leoni229 Madrid HIV +ve
General
population
5.9/1000/?year
0.87/1000/?year
10/84-10/85 Woodhead2®o Nottingham General adult
population
(70,000)
1.2/1000/year
Table 6.6
Published studies on the incidence o f bacterial pneum onia
Study period Reference Place Population Incidence
bacterial
pneumonia
10/85-10/86 Selwyn®9 New York MMP IDUs 
144 HIV+ves 
289 HIV-ves
97/1000/year
21/1000/year
1/80-4/85 Polsky25' New York 336 AIDS pts 53.5/1000/51
months
11/85-11/89 Edinburgh 1000 HIV +ve 
IDUs
12/1000/year
1985-86 2000 IDUs pre
m v
1.4/1000/year
1985-86 Edinburgh 
population 
aged 15-44
0.6/1000/year
10/84-10/85 Woodhead2®° Nottingham General adult
population
(70,000)
4.7/1000/year
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ABBREVIATIONS 
HIV Human immunodeficiency vims
AIDS Acquired immunodeficiency syndrome
OI Oppoitunistic infection
PCP Pneumocystis carinii pneumonia
KS Kaposi’s sarcoma
CMV Cytomegalovims
TB Tuberculosis
CDC Centers for Disease Control
MMP Methadone maintenance programme
IDU Injection dmg use/user
BCI Bacterial chest infection
UTI Urinaiy tract infection
PID Pelvic inflammatoiy disease
GI Gastro-intestinal
GU Genito-urinaiy
Heterosexual HIV infected via heterosexual intercourse
Homosexual HIV infected via homosexual intercomse
CD4 count CD4 positive lymphocyte count
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